id	sid	tid	token	lemma	pos
cord-284008-vlwdtjbe	1	1	key	key	JJ
cord-284008-vlwdtjbe	1	2	:	:	:
cord-284008-vlwdtjbe	1	3	cord-284008-vlwdtjbe	cord-284008-vlwdtjbe	XX
cord-284008-vlwdtjbe	2	1	authors	author	NNS
cord-284008-vlwdtjbe	2	2	:	:	:
cord-284008-vlwdtjbe	2	3	Li	Li	NNP
cord-284008-vlwdtjbe	2	4	,	,	,
cord-284008-vlwdtjbe	2	5	Na	Na	NNP
cord-284008-vlwdtjbe	2	6	;	;	:
cord-284008-vlwdtjbe	2	7	Jie	Jie	NNP
cord-284008-vlwdtjbe	2	8	,	,	,
cord-284008-vlwdtjbe	2	9	Zhijun	Zhijun	NNP
cord-284008-vlwdtjbe	2	10	title	title	NN
cord-284008-vlwdtjbe	2	11	:	:	:
cord-284008-vlwdtjbe	3	1	The	the	DT
cord-284008-vlwdtjbe	3	2	Application	Application	NNP
cord-284008-vlwdtjbe	3	3	of	of	IN
cord-284008-vlwdtjbe	3	4	Corticosteroids	Corticosteroids	NNPS
cord-284008-vlwdtjbe	3	5	in	in	IN
cord-284008-vlwdtjbe	3	6	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	3	7	:	:	:
cord-284008-vlwdtjbe	3	8	A	a	DT
cord-284008-vlwdtjbe	3	9	Two	two	CD
cord-284008-vlwdtjbe	3	10	-	-	HYPH
cord-284008-vlwdtjbe	3	11	edged	edge	VBN
cord-284008-vlwdtjbe	3	12	Sword	Sword	NNP
cord-284008-vlwdtjbe	3	13	date	date	NN
cord-284008-vlwdtjbe	3	14	:	:	:
cord-284008-vlwdtjbe	3	15	2020	2020	CD
cord-284008-vlwdtjbe	3	16	-	-	HYPH
cord-284008-vlwdtjbe	3	17	06	06	CD
cord-284008-vlwdtjbe	3	18	-	-	SYM
cord-284008-vlwdtjbe	3	19	25	25	CD
cord-284008-vlwdtjbe	3	20	journal	journal	NN
cord-284008-vlwdtjbe	3	21	:	:	:
cord-284008-vlwdtjbe	3	22	J	J	NNP
cord-284008-vlwdtjbe	3	23	Transl	Transl	NNP
cord-284008-vlwdtjbe	3	24	Int	Int	NNP
cord-284008-vlwdtjbe	3	25	Med	Med	NNP
cord-284008-vlwdtjbe	3	26	DOI	doi	NN
cord-284008-vlwdtjbe	3	27	:	:	:
cord-284008-vlwdtjbe	3	28	10.2478	10.2478	CD
cord-284008-vlwdtjbe	3	29	/	/	SYM
cord-284008-vlwdtjbe	3	30	jtim-2020	jtim-2020	NN
cord-284008-vlwdtjbe	3	31	-	-	HYPH
cord-284008-vlwdtjbe	3	32	0011	0011	CD
cord-284008-vlwdtjbe	3	33	sha	sha	NNP
cord-284008-vlwdtjbe	3	34	:	:	:
cord-284008-vlwdtjbe	3	35	899c4e94b4b08a45f3a00a3743768baf8996ef79	899c4e94b4b08a45f3a00a3743768baf8996ef79	CD
cord-284008-vlwdtjbe	3	36	doc_id	doc_id	CD
cord-284008-vlwdtjbe	3	37	:	:	:
cord-284008-vlwdtjbe	3	38	284008	284008	CD
cord-284008-vlwdtjbe	3	39	cord_uid	cord_uid	NNS
cord-284008-vlwdtjbe	3	40	:	:	:
cord-284008-vlwdtjbe	3	41	vlwdtjbe	vlwdtjbe	NNP
cord-284008-vlwdtjbe	4	1	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	4	2	has	have	VBZ
cord-284008-vlwdtjbe	4	3	become	become	VBN
cord-284008-vlwdtjbe	4	4	a	a	DT
cord-284008-vlwdtjbe	4	5	global	global	JJ
cord-284008-vlwdtjbe	4	6	pandemic	pandemic	NN
cord-284008-vlwdtjbe	4	7	and	and	CC
cord-284008-vlwdtjbe	4	8	requires	require	VBZ
cord-284008-vlwdtjbe	4	9	the	the	DT
cord-284008-vlwdtjbe	4	10	whole	whole	JJ
cord-284008-vlwdtjbe	4	11	world	world	NN
cord-284008-vlwdtjbe	4	12	to	to	TO
cord-284008-vlwdtjbe	4	13	respond	respond	VB
cord-284008-vlwdtjbe	4	14	together	together	RB
cord-284008-vlwdtjbe	4	15	.	.	.
cord-284008-vlwdtjbe	5	1	There	there	EX
cord-284008-vlwdtjbe	5	2	is	be	VBZ
cord-284008-vlwdtjbe	5	3	no	no	DT
cord-284008-vlwdtjbe	5	4	specific	specific	JJ
cord-284008-vlwdtjbe	5	5	antiviral	antiviral	JJ
cord-284008-vlwdtjbe	5	6	treatment	treatment	NN
cord-284008-vlwdtjbe	5	7	recommended	recommend	VBN
cord-284008-vlwdtjbe	5	8	at	at	IN
cord-284008-vlwdtjbe	5	9	present	present	NN
cord-284008-vlwdtjbe	5	10	for	for	IN
cord-284008-vlwdtjbe	5	11	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	5	12	.	.	.
cord-284008-vlwdtjbe	6	1	The	the	DT
cord-284008-vlwdtjbe	6	2	patients	patient	NNS
cord-284008-vlwdtjbe	6	3	must	must	MD
cord-284008-vlwdtjbe	6	4	receive	receive	VB
cord-284008-vlwdtjbe	6	5	the	the	DT
cord-284008-vlwdtjbe	6	6	supportive	supportive	JJ
cord-284008-vlwdtjbe	6	7	care	care	NN
cord-284008-vlwdtjbe	6	8	to	to	TO
cord-284008-vlwdtjbe	6	9	help	help	VB
cord-284008-vlwdtjbe	6	10	relieve	relieve	VB
cord-284008-vlwdtjbe	6	11	the	the	DT
cord-284008-vlwdtjbe	6	12	symptoms	symptom	NNS
cord-284008-vlwdtjbe	6	13	and	and	CC
cord-284008-vlwdtjbe	6	14	ensure	ensure	VB
cord-284008-vlwdtjbe	6	15	appropriate	appropriate	JJ
cord-284008-vlwdtjbe	6	16	infection	infection	NN
cord-284008-vlwdtjbe	6	17	control	control	NN
cord-284008-vlwdtjbe	6	18	.	.	.
cord-284008-vlwdtjbe	7	1	Whether	whether	IN
cord-284008-vlwdtjbe	7	2	or	or	CC
cord-284008-vlwdtjbe	7	3	not	not	RB
cord-284008-vlwdtjbe	7	4	to	to	TO
cord-284008-vlwdtjbe	7	5	use	use	VB
cord-284008-vlwdtjbe	7	6	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	7	7	clinically	clinically	RB
cord-284008-vlwdtjbe	7	8	caused	cause	VBD
cord-284008-vlwdtjbe	7	9	controversy	controversy	NN
cord-284008-vlwdtjbe	7	10	.	.	.
cord-284008-vlwdtjbe	8	1	This	this	DT
cord-284008-vlwdtjbe	8	2	article	article	NN
cord-284008-vlwdtjbe	8	3	has	have	VBZ
cord-284008-vlwdtjbe	8	4	summarized	summarize	VBN
cord-284008-vlwdtjbe	8	5	previous	previous	JJ
cord-284008-vlwdtjbe	8	6	researches	research	NNS
cord-284008-vlwdtjbe	8	7	about	about	IN
cord-284008-vlwdtjbe	8	8	the	the	DT
cord-284008-vlwdtjbe	8	9	using	using	NN
cord-284008-vlwdtjbe	8	10	of	of	IN
cord-284008-vlwdtjbe	8	11	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	8	12	in	in	IN
cord-284008-vlwdtjbe	8	13	other	other	JJ
cord-284008-vlwdtjbe	8	14	viral	viral	JJ
cord-284008-vlwdtjbe	8	15	pneumonia	pneumonia	NN
cord-284008-vlwdtjbe	8	16	,	,	,
cord-284008-vlwdtjbe	8	17	related	relate	VBN
cord-284008-vlwdtjbe	8	18	clinical	clinical	JJ
cord-284008-vlwdtjbe	8	19	data	datum	NNS
cord-284008-vlwdtjbe	8	20	in	in	IN
cord-284008-vlwdtjbe	8	21	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	8	22	,	,	,
cord-284008-vlwdtjbe	8	23	and	and	CC
cord-284008-vlwdtjbe	8	24	recommendations	recommendation	NNS
cord-284008-vlwdtjbe	8	25	in	in	IN
cord-284008-vlwdtjbe	8	26	Chinese	chinese	JJ
cord-284008-vlwdtjbe	8	27	guideline	guideline	NN
cord-284008-vlwdtjbe	8	28	.	.	.
cord-284008-vlwdtjbe	9	1	Since	since	IN
cord-284008-vlwdtjbe	9	2	December	December	NNP
cord-284008-vlwdtjbe	9	3	2019	2019	CD
cord-284008-vlwdtjbe	9	4	,	,	,
cord-284008-vlwdtjbe	9	5	a	a	DT
cord-284008-vlwdtjbe	9	6	new	new	JJ
cord-284008-vlwdtjbe	9	7	strain	strain	NN
cord-284008-vlwdtjbe	9	8	of	of	IN
cord-284008-vlwdtjbe	9	9	the	the	DT
cord-284008-vlwdtjbe	9	10	coronavirus	coronavirus	NN
cord-284008-vlwdtjbe	9	11	called	call	VBN
cord-284008-vlwdtjbe	9	12	severe	severe	JJ
cord-284008-vlwdtjbe	9	13	acute	acute	JJ
cord-284008-vlwdtjbe	9	14	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	9	15	syndrome	syndrome	NN
cord-284008-vlwdtjbe	9	16	coronavirus	coronavirus	NN
cord-284008-vlwdtjbe	9	17	2	2	CD
cord-284008-vlwdtjbe	10	1	(	(	-LRB-
cord-284008-vlwdtjbe	10	2	SARS	SARS	NNP
cord-284008-vlwdtjbe	10	3	-	-	HYPH
cord-284008-vlwdtjbe	10	4	CoV-2	CoV-2	NNP
cord-284008-vlwdtjbe	10	5	)	)	-RRB-
cord-284008-vlwdtjbe	10	6	has	have	VBZ
cord-284008-vlwdtjbe	10	7	appeared	appear	VBN
cord-284008-vlwdtjbe	10	8	in	in	IN
cord-284008-vlwdtjbe	10	9	Wuhan	Wuhan	NNP
cord-284008-vlwdtjbe	10	10	,	,	,
cord-284008-vlwdtjbe	10	11	Hubei	Hubei	NNP
cord-284008-vlwdtjbe	10	12	Province	Province	NNP
cord-284008-vlwdtjbe	10	13	,	,	,
cord-284008-vlwdtjbe	10	14	China	China	NNP
cord-284008-vlwdtjbe	10	15	.	.	.
cord-284008-vlwdtjbe	11	1	The	the	DT
cord-284008-vlwdtjbe	11	2	disease	disease	NN
cord-284008-vlwdtjbe	11	3	caused	cause	VBN
cord-284008-vlwdtjbe	11	4	by	by	IN
cord-284008-vlwdtjbe	11	5	SARS	SARS	NNP
cord-284008-vlwdtjbe	11	6	-	-	HYPH
cord-284008-vlwdtjbe	11	7	CoV-2	CoV-2	NNP
cord-284008-vlwdtjbe	11	8	was	be	VBD
cord-284008-vlwdtjbe	11	9	officially	officially	RB
cord-284008-vlwdtjbe	11	10	named	name	VBN
cord-284008-vlwdtjbe	11	11	"	"	``
cord-284008-vlwdtjbe	11	12	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	11	13	"	"	''
cord-284008-vlwdtjbe	11	14	by	by	IN
cord-284008-vlwdtjbe	11	15	the	the	DT
cord-284008-vlwdtjbe	11	16	World	World	NNP
cord-284008-vlwdtjbe	11	17	Health	Health	NNP
cord-284008-vlwdtjbe	11	18	Organization	Organization	NNP
cord-284008-vlwdtjbe	11	19	on	on	IN
cord-284008-vlwdtjbe	11	20	February	February	NNP
cord-284008-vlwdtjbe	11	21	11	11	CD
cord-284008-vlwdtjbe	11	22	,	,	,
cord-284008-vlwdtjbe	11	23	2020	2020	CD
cord-284008-vlwdtjbe	11	24	.	.	.
cord-284008-vlwdtjbe	12	1	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	12	2	has	have	VBZ
cord-284008-vlwdtjbe	12	3	become	become	VBN
cord-284008-vlwdtjbe	12	4	a	a	DT
cord-284008-vlwdtjbe	12	5	pandemic	pandemic	NN
cord-284008-vlwdtjbe	12	6	,	,	,
cord-284008-vlwdtjbe	12	7	which	which	WDT
cord-284008-vlwdtjbe	12	8	spread	spread	VBD
cord-284008-vlwdtjbe	12	9	across	across	IN
cord-284008-vlwdtjbe	12	10	the	the	DT
cord-284008-vlwdtjbe	12	11	world	world	NN
cord-284008-vlwdtjbe	12	12	including	include	VBG
cord-284008-vlwdtjbe	12	13	more	more	JJR
cord-284008-vlwdtjbe	12	14	than	than	IN
cord-284008-vlwdtjbe	12	15	211	211	CD
cord-284008-vlwdtjbe	12	16	countries	country	NNS
cord-284008-vlwdtjbe	12	17	or	or	CC
cord-284008-vlwdtjbe	12	18	regions	region	NNS
cord-284008-vlwdtjbe	12	19	and	and	CC
cord-284008-vlwdtjbe	12	20	infected	infect	VBD
cord-284008-vlwdtjbe	12	21	1,914,916	1,914,916	CD
cord-284008-vlwdtjbe	12	22	patients	patient	NNS
cord-284008-vlwdtjbe	12	23	globally	globally	RB
cord-284008-vlwdtjbe	12	24	(	(	-LRB-
cord-284008-vlwdtjbe	12	25	83,747	83,747	CD
cord-284008-vlwdtjbe	12	26	in	in	IN
cord-284008-vlwdtjbe	12	27	China	China	NNP
cord-284008-vlwdtjbe	12	28	)	)	-RRB-
cord-284008-vlwdtjbe	12	29	by	by	IN
cord-284008-vlwdtjbe	12	30	April	April	NNP
cord-284008-vlwdtjbe	12	31	15	15	CD
cord-284008-vlwdtjbe	12	32	,	,	,
cord-284008-vlwdtjbe	12	33	2020	2020	CD
cord-284008-vlwdtjbe	12	34	.	.	.
cord-284008-vlwdtjbe	13	1	[	[	-LRB-
cord-284008-vlwdtjbe	13	2	1	1	CD
cord-284008-vlwdtjbe	13	3	]	]	-RRB-
cord-284008-vlwdtjbe	13	4	SARS	SARS	NNP
cord-284008-vlwdtjbe	13	5	-	-	HYPH
cord-284008-vlwdtjbe	13	6	CoV-2	CoV-2	NNP
cord-284008-vlwdtjbe	13	7	,	,	,
cord-284008-vlwdtjbe	13	8	which	which	WDT
cord-284008-vlwdtjbe	13	9	has	have	VBZ
cord-284008-vlwdtjbe	13	10	a	a	DT
cord-284008-vlwdtjbe	13	11	typical	typical	JJ
cord-284008-vlwdtjbe	13	12	genome	genome	NN
cord-284008-vlwdtjbe	13	13	structure	structure	NN
cord-284008-vlwdtjbe	13	14	of	of	IN
cord-284008-vlwdtjbe	13	15	CoV	cov	NN
cord-284008-vlwdtjbe	13	16	,	,	,
cord-284008-vlwdtjbe	13	17	belongs	belong	VBZ
cord-284008-vlwdtjbe	13	18	to	to	IN
cord-284008-vlwdtjbe	13	19	the	the	DT
cord-284008-vlwdtjbe	13	20	cluster	cluster	NN
cord-284008-vlwdtjbe	13	21	of	of	IN
cord-284008-vlwdtjbe	13	22	betacoronaviruses	betacoronaviruse	NNS
cord-284008-vlwdtjbe	13	23	;	;	:
cord-284008-vlwdtjbe	13	24	this	this	DT
cord-284008-vlwdtjbe	13	25	new	new	JJ
cord-284008-vlwdtjbe	13	26	virus	virus	NN
cord-284008-vlwdtjbe	13	27	and	and	CC
cord-284008-vlwdtjbe	13	28	SARS	SARS	NNP
cord-284008-vlwdtjbe	13	29	-	-	HYPH
cord-284008-vlwdtjbe	13	30	CoV	CoV	NNP
cord-284008-vlwdtjbe	13	31	have	have	VBP
cord-284008-vlwdtjbe	13	32	approximate	approximate	JJ
cord-284008-vlwdtjbe	13	33	70	70	CD
cord-284008-vlwdtjbe	13	34	%	%	NN
cord-284008-vlwdtjbe	13	35	similarity	similarity	NN
cord-284008-vlwdtjbe	13	36	in	in	IN
cord-284008-vlwdtjbe	13	37	gene	gene	NN
cord-284008-vlwdtjbe	13	38	sequence	sequence	NN
cord-284008-vlwdtjbe	13	39	.	.	.
cord-284008-vlwdtjbe	14	1	[	[	-LRB-
cord-284008-vlwdtjbe	14	2	2	2	CD
cord-284008-vlwdtjbe	14	3	,	,	,
cord-284008-vlwdtjbe	14	4	3	3	CD
cord-284008-vlwdtjbe	14	5	]	]	-RRB-
cord-284008-vlwdtjbe	14	6	There	there	EX
cord-284008-vlwdtjbe	14	7	are	be	VBP
cord-284008-vlwdtjbe	14	8	some	some	DT
cord-284008-vlwdtjbe	14	9	differences	difference	NNS
cord-284008-vlwdtjbe	14	10	in	in	IN
cord-284008-vlwdtjbe	14	11	lethality	lethality	NN
cord-284008-vlwdtjbe	14	12	and	and	CC
cord-284008-vlwdtjbe	14	13	infectivity	infectivity	NN
cord-284008-vlwdtjbe	14	14	between	between	IN
cord-284008-vlwdtjbe	14	15	SARS	SARS	NNP
cord-284008-vlwdtjbe	14	16	-	-	HYPH
cord-284008-vlwdtjbe	14	17	CoV-2	CoV-2	NNP
cord-284008-vlwdtjbe	14	18	and	and	CC
cord-284008-vlwdtjbe	14	19	other	other	JJ
cord-284008-vlwdtjbe	14	20	coronaviruses	coronaviruse	NNS
cord-284008-vlwdtjbe	14	21	.	.	.
cord-284008-vlwdtjbe	15	1	Early	early	JJ
cord-284008-vlwdtjbe	15	2	data	datum	NNS
cord-284008-vlwdtjbe	15	3	showed	show	VBD
cord-284008-vlwdtjbe	15	4	that	that	IN
cord-284008-vlwdtjbe	15	5	compared	compare	VBN
cord-284008-vlwdtjbe	15	6	with	with	IN
cord-284008-vlwdtjbe	15	7	SARS	SARS	NNP
cord-284008-vlwdtjbe	15	8	-	-	HYPH
cord-284008-vlwdtjbe	15	9	CoV	CoV	NNP
cord-284008-vlwdtjbe	15	10	and	and	CC
cord-284008-vlwdtjbe	15	11	Middle	Middle	NNP
cord-284008-vlwdtjbe	15	12	East	East	NNP
cord-284008-vlwdtjbe	15	13	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	15	14	syndrome	syndrome	NN
cord-284008-vlwdtjbe	15	15	coronavirus	coronavirus	NN
cord-284008-vlwdtjbe	15	16	(	(	-LRB-
cord-284008-vlwdtjbe	15	17	MERS	MERS	NNP
cord-284008-vlwdtjbe	15	18	-	-	HYPH
cord-284008-vlwdtjbe	15	19	CoV	CoV	NNP
cord-284008-vlwdtjbe	15	20	)	)	-RRB-
cord-284008-vlwdtjbe	15	21	,	,	,
cord-284008-vlwdtjbe	15	22	which	which	WDT
cord-284008-vlwdtjbe	15	23	also	also	RB
cord-284008-vlwdtjbe	15	24	caused	cause	VBD
cord-284008-vlwdtjbe	15	25	severe	severe	JJ
cord-284008-vlwdtjbe	15	26	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	15	27	syndrome	syndrome	NN
cord-284008-vlwdtjbe	15	28	in	in	IN
cord-284008-vlwdtjbe	15	29	humans	human	NNS
cord-284008-vlwdtjbe	15	30	,	,	,
cord-284008-vlwdtjbe	16	1	the	the	DT
cord-284008-vlwdtjbe	16	2	mortality	mortality	NN
cord-284008-vlwdtjbe	16	3	of	of	IN
cord-284008-vlwdtjbe	16	4	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	16	5	was	be	VBD
cord-284008-vlwdtjbe	16	6	lower	low	JJR
cord-284008-vlwdtjbe	16	7	but	but	CC
cord-284008-vlwdtjbe	16	8	the	the	DT
cord-284008-vlwdtjbe	16	9	contagion	contagion	NN
cord-284008-vlwdtjbe	16	10	was	be	VBD
cord-284008-vlwdtjbe	16	11	very	very	RB
cord-284008-vlwdtjbe	16	12	higher	high	JJR
cord-284008-vlwdtjbe	16	13	.	.	.
cord-284008-vlwdtjbe	17	1	[	[	-LRB-
cord-284008-vlwdtjbe	17	2	4	4	CD
cord-284008-vlwdtjbe	17	3	]	]	-RRB-
cord-284008-vlwdtjbe	17	4	[	[	-LRB-
cord-284008-vlwdtjbe	17	5	5	5	CD
cord-284008-vlwdtjbe	17	6	]	]	-RRB-
cord-284008-vlwdtjbe	17	7	[	[	-LRB-
cord-284008-vlwdtjbe	17	8	6	6	CD
cord-284008-vlwdtjbe	17	9	]	]	-RRB-
cord-284008-vlwdtjbe	18	1	In	in	IN
cord-284008-vlwdtjbe	18	2	early	early	JJ
cord-284008-vlwdtjbe	18	3	stage	stage	NN
cord-284008-vlwdtjbe	18	4	of	of	IN
cord-284008-vlwdtjbe	18	5	the	the	DT
cord-284008-vlwdtjbe	18	6	outbreak	outbreak	NN
cord-284008-vlwdtjbe	18	7	of	of	IN
cord-284008-vlwdtjbe	18	8	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	18	9	,	,	,
cord-284008-vlwdtjbe	18	10	China	China	NNP
cord-284008-vlwdtjbe	18	11	has	have	VBZ
cord-284008-vlwdtjbe	18	12	adopted	adopt	VBN
cord-284008-vlwdtjbe	18	13	a	a	DT
cord-284008-vlwdtjbe	18	14	series	series	NN
cord-284008-vlwdtjbe	18	15	of	of	IN
cord-284008-vlwdtjbe	18	16	measures	measure	NNS
cord-284008-vlwdtjbe	18	17	to	to	TO
cord-284008-vlwdtjbe	18	18	block	block	VB
cord-284008-vlwdtjbe	18	19	the	the	DT
cord-284008-vlwdtjbe	18	20	explosive	explosive	JJ
cord-284008-vlwdtjbe	18	21	spread	spread	NN
cord-284008-vlwdtjbe	18	22	of	of	IN
cord-284008-vlwdtjbe	18	23	this	this	DT
cord-284008-vlwdtjbe	18	24	virus	virus	NN
cord-284008-vlwdtjbe	18	25	.	.	.
cord-284008-vlwdtjbe	19	1	Although	although	IN
cord-284008-vlwdtjbe	19	2	some	some	DT
cord-284008-vlwdtjbe	19	3	antiviral	antiviral	JJ
cord-284008-vlwdtjbe	19	4	drugs	drug	NNS
cord-284008-vlwdtjbe	19	5	,	,	,
cord-284008-vlwdtjbe	19	6	convalescent	convalescent	JJ
cord-284008-vlwdtjbe	19	7	plasma	plasma	NN
cord-284008-vlwdtjbe	19	8	transfusion	transfusion	NN
cord-284008-vlwdtjbe	19	9	,	,	,
cord-284008-vlwdtjbe	19	10	and	and	CC
cord-284008-vlwdtjbe	19	11	chloroquine	chloroquine	NN
cord-284008-vlwdtjbe	19	12	phosphate	phosphate	NN
cord-284008-vlwdtjbe	19	13	have	have	VBP
cord-284008-vlwdtjbe	19	14	been	be	VBN
cord-284008-vlwdtjbe	19	15	proven	prove	VBN
cord-284008-vlwdtjbe	19	16	to	to	TO
cord-284008-vlwdtjbe	19	17	have	have	VB
cord-284008-vlwdtjbe	19	18	partial	partial	JJ
cord-284008-vlwdtjbe	19	19	efficacy	efficacy	NN
cord-284008-vlwdtjbe	19	20	in	in	IN
cord-284008-vlwdtjbe	19	21	the	the	DT
cord-284008-vlwdtjbe	19	22	treatment	treatment	NN
cord-284008-vlwdtjbe	19	23	of	of	IN
cord-284008-vlwdtjbe	19	24	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	19	25	,	,	,
cord-284008-vlwdtjbe	19	26	there	there	EX
cord-284008-vlwdtjbe	19	27	is	be	VBZ
cord-284008-vlwdtjbe	19	28	still	still	RB
cord-284008-vlwdtjbe	19	29	no	no	DT
cord-284008-vlwdtjbe	19	30	specific	specific	JJ
cord-284008-vlwdtjbe	19	31	antiviral	antiviral	JJ
cord-284008-vlwdtjbe	19	32	treatment	treatment	NN
cord-284008-vlwdtjbe	19	33	recommended	recommend	VBN
cord-284008-vlwdtjbe	19	34	at	at	IN
cord-284008-vlwdtjbe	19	35	present	present	NN
cord-284008-vlwdtjbe	19	36	for	for	IN
cord-284008-vlwdtjbe	19	37	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	19	38	.	.	.
cord-284008-vlwdtjbe	20	1	Whether	whether	IN
cord-284008-vlwdtjbe	20	2	or	or	CC
cord-284008-vlwdtjbe	20	3	not	not	RB
cord-284008-vlwdtjbe	20	4	to	to	TO
cord-284008-vlwdtjbe	20	5	use	use	VB
cord-284008-vlwdtjbe	20	6	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	20	7	clinically	clinically	RB
cord-284008-vlwdtjbe	20	8	caused	cause	VBD
cord-284008-vlwdtjbe	20	9	controversy	controversy	NN
cord-284008-vlwdtjbe	20	10	.	.	.
cord-284008-vlwdtjbe	21	1	This	this	DT
cord-284008-vlwdtjbe	21	2	article	article	NN
cord-284008-vlwdtjbe	21	3	has	have	VBZ
cord-284008-vlwdtjbe	21	4	summarized	summarize	VBN
cord-284008-vlwdtjbe	21	5	previous	previous	JJ
cord-284008-vlwdtjbe	21	6	researches	research	NNS
cord-284008-vlwdtjbe	21	7	about	about	IN
cord-284008-vlwdtjbe	21	8	the	the	DT
cord-284008-vlwdtjbe	21	9	using	using	NN
cord-284008-vlwdtjbe	21	10	of	of	IN
cord-284008-vlwdtjbe	21	11	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	21	12	in	in	IN
cord-284008-vlwdtjbe	21	13	other	other	JJ
cord-284008-vlwdtjbe	21	14	viral	viral	JJ
cord-284008-vlwdtjbe	21	15	pneumonia	pneumonia	NN
cord-284008-vlwdtjbe	21	16	,	,	,
cord-284008-vlwdtjbe	21	17	related	relate	VBN
cord-284008-vlwdtjbe	21	18	clinical	clinical	JJ
cord-284008-vlwdtjbe	21	19	data	datum	NNS
cord-284008-vlwdtjbe	21	20	in	in	IN
cord-284008-vlwdtjbe	21	21	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	21	22	,	,	,
cord-284008-vlwdtjbe	21	23	and	and	CC
cord-284008-vlwdtjbe	21	24	recommendations	recommendation	NNS
cord-284008-vlwdtjbe	21	25	in	in	IN
cord-284008-vlwdtjbe	21	26	Chinese	chinese	JJ
cord-284008-vlwdtjbe	21	27	guideline	guideline	NN
cord-284008-vlwdtjbe	21	28	.	.	.
cord-284008-vlwdtjbe	22	1	The	the	DT
cord-284008-vlwdtjbe	22	2	cytokine	cytokine	NN
cord-284008-vlwdtjbe	22	3	storm	storm	NN
cord-284008-vlwdtjbe	22	4	is	be	VBZ
cord-284008-vlwdtjbe	22	5	an	an	DT
cord-284008-vlwdtjbe	22	6	important	important	JJ
cord-284008-vlwdtjbe	22	7	cause	cause	NN
cord-284008-vlwdtjbe	22	8	of	of	IN
cord-284008-vlwdtjbe	22	9	acute	acute	JJ
cord-284008-vlwdtjbe	22	10	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	22	11	distress	distress	NN
cord-284008-vlwdtjbe	22	12	and	and	CC
cord-284008-vlwdtjbe	22	13	multiple	multiple	JJ
cord-284008-vlwdtjbe	22	14	organ	organ	NN
cord-284008-vlwdtjbe	22	15	failure	failure	NN
cord-284008-vlwdtjbe	22	16	,	,	,
cord-284008-vlwdtjbe	22	17	which	which	WDT
cord-284008-vlwdtjbe	22	18	seriously	seriously	RB
cord-284008-vlwdtjbe	22	19	threatens	threaten	VBZ
cord-284008-vlwdtjbe	22	20	patients	patient	NNS
cord-284008-vlwdtjbe	22	21	'	'	POS
cord-284008-vlwdtjbe	22	22	life	life	NN
cord-284008-vlwdtjbe	22	23	.	.	.
cord-284008-vlwdtjbe	23	1	Zhou	Zhou	NNP
cord-284008-vlwdtjbe	23	2	et	et	NNP
cord-284008-vlwdtjbe	23	3	al	al	NNP
cord-284008-vlwdtjbe	23	4	.	.	.
cord-284008-vlwdtjbe	24	1	[	[	-LRB-
cord-284008-vlwdtjbe	24	2	7	7	CD
cord-284008-vlwdtjbe	24	3	]	]	-RRB-
cord-284008-vlwdtjbe	24	4	first	first	RB
cord-284008-vlwdtjbe	24	5	described	describe	VBD
cord-284008-vlwdtjbe	24	6	the	the	DT
cord-284008-vlwdtjbe	24	7	risk	risk	NN
cord-284008-vlwdtjbe	24	8	factors	factor	NNS
cord-284008-vlwdtjbe	24	9	for	for	IN
cord-284008-vlwdtjbe	24	10	the	the	DT
cord-284008-vlwdtjbe	24	11	mortality	mortality	NN
cord-284008-vlwdtjbe	24	12	of	of	IN
cord-284008-vlwdtjbe	24	13	53	53	CD
cord-284008-vlwdtjbe	24	14	nonsurvivors	nonsurvivor	NNS
cord-284008-vlwdtjbe	24	15	and	and	CC
cord-284008-vlwdtjbe	24	16	118	118	CD
cord-284008-vlwdtjbe	24	17	survivors	survivor	NNS
cord-284008-vlwdtjbe	24	18	with	with	IN
cord-284008-vlwdtjbe	24	19	COVID-19	covid-19	CD
cord-284008-vlwdtjbe	24	20	in	in	IN
cord-284008-vlwdtjbe	24	21	a	a	DT
cord-284008-vlwdtjbe	24	22	retrospective	retrospective	JJ
cord-284008-vlwdtjbe	24	23	,	,	,
cord-284008-vlwdtjbe	24	24	multicenter	multicenter	JJ
cord-284008-vlwdtjbe	24	25	,	,	,
cord-284008-vlwdtjbe	24	26	cohort	cohort	NN
cord-284008-vlwdtjbe	24	27	study	study	NN
cord-284008-vlwdtjbe	24	28	.	.	.
cord-284008-vlwdtjbe	25	1	The	the	DT
cord-284008-vlwdtjbe	25	2	result	result	NN
cord-284008-vlwdtjbe	25	3	showed	show	VBD
cord-284008-vlwdtjbe	25	4	that	that	IN
cord-284008-vlwdtjbe	25	5	higher	high	JJR
cord-284008-vlwdtjbe	25	6	Sequential	Sequential	NNP
cord-284008-vlwdtjbe	25	7	Organ	Organ	NNP
cord-284008-vlwdtjbe	25	8	Failure	Failure	NNP
cord-284008-vlwdtjbe	25	9	Assessment	Assessment	NNP
cord-284008-vlwdtjbe	25	10	(	(	-LRB-
cord-284008-vlwdtjbe	25	11	SOFA	SOFA	NNP
cord-284008-vlwdtjbe	25	12	)	)	-RRB-
cord-284008-vlwdtjbe	25	13	score	score	NN
cord-284008-vlwdtjbe	25	14	(	(	-LRB-
cord-284008-vlwdtjbe	25	15	5.65	5.65	CD
cord-284008-vlwdtjbe	25	16	,	,	,
cord-284008-vlwdtjbe	25	17	2.61	2.61	CD
cord-284008-vlwdtjbe	25	18	-	-	SYM
cord-284008-vlwdtjbe	25	19	12.23	12.23	CD
cord-284008-vlwdtjbe	25	20	;	;	:
cord-284008-vlwdtjbe	25	21	P<0.0001	p<0.0001	LS
cord-284008-vlwdtjbe	25	22	)	)	-RRB-
cord-284008-vlwdtjbe	25	23	was	be	VBD
cord-284008-vlwdtjbe	25	24	associated	associate	VBN
cord-284008-vlwdtjbe	25	25	with	with	IN
cord-284008-vlwdtjbe	25	26	increased	increase	VBN
cord-284008-vlwdtjbe	25	27	odds	odd	NNS
cord-284008-vlwdtjbe	25	28	of	of	IN
cord-284008-vlwdtjbe	25	29	death	death	NN
cord-284008-vlwdtjbe	25	30	.	.	.
cord-284008-vlwdtjbe	26	1	Sepsis	sepsis	NN
cord-284008-vlwdtjbe	26	2	was	be	VBD
cord-284008-vlwdtjbe	26	3	the	the	DT
cord-284008-vlwdtjbe	26	4	most	most	RBS
cord-284008-vlwdtjbe	26	5	common	common	JJ
cord-284008-vlwdtjbe	26	6	complication	complication	NN
cord-284008-vlwdtjbe	26	7	in	in	IN
cord-284008-vlwdtjbe	26	8	all	all	DT
cord-284008-vlwdtjbe	26	9	patients	patient	NNS
cord-284008-vlwdtjbe	26	10	,	,	,
cord-284008-vlwdtjbe	26	11	followed	follow	VBN
cord-284008-vlwdtjbe	26	12	by	by	IN
cord-284008-vlwdtjbe	26	13	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	26	14	failure	failure	NN
cord-284008-vlwdtjbe	26	15	,	,	,
cord-284008-vlwdtjbe	26	16	acute	acute	JJ
cord-284008-vlwdtjbe	26	17	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	26	18	distress	distress	NN
cord-284008-vlwdtjbe	26	19	syndrome	syndrome	NN
cord-284008-vlwdtjbe	26	20	(	(	-LRB-
cord-284008-vlwdtjbe	26	21	ARDS	ARDS	NNP
cord-284008-vlwdtjbe	26	22	)	)	-RRB-
cord-284008-vlwdtjbe	26	23	,	,	,
cord-284008-vlwdtjbe	26	24	or	or	CC
cord-284008-vlwdtjbe	26	25	heart	heart	NN
cord-284008-vlwdtjbe	26	26	failure	failure	NN
cord-284008-vlwdtjbe	26	27	.	.	.
cord-284008-vlwdtjbe	27	1	The	the	DT
cord-284008-vlwdtjbe	27	2	frequency	frequency	NN
cord-284008-vlwdtjbe	27	3	of	of	IN
cord-284008-vlwdtjbe	27	4	these	these	DT
cord-284008-vlwdtjbe	27	5	complications	complication	NNS
cord-284008-vlwdtjbe	27	6	and	and	CC
cord-284008-vlwdtjbe	27	7	levels	level	NNS
cord-284008-vlwdtjbe	27	8	of	of	IN
cord-284008-vlwdtjbe	27	9	IL-6	IL-6	NNP
cord-284008-vlwdtjbe	27	10	were	be	VBD
cord-284008-vlwdtjbe	27	11	all	all	RB
cord-284008-vlwdtjbe	27	12	higher	high	JJR
cord-284008-vlwdtjbe	27	13	in	in	IN
cord-284008-vlwdtjbe	27	14	nonsurvivors	nonsurvivor	NNS
cord-284008-vlwdtjbe	27	15	compared	compare	VBN
cord-284008-vlwdtjbe	27	16	with	with	IN
cord-284008-vlwdtjbe	27	17	survivors	survivor	NNS
cord-284008-vlwdtjbe	27	18	.	.	.
cord-284008-vlwdtjbe	28	1	These	these	DT
cord-284008-vlwdtjbe	28	2	severe	severe	JJ
cord-284008-vlwdtjbe	28	3	symptoms	symptom	NNS
cord-284008-vlwdtjbe	28	4	explained	explain	VBD
cord-284008-vlwdtjbe	28	5	the	the	DT
cord-284008-vlwdtjbe	28	6	difficulty	difficulty	NN
cord-284008-vlwdtjbe	28	7	in	in	IN
cord-284008-vlwdtjbe	28	8	treatment	treatment	NN
cord-284008-vlwdtjbe	28	9	and	and	CC
cord-284008-vlwdtjbe	28	10	led	lead	VBD
cord-284008-vlwdtjbe	28	11	us	-PRON-	PRP
cord-284008-vlwdtjbe	28	12	to	to	TO
cord-284008-vlwdtjbe	28	13	wonder	wonder	VB
cord-284008-vlwdtjbe	28	14	what	what	WDT
cord-284008-vlwdtjbe	28	15	role	role	NN
cord-284008-vlwdtjbe	28	16	the	the	DT
cord-284008-vlwdtjbe	28	17	cytokine	cytokine	NN
cord-284008-vlwdtjbe	28	18	storm	storm	NN
cord-284008-vlwdtjbe	28	19	has	have	VBZ
cord-284008-vlwdtjbe	28	20	played	play	VBN
cord-284008-vlwdtjbe	28	21	in	in	IN
cord-284008-vlwdtjbe	28	22	patients	patient	NNS
cord-284008-vlwdtjbe	28	23	with	with	IN
cord-284008-vlwdtjbe	28	24	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	28	25	.	.	.
cord-284008-vlwdtjbe	29	1	Qin	Qin	NNP
cord-284008-vlwdtjbe	29	2	et	et	NNP
cord-284008-vlwdtjbe	29	3	al	al	NNP
cord-284008-vlwdtjbe	29	4	.	.	.
cord-284008-vlwdtjbe	30	1	[	[	-LRB-
cord-284008-vlwdtjbe	30	2	8	8	CD
cord-284008-vlwdtjbe	30	3	]	]	-RRB-
cord-284008-vlwdtjbe	30	4	analyzed	analyze	VBD
cord-284008-vlwdtjbe	30	5	the	the	DT
cord-284008-vlwdtjbe	30	6	clinical	clinical	JJ
cord-284008-vlwdtjbe	30	7	data	datum	NNS
cord-284008-vlwdtjbe	30	8	of	of	IN
cord-284008-vlwdtjbe	30	9	452	452	CD
cord-284008-vlwdtjbe	30	10	patients	patient	NNS
cord-284008-vlwdtjbe	30	11	with	with	IN
cord-284008-vlwdtjbe	30	12	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	30	13	in	in	IN
cord-284008-vlwdtjbe	30	14	a	a	DT
cord-284008-vlwdtjbe	30	15	retrospective	retrospective	JJ
cord-284008-vlwdtjbe	30	16	single	single	JJ
cord-284008-vlwdtjbe	30	17	-	-	HYPH
cord-284008-vlwdtjbe	30	18	center	center	NN
cord-284008-vlwdtjbe	30	19	study	study	NN
cord-284008-vlwdtjbe	30	20	and	and	CC
cord-284008-vlwdtjbe	30	21	found	find	VBD
cord-284008-vlwdtjbe	30	22	most	most	JJS
cord-284008-vlwdtjbe	30	23	of	of	IN
cord-284008-vlwdtjbe	30	24	them	-PRON-	PRP
cord-284008-vlwdtjbe	30	25	tended	tend	VBD
cord-284008-vlwdtjbe	30	26	to	to	TO
cord-284008-vlwdtjbe	30	27	have	have	VB
cord-284008-vlwdtjbe	30	28	elevated	elevate	VBN
cord-284008-vlwdtjbe	30	29	inflammatory	inflammatory	JJ
cord-284008-vlwdtjbe	30	30	cytokines	cytokine	NNS
cord-284008-vlwdtjbe	30	31	.	.	.
cord-284008-vlwdtjbe	31	1	Plasma	plasma	NN
cord-284008-vlwdtjbe	31	2	levels	level	NNS
cord-284008-vlwdtjbe	31	3	of	of	IN
cord-284008-vlwdtjbe	31	4	IL-6	IL-6	NNP
cord-284008-vlwdtjbe	31	5	,	,	,
cord-284008-vlwdtjbe	31	6	IL-8	IL-8	NNP
cord-284008-vlwdtjbe	31	7	,	,	,
cord-284008-vlwdtjbe	31	8	IL-10	IL-10	NNP
cord-284008-vlwdtjbe	31	9	,	,	,
cord-284008-vlwdtjbe	31	10	and	and	CC
cord-284008-vlwdtjbe	31	11	TNF	TNF	NNP
cord-284008-vlwdtjbe	31	12	-	-	HYPH
cord-284008-vlwdtjbe	31	13	α	α	NN
cord-284008-vlwdtjbe	31	14	in	in	IN
cord-284008-vlwdtjbe	31	15	patients	patient	NNS
cord-284008-vlwdtjbe	31	16	with	with	IN
cord-284008-vlwdtjbe	31	17	severe	severe	JJ
cord-284008-vlwdtjbe	31	18	infection	infection	NN
cord-284008-vlwdtjbe	31	19	were	be	VBD
cord-284008-vlwdtjbe	31	20	significantly	significantly	RB
cord-284008-vlwdtjbe	31	21	higher	high	JJR
cord-284008-vlwdtjbe	31	22	than	than	IN
cord-284008-vlwdtjbe	31	23	those	those	DT
cord-284008-vlwdtjbe	31	24	in	in	IN
cord-284008-vlwdtjbe	31	25	patients	patient	NNS
cord-284008-vlwdtjbe	31	26	with	with	IN
cord-284008-vlwdtjbe	31	27	nonsevere	nonsevere	JJ
cord-284008-vlwdtjbe	31	28	infection	infection	NN
cord-284008-vlwdtjbe	31	29	,	,	,
cord-284008-vlwdtjbe	31	30	similar	similar	JJ
cord-284008-vlwdtjbe	31	31	to	to	IN
cord-284008-vlwdtjbe	31	32	the	the	DT
cord-284008-vlwdtjbe	31	33	results	result	NNS
cord-284008-vlwdtjbe	31	34	in	in	IN
cord-284008-vlwdtjbe	31	35	SARS	SARS	NNP
cord-284008-vlwdtjbe	31	36	and	and	CC
cord-284008-vlwdtjbe	31	37	MERS	MERS	NNP
cord-284008-vlwdtjbe	31	38	.	.	.
cord-284008-vlwdtjbe	32	1	[	[	-LRB-
cord-284008-vlwdtjbe	32	2	9	9	CD
cord-284008-vlwdtjbe	32	3	,	,	,
cord-284008-vlwdtjbe	32	4	10	10	CD
cord-284008-vlwdtjbe	32	5	]	]	-RRB-
cord-284008-vlwdtjbe	33	1	In	in	IN
cord-284008-vlwdtjbe	33	2	a	a	DT
cord-284008-vlwdtjbe	33	3	report	report	NN
cord-284008-vlwdtjbe	33	4	,	,	,
cord-284008-vlwdtjbe	33	5	the	the	DT
cord-284008-vlwdtjbe	33	6	average	average	JJ
cord-284008-vlwdtjbe	33	7	level	level	NN
cord-284008-vlwdtjbe	33	8	of	of	IN
cord-284008-vlwdtjbe	33	9	IL-6	IL-6	NNP
cord-284008-vlwdtjbe	33	10	in	in	IN
cord-284008-vlwdtjbe	33	11	99	99	CD
cord-284008-vlwdtjbe	33	12	patients	patient	NNS
cord-284008-vlwdtjbe	33	13	was	be	VBD
cord-284008-vlwdtjbe	33	14	much	much	RB
cord-284008-vlwdtjbe	33	15	higher	high	JJR
cord-284008-vlwdtjbe	33	16	than	than	IN
cord-284008-vlwdtjbe	33	17	the	the	DT
cord-284008-vlwdtjbe	33	18	upper	upper	JJ
cord-284008-vlwdtjbe	33	19	limit	limit	NN
cord-284008-vlwdtjbe	33	20	of	of	IN
cord-284008-vlwdtjbe	33	21	the	the	DT
cord-284008-vlwdtjbe	33	22	normal	normal	JJ
cord-284008-vlwdtjbe	33	23	range	range	NN
cord-284008-vlwdtjbe	33	24	.	.	.
cord-284008-vlwdtjbe	34	1	However	however	RB
cord-284008-vlwdtjbe	34	2	,	,	,
cord-284008-vlwdtjbe	34	3	the	the	DT
cord-284008-vlwdtjbe	34	4	author	author	NN
cord-284008-vlwdtjbe	34	5	did	do	VBD
cord-284008-vlwdtjbe	34	6	not	not	RB
cord-284008-vlwdtjbe	34	7	analyze	analyze	VB
cord-284008-vlwdtjbe	34	8	the	the	DT
cord-284008-vlwdtjbe	34	9	relationship	relationship	NN
cord-284008-vlwdtjbe	34	10	between	between	IN
cord-284008-vlwdtjbe	34	11	increased	increase	VBN
cord-284008-vlwdtjbe	34	12	inflammatory	inflammatory	JJ
cord-284008-vlwdtjbe	34	13	factors	factor	NNS
cord-284008-vlwdtjbe	34	14	and	and	CC
cord-284008-vlwdtjbe	34	15	clinical	clinical	JJ
cord-284008-vlwdtjbe	34	16	outcomes	outcome	NNS
cord-284008-vlwdtjbe	34	17	.	.	.
cord-284008-vlwdtjbe	35	1	[	[	-LRB-
cord-284008-vlwdtjbe	35	2	11	11	CD
cord-284008-vlwdtjbe	35	3	]	]	-RRB-
cord-284008-vlwdtjbe	35	4	Liu	Liu	NNP
cord-284008-vlwdtjbe	35	5	et	et	NNP
cord-284008-vlwdtjbe	35	6	al	al	NNP
cord-284008-vlwdtjbe	35	7	.	.	.
cord-284008-vlwdtjbe	36	1	[	[	-LRB-
cord-284008-vlwdtjbe	36	2	12	12	CD
cord-284008-vlwdtjbe	36	3	]	]	-RRB-
cord-284008-vlwdtjbe	36	4	described	describe	VBD
cord-284008-vlwdtjbe	36	5	the	the	DT
cord-284008-vlwdtjbe	36	6	dynamic	dynamic	JJ
cord-284008-vlwdtjbe	36	7	changes	change	NNS
cord-284008-vlwdtjbe	36	8	in	in	IN
cord-284008-vlwdtjbe	36	9	inflammatory	inflammatory	JJ
cord-284008-vlwdtjbe	36	10	cytokines	cytokine	NNS
cord-284008-vlwdtjbe	36	11	in	in	IN
cord-284008-vlwdtjbe	36	12	patients	patient	NNS
cord-284008-vlwdtjbe	36	13	with	with	IN
cord-284008-vlwdtjbe	36	14	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	36	15	.	.	.
cord-284008-vlwdtjbe	37	1	The	the	DT
cord-284008-vlwdtjbe	37	2	levels	level	NNS
cord-284008-vlwdtjbe	37	3	of	of	IN
cord-284008-vlwdtjbe	37	4	IL-6	IL-6	NNP
cord-284008-vlwdtjbe	37	5	and	and	CC
cord-284008-vlwdtjbe	37	6	IL-10	IL-10	NNP
cord-284008-vlwdtjbe	37	7	showed	show	VBD
cord-284008-vlwdtjbe	37	8	a	a	DT
cord-284008-vlwdtjbe	37	9	continuous	continuous	JJ
cord-284008-vlwdtjbe	37	10	increase	increase	NN
cord-284008-vlwdtjbe	37	11	in	in	IN
cord-284008-vlwdtjbe	37	12	patients	patient	NNS
cord-284008-vlwdtjbe	37	13	with	with	IN
cord-284008-vlwdtjbe	37	14	severe	severe	JJ
cord-284008-vlwdtjbe	37	15	infection	infection	NN
cord-284008-vlwdtjbe	37	16	.	.	.
cord-284008-vlwdtjbe	38	1	The	the	DT
cord-284008-vlwdtjbe	38	2	levels	level	NNS
cord-284008-vlwdtjbe	38	3	of	of	IN
cord-284008-vlwdtjbe	38	4	cytokines	cytokine	NNS
cord-284008-vlwdtjbe	38	5	in	in	IN
cord-284008-vlwdtjbe	38	6	patients	patient	NNS
cord-284008-vlwdtjbe	38	7	with	with	IN
cord-284008-vlwdtjbe	38	8	severe	severe	JJ
cord-284008-vlwdtjbe	38	9	infection	infection	NN
cord-284008-vlwdtjbe	38	10	who	who	WP
cord-284008-vlwdtjbe	38	11	survived	survive	VBD
cord-284008-vlwdtjbe	38	12	gradually	gradually	RB
cord-284008-vlwdtjbe	38	13	returned	return	VBD
cord-284008-vlwdtjbe	38	14	to	to	IN
cord-284008-vlwdtjbe	38	15	the	the	DT
cord-284008-vlwdtjbe	38	16	levels	level	NNS
cord-284008-vlwdtjbe	38	17	that	that	WDT
cord-284008-vlwdtjbe	38	18	were	be	VBD
cord-284008-vlwdtjbe	38	19	comparable	comparable	JJ
cord-284008-vlwdtjbe	38	20	with	with	IN
cord-284008-vlwdtjbe	38	21	those	those	DT
cord-284008-vlwdtjbe	38	22	of	of	IN
cord-284008-vlwdtjbe	38	23	mild	mild	JJ
cord-284008-vlwdtjbe	38	24	cases	case	NNS
cord-284008-vlwdtjbe	38	25	.	.	.
cord-284008-vlwdtjbe	39	1	The	the	DT
cord-284008-vlwdtjbe	39	2	results	result	NNS
cord-284008-vlwdtjbe	39	3	concluded	conclude	VBD
cord-284008-vlwdtjbe	39	4	that	that	IN
cord-284008-vlwdtjbe	39	5	the	the	DT
cord-284008-vlwdtjbe	39	6	progression	progression	NN
cord-284008-vlwdtjbe	39	7	of	of	IN
cord-284008-vlwdtjbe	39	8	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	39	9	could	could	MD
cord-284008-vlwdtjbe	39	10	be	be	VB
cord-284008-vlwdtjbe	39	11	predicted	predict	VBN
cord-284008-vlwdtjbe	39	12	from	from	IN
cord-284008-vlwdtjbe	39	13	cytokines	cytokine	NNS
cord-284008-vlwdtjbe	39	14	.	.	.
cord-284008-vlwdtjbe	40	1	[	[	-LRB-
cord-284008-vlwdtjbe	40	2	13	13	CD
cord-284008-vlwdtjbe	40	3	]	]	-RRB-
cord-284008-vlwdtjbe	41	1	As	as	IN
cord-284008-vlwdtjbe	41	2	changes	change	NNS
cord-284008-vlwdtjbe	41	3	in	in	IN
cord-284008-vlwdtjbe	41	4	inflammatory	inflammatory	JJ
cord-284008-vlwdtjbe	41	5	cytokines	cytokine	NNS
cord-284008-vlwdtjbe	41	6	were	be	VBD
cord-284008-vlwdtjbe	41	7	related	relate	VBN
cord-284008-vlwdtjbe	41	8	to	to	IN
cord-284008-vlwdtjbe	41	9	the	the	DT
cord-284008-vlwdtjbe	41	10	severity	severity	NN
cord-284008-vlwdtjbe	41	11	of	of	IN
cord-284008-vlwdtjbe	41	12	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	41	13	,	,	,
cord-284008-vlwdtjbe	41	14	it	-PRON-	PRP
cord-284008-vlwdtjbe	41	15	should	should	MD
cord-284008-vlwdtjbe	41	16	be	be	VB
cord-284008-vlwdtjbe	41	17	beneficial	beneficial	JJ
cord-284008-vlwdtjbe	41	18	for	for	IN
cord-284008-vlwdtjbe	41	19	critical	critical	JJ
cord-284008-vlwdtjbe	41	20	patients	patient	NNS
cord-284008-vlwdtjbe	41	21	to	to	TO
cord-284008-vlwdtjbe	41	22	suppress	suppress	VB
cord-284008-vlwdtjbe	41	23	the	the	DT
cord-284008-vlwdtjbe	41	24	cytokine	cytokine	NN
cord-284008-vlwdtjbe	41	25	storm	storm	NN
cord-284008-vlwdtjbe	41	26	.	.	.
cord-284008-vlwdtjbe	42	1	Corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	42	2	could	could	MD
cord-284008-vlwdtjbe	42	3	achieve	achieve	VB
cord-284008-vlwdtjbe	42	4	the	the	DT
cord-284008-vlwdtjbe	42	5	purpose	purpose	NN
cord-284008-vlwdtjbe	42	6	of	of	IN
cord-284008-vlwdtjbe	42	7	suppressing	suppress	VBG
cord-284008-vlwdtjbe	42	8	lung	lung	NN
cord-284008-vlwdtjbe	42	9	inflammation	inflammation	NN
cord-284008-vlwdtjbe	42	10	,	,	,
cord-284008-vlwdtjbe	42	11	but	but	CC
cord-284008-vlwdtjbe	42	12	they	-PRON-	PRP
cord-284008-vlwdtjbe	42	13	can	can	MD
cord-284008-vlwdtjbe	42	14	also	also	RB
cord-284008-vlwdtjbe	42	15	restrain	restrain	VB
cord-284008-vlwdtjbe	42	16	the	the	DT
cord-284008-vlwdtjbe	42	17	immune	immune	JJ
cord-284008-vlwdtjbe	42	18	response	response	NN
cord-284008-vlwdtjbe	42	19	.	.	.
cord-284008-vlwdtjbe	43	1	This	this	DT
cord-284008-vlwdtjbe	43	2	contradictory	contradictory	JJ
cord-284008-vlwdtjbe	43	3	aspect	aspect	NN
cord-284008-vlwdtjbe	43	4	put	put	VBD
cord-284008-vlwdtjbe	43	5	the	the	DT
cord-284008-vlwdtjbe	43	6	application	application	NN
cord-284008-vlwdtjbe	43	7	of	of	IN
cord-284008-vlwdtjbe	43	8	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	43	9	in	in	IN
cord-284008-vlwdtjbe	43	10	an	an	DT
cord-284008-vlwdtjbe	43	11	awkward	awkward	JJ
cord-284008-vlwdtjbe	43	12	position	position	NN
cord-284008-vlwdtjbe	43	13	,	,	,
cord-284008-vlwdtjbe	43	14	especially	especially	RB
cord-284008-vlwdtjbe	43	15	the	the	DT
cord-284008-vlwdtjbe	43	16	results	result	NNS
cord-284008-vlwdtjbe	43	17	of	of	IN
cord-284008-vlwdtjbe	43	18	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	43	19	therapy	therapy	NN
cord-284008-vlwdtjbe	43	20	in	in	IN
cord-284008-vlwdtjbe	43	21	previous	previous	JJ
cord-284008-vlwdtjbe	43	22	SARS	SARS	NNP
cord-284008-vlwdtjbe	43	23	,	,	,
cord-284008-vlwdtjbe	43	24	MERS	MERS	NNP
cord-284008-vlwdtjbe	43	25	,	,	,
cord-284008-vlwdtjbe	43	26	and	and	CC
cord-284008-vlwdtjbe	43	27	influenza	influenza	NN
cord-284008-vlwdtjbe	43	28	seemed	seem	VBD
cord-284008-vlwdtjbe	43	29	to	to	TO
cord-284008-vlwdtjbe	43	30	be	be	VB
cord-284008-vlwdtjbe	43	31	uncertain	uncertain	JJ
cord-284008-vlwdtjbe	43	32	.	.	.
cord-284008-vlwdtjbe	44	1	Corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	44	2	have	have	VBP
cord-284008-vlwdtjbe	44	3	unique	unique	JJ
cord-284008-vlwdtjbe	44	4	advantages	advantage	NNS
cord-284008-vlwdtjbe	44	5	in	in	IN
cord-284008-vlwdtjbe	44	6	inhibiting	inhibit	VBG
cord-284008-vlwdtjbe	44	7	inflammatory	inflammatory	JJ
cord-284008-vlwdtjbe	44	8	responses	response	NNS
cord-284008-vlwdtjbe	44	9	and	and	CC
cord-284008-vlwdtjbe	44	10	have	have	VBP
cord-284008-vlwdtjbe	44	11	been	be	VBN
cord-284008-vlwdtjbe	44	12	previously	previously	RB
cord-284008-vlwdtjbe	44	13	used	use	VBN
cord-284008-vlwdtjbe	44	14	in	in	IN
cord-284008-vlwdtjbe	44	15	the	the	DT
cord-284008-vlwdtjbe	44	16	treatment	treatment	NN
cord-284008-vlwdtjbe	44	17	of	of	IN
cord-284008-vlwdtjbe	44	18	SARS	SARS	NNP
cord-284008-vlwdtjbe	44	19	,	,	,
cord-284008-vlwdtjbe	44	20	MERS	MERS	NNP
cord-284008-vlwdtjbe	44	21	,	,	,
cord-284008-vlwdtjbe	44	22	and	and	CC
cord-284008-vlwdtjbe	44	23	influenza	influenza	NN
cord-284008-vlwdtjbe	44	24	.	.	.
cord-284008-vlwdtjbe	45	1	However	however	RB
cord-284008-vlwdtjbe	45	2	,	,	,
cord-284008-vlwdtjbe	45	3	its	-PRON-	PRP$
cord-284008-vlwdtjbe	45	4	uncertain	uncertain	JJ
cord-284008-vlwdtjbe	45	5	efficacy	efficacy	NN
cord-284008-vlwdtjbe	45	6	and	and	CC
cord-284008-vlwdtjbe	45	7	adverse	adverse	JJ
cord-284008-vlwdtjbe	45	8	reactions	reaction	NNS
cord-284008-vlwdtjbe	45	9	make	make	VBP
cord-284008-vlwdtjbe	45	10	doctors	doctor	NNS
cord-284008-vlwdtjbe	45	11	hesitate	hesitate	VBP
cord-284008-vlwdtjbe	45	12	to	to	TO
cord-284008-vlwdtjbe	45	13	use	use	VB
cord-284008-vlwdtjbe	45	14	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	45	15	in	in	IN
cord-284008-vlwdtjbe	45	16	the	the	DT
cord-284008-vlwdtjbe	45	17	treatment	treatment	NN
cord-284008-vlwdtjbe	45	18	of	of	IN
cord-284008-vlwdtjbe	45	19	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	45	20	.	.	.
cord-284008-vlwdtjbe	46	1	Here	here	RB
cord-284008-vlwdtjbe	46	2	we	-PRON-	PRP
cord-284008-vlwdtjbe	46	3	reviewed	review	VBD
cord-284008-vlwdtjbe	46	4	the	the	DT
cord-284008-vlwdtjbe	46	5	application	application	NN
cord-284008-vlwdtjbe	46	6	of	of	IN
cord-284008-vlwdtjbe	46	7	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	46	8	in	in	IN
cord-284008-vlwdtjbe	46	9	the	the	DT
cord-284008-vlwdtjbe	46	10	previous	previous	JJ
cord-284008-vlwdtjbe	46	11	infectious	infectious	JJ
cord-284008-vlwdtjbe	46	12	diseases	disease	NNS
cord-284008-vlwdtjbe	46	13	,	,	,
cord-284008-vlwdtjbe	46	14	hoping	hope	VBG
cord-284008-vlwdtjbe	46	15	to	to	TO
cord-284008-vlwdtjbe	46	16	provide	provide	VB
cord-284008-vlwdtjbe	46	17	some	some	DT
cord-284008-vlwdtjbe	46	18	references	reference	NNS
cord-284008-vlwdtjbe	46	19	for	for	IN
cord-284008-vlwdtjbe	46	20	the	the	DT
cord-284008-vlwdtjbe	46	21	use	use	NN
cord-284008-vlwdtjbe	46	22	of	of	IN
cord-284008-vlwdtjbe	46	23	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	46	24	in	in	IN
cord-284008-vlwdtjbe	46	25	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	46	26	.	.	.
cord-284008-vlwdtjbe	47	1	Auyeung	Auyeung	NNP
cord-284008-vlwdtjbe	47	2	et	et	NNP
cord-284008-vlwdtjbe	47	3	al	al	NNP
cord-284008-vlwdtjbe	47	4	.	.	.
cord-284008-vlwdtjbe	48	1	[	[	-LRB-
cord-284008-vlwdtjbe	48	2	14	14	CD
cord-284008-vlwdtjbe	48	3	]	]	-RRB-
cord-284008-vlwdtjbe	48	4	performed	perform	VBD
cord-284008-vlwdtjbe	48	5	a	a	DT
cord-284008-vlwdtjbe	48	6	retrospective	retrospective	JJ
cord-284008-vlwdtjbe	48	7	cohort	cohort	NN
cord-284008-vlwdtjbe	48	8	study	study	NN
cord-284008-vlwdtjbe	48	9	on	on	IN
cord-284008-vlwdtjbe	48	10	78	78	CD
cord-284008-vlwdtjbe	48	11	adult	adult	NN
cord-284008-vlwdtjbe	48	12	patients	patient	NNS
cord-284008-vlwdtjbe	48	13	with	with	IN
cord-284008-vlwdtjbe	48	14	SARS	SARS	NNP
cord-284008-vlwdtjbe	48	15	in	in	IN
cord-284008-vlwdtjbe	48	16	Hong	Hong	NNP
cord-284008-vlwdtjbe	48	17	Kong	Kong	NNP
cord-284008-vlwdtjbe	48	18	.	.	.
cord-284008-vlwdtjbe	49	1	Sixty	sixty	CD
cord-284008-vlwdtjbe	49	2	-	-	HYPH
cord-284008-vlwdtjbe	49	3	six	six	CD
cord-284008-vlwdtjbe	49	4	of	of	IN
cord-284008-vlwdtjbe	49	5	78	78	CD
cord-284008-vlwdtjbe	49	6	(	(	-LRB-
cord-284008-vlwdtjbe	49	7	84.6	84.6	CD
cord-284008-vlwdtjbe	49	8	%	%	NN
cord-284008-vlwdtjbe	49	9	)	)	-RRB-
cord-284008-vlwdtjbe	49	10	patients	patient	NNS
cord-284008-vlwdtjbe	49	11	accepted	accept	VBD
cord-284008-vlwdtjbe	49	12	different	different	JJ
cord-284008-vlwdtjbe	49	13	doses	dose	NNS
cord-284008-vlwdtjbe	49	14	of	of	IN
cord-284008-vlwdtjbe	49	15	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	49	16	,	,	,
cord-284008-vlwdtjbe	49	17	and	and	CC
cord-284008-vlwdtjbe	49	18	the	the	DT
cord-284008-vlwdtjbe	49	19	result	result	NN
cord-284008-vlwdtjbe	49	20	showed	show	VBD
cord-284008-vlwdtjbe	49	21	that	that	IN
cord-284008-vlwdtjbe	49	22	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	49	23	treatment	treatment	NN
cord-284008-vlwdtjbe	49	24	was	be	VBD
cord-284008-vlwdtjbe	49	25	associated	associate	VBN
cord-284008-vlwdtjbe	49	26	with	with	IN
cord-284008-vlwdtjbe	49	27	a	a	DT
cord-284008-vlwdtjbe	49	28	20.7-fold	20.7-fold	CD
cord-284008-vlwdtjbe	49	29	increase	increase	NN
cord-284008-vlwdtjbe	49	30	in	in	IN
cord-284008-vlwdtjbe	49	31	the	the	DT
cord-284008-vlwdtjbe	49	32	risk	risk	NN
cord-284008-vlwdtjbe	49	33	of	of	IN
cord-284008-vlwdtjbe	49	34	either	either	DT
cord-284008-vlwdtjbe	49	35	ICU	ICU	NNP
cord-284008-vlwdtjbe	49	36	admission	admission	NN
cord-284008-vlwdtjbe	49	37	or	or	CC
cord-284008-vlwdtjbe	49	38	mortality	mortality	NN
cord-284008-vlwdtjbe	49	39	.	.	.
cord-284008-vlwdtjbe	50	1	But	but	CC
cord-284008-vlwdtjbe	50	2	only	only	RB
cord-284008-vlwdtjbe	50	3	advanced	advanced	JJ
cord-284008-vlwdtjbe	50	4	age	age	NN
cord-284008-vlwdtjbe	50	5	and	and	CC
cord-284008-vlwdtjbe	50	6	high	high	JJ
cord-284008-vlwdtjbe	50	7	LDH	LDH	NNP
cord-284008-vlwdtjbe	50	8	levels	level	NNS
cord-284008-vlwdtjbe	50	9	were	be	VBD
cord-284008-vlwdtjbe	50	10	used	use	VBN
cord-284008-vlwdtjbe	50	11	to	to	TO
cord-284008-vlwdtjbe	50	12	eliminate	eliminate	VB
cord-284008-vlwdtjbe	50	13	confounding	confounding	JJ
cord-284008-vlwdtjbe	50	14	effect	effect	NN
cord-284008-vlwdtjbe	50	15	by	by	IN
cord-284008-vlwdtjbe	50	16	multivariate	multivariate	JJ
cord-284008-vlwdtjbe	50	17	adjustment	adjustment	NN
cord-284008-vlwdtjbe	50	18	;	;	:
cord-284008-vlwdtjbe	50	19	the	the	DT
cord-284008-vlwdtjbe	50	20	results	result	NNS
cord-284008-vlwdtjbe	50	21	of	of	IN
cord-284008-vlwdtjbe	50	22	this	this	DT
cord-284008-vlwdtjbe	50	23	study	study	NN
cord-284008-vlwdtjbe	50	24	could	could	MD
cord-284008-vlwdtjbe	50	25	be	be	VB
cord-284008-vlwdtjbe	50	26	biased	bias	VBN
cord-284008-vlwdtjbe	50	27	by	by	IN
cord-284008-vlwdtjbe	50	28	many	many	JJ
cord-284008-vlwdtjbe	50	29	unknown	unknown	JJ
cord-284008-vlwdtjbe	50	30	confounding	confounding	JJ
cord-284008-vlwdtjbe	50	31	factors	factor	NNS
cord-284008-vlwdtjbe	50	32	.	.	.
cord-284008-vlwdtjbe	51	1	Stockman	Stockman	NNP
cord-284008-vlwdtjbe	51	2	et	et	NNP
cord-284008-vlwdtjbe	51	3	al	al	NNP
cord-284008-vlwdtjbe	51	4	.	.	.
cord-284008-vlwdtjbe	52	1	[	[	-LRB-
cord-284008-vlwdtjbe	52	2	15	15	CD
cord-284008-vlwdtjbe	52	3	]	]	-RRB-
cord-284008-vlwdtjbe	52	4	conducted	conduct	VBD
cord-284008-vlwdtjbe	52	5	a	a	DT
cord-284008-vlwdtjbe	52	6	systematic	systematic	JJ
cord-284008-vlwdtjbe	52	7	review	review	NN
cord-284008-vlwdtjbe	52	8	and	and	CC
cord-284008-vlwdtjbe	52	9	comprehensive	comprehensive	JJ
cord-284008-vlwdtjbe	52	10	summary	summary	NN
cord-284008-vlwdtjbe	52	11	of	of	IN
cord-284008-vlwdtjbe	52	12	the	the	DT
cord-284008-vlwdtjbe	52	13	treatments	treatment	NNS
cord-284008-vlwdtjbe	52	14	used	use	VBN
cord-284008-vlwdtjbe	52	15	for	for	IN
cord-284008-vlwdtjbe	52	16	patients	patient	NNS
cord-284008-vlwdtjbe	52	17	infected	infect	VBN
cord-284008-vlwdtjbe	52	18	with	with	IN
cord-284008-vlwdtjbe	52	19	SARS	SARS	NNP
cord-284008-vlwdtjbe	52	20	.	.	.
cord-284008-vlwdtjbe	53	1	The	the	DT
cord-284008-vlwdtjbe	53	2	possible	possible	JJ
cord-284008-vlwdtjbe	53	3	harm	harm	NN
cord-284008-vlwdtjbe	53	4	,	,	,
cord-284008-vlwdtjbe	53	5	such	such	JJ
cord-284008-vlwdtjbe	53	6	as	as	IN
cord-284008-vlwdtjbe	53	7	delayed	delay	VBN
cord-284008-vlwdtjbe	53	8	virus	virus	NN
cord-284008-vlwdtjbe	53	9	clearance	clearance	NN
cord-284008-vlwdtjbe	53	10	,	,	,
cord-284008-vlwdtjbe	53	11	onset	onset	NN
cord-284008-vlwdtjbe	53	12	of	of	IN
cord-284008-vlwdtjbe	53	13	diabetes	diabetes	NN
cord-284008-vlwdtjbe	53	14	,	,	,
cord-284008-vlwdtjbe	53	15	avascular	avascular	JJ
cord-284008-vlwdtjbe	53	16	necrosis	necrosis	NN
cord-284008-vlwdtjbe	53	17	,	,	,
cord-284008-vlwdtjbe	53	18	and	and	CC
cord-284008-vlwdtjbe	53	19	osteoporosis	osteoporosis	NN
cord-284008-vlwdtjbe	53	20	,	,	,
cord-284008-vlwdtjbe	53	21	were	be	VBD
cord-284008-vlwdtjbe	53	22	reported	report	VBN
cord-284008-vlwdtjbe	53	23	in	in	IN
cord-284008-vlwdtjbe	53	24	patients	patient	NNS
cord-284008-vlwdtjbe	53	25	with	with	IN
cord-284008-vlwdtjbe	53	26	SARS	SARS	NNP
cord-284008-vlwdtjbe	53	27	treated	treat	VBN
cord-284008-vlwdtjbe	53	28	with	with	IN
cord-284008-vlwdtjbe	53	29	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	53	30	.	.	.
cord-284008-vlwdtjbe	54	1	One	one	CD
cord-284008-vlwdtjbe	54	2	small	small	JJ
cord-284008-vlwdtjbe	54	3	RCT	RCT	NNP
cord-284008-vlwdtjbe	54	4	showed	show	VBD
cord-284008-vlwdtjbe	54	5	that	that	IN
cord-284008-vlwdtjbe	54	6	low	low	JJ
cord-284008-vlwdtjbe	54	7	-	-	HYPH
cord-284008-vlwdtjbe	54	8	dose	dose	NN
cord-284008-vlwdtjbe	54	9	rather	rather	RB
cord-284008-vlwdtjbe	54	10	than	than	IN
cord-284008-vlwdtjbe	54	11	highdose	highdose	NN
cord-284008-vlwdtjbe	54	12	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	54	13	may	may	MD
cord-284008-vlwdtjbe	54	14	be	be	VB
cord-284008-vlwdtjbe	54	15	beneficial	beneficial	JJ
cord-284008-vlwdtjbe	54	16	for	for	IN
cord-284008-vlwdtjbe	54	17	the	the	DT
cord-284008-vlwdtjbe	54	18	improvement	improvement	NN
cord-284008-vlwdtjbe	54	19	of	of	IN
cord-284008-vlwdtjbe	54	20	ARDS	ARDS	NNP
cord-284008-vlwdtjbe	54	21	.	.	.
cord-284008-vlwdtjbe	55	1	Zhao	Zhao	NNP
cord-284008-vlwdtjbe	55	2	et	et	NNP
cord-284008-vlwdtjbe	55	3	al	al	NNP
cord-284008-vlwdtjbe	55	4	.	.	.
cord-284008-vlwdtjbe	56	1	[	[	-LRB-
cord-284008-vlwdtjbe	56	2	16	16	CD
cord-284008-vlwdtjbe	56	3	]	]	-RRB-
cord-284008-vlwdtjbe	56	4	aimed	aim	VBN
cord-284008-vlwdtjbe	56	5	to	to	TO
cord-284008-vlwdtjbe	56	6	examine	examine	VB
cord-284008-vlwdtjbe	56	7	the	the	DT
cord-284008-vlwdtjbe	56	8	effects	effect	NNS
cord-284008-vlwdtjbe	56	9	of	of	IN
cord-284008-vlwdtjbe	56	10	steroid	steroid	NN
cord-284008-vlwdtjbe	56	11	therapy	therapy	NN
cord-284008-vlwdtjbe	56	12	on	on	IN
cord-284008-vlwdtjbe	56	13	osteonecrosis	osteonecrosis	NNP
cord-284008-vlwdtjbe	56	14	in	in	IN
cord-284008-vlwdtjbe	56	15	recovered	recover	VBN
cord-284008-vlwdtjbe	56	16	patients	patient	NNS
cord-284008-vlwdtjbe	56	17	with	with	IN
cord-284008-vlwdtjbe	56	18	SARS	SARS	NNP
cord-284008-vlwdtjbe	56	19	in	in	IN
cord-284008-vlwdtjbe	56	20	a	a	DT
cord-284008-vlwdtjbe	56	21	meta	meta	JJ
cord-284008-vlwdtjbe	56	22	-	-	HYPH
cord-284008-vlwdtjbe	56	23	analysis	analysis	NN
cord-284008-vlwdtjbe	56	24	.	.	.
cord-284008-vlwdtjbe	57	1	They	-PRON-	PRP
cord-284008-vlwdtjbe	57	2	observed	observe	VBD
cord-284008-vlwdtjbe	57	3	a	a	DT
cord-284008-vlwdtjbe	57	4	nonlinear	nonlinear	JJ
cord-284008-vlwdtjbe	57	5	relationship	relationship	NN
cord-284008-vlwdtjbe	57	6	between	between	IN
cord-284008-vlwdtjbe	57	7	osteonecrosis	osteonecrosis	NN
cord-284008-vlwdtjbe	57	8	and	and	CC
cord-284008-vlwdtjbe	57	9	the	the	DT
cord-284008-vlwdtjbe	57	10	cumulative	cumulative	JJ
cord-284008-vlwdtjbe	57	11	dose	dose	NN
cord-284008-vlwdtjbe	57	12	and	and	CC
cord-284008-vlwdtjbe	57	13	treatment	treatment	NN
cord-284008-vlwdtjbe	57	14	duration	duration	NN
cord-284008-vlwdtjbe	57	15	of	of	IN
cord-284008-vlwdtjbe	57	16	steroids	steroid	NNS
cord-284008-vlwdtjbe	57	17	.	.	.
cord-284008-vlwdtjbe	58	1	Their	-PRON-	PRP$
cord-284008-vlwdtjbe	58	2	further	further	JJ
cord-284008-vlwdtjbe	58	3	analysis	analysis	NN
cord-284008-vlwdtjbe	58	4	indicated	indicate	VBD
cord-284008-vlwdtjbe	58	5	that	that	IN
cord-284008-vlwdtjbe	58	6	the	the	DT
cord-284008-vlwdtjbe	58	7	risk	risk	NN
cord-284008-vlwdtjbe	58	8	of	of	IN
cord-284008-vlwdtjbe	58	9	osteonecrosis	osteonecrosis	NN
cord-284008-vlwdtjbe	58	10	remained	remain	VBD
cord-284008-vlwdtjbe	58	11	relatively	relatively	RB
cord-284008-vlwdtjbe	58	12	low	low	JJ
cord-284008-vlwdtjbe	58	13	when	when	WRB
cord-284008-vlwdtjbe	58	14	the	the	DT
cord-284008-vlwdtjbe	58	15	total	total	JJ
cord-284008-vlwdtjbe	58	16	dose	dose	NN
cord-284008-vlwdtjbe	58	17	of	of	IN
cord-284008-vlwdtjbe	58	18	steroids	steroid	NNS
cord-284008-vlwdtjbe	58	19	(	(	-LRB-
cord-284008-vlwdtjbe	58	20	methylprednisolone	methylprednisolone	NNP
cord-284008-vlwdtjbe	58	21	)	)	-RRB-
cord-284008-vlwdtjbe	58	22	was	be	VBD
cord-284008-vlwdtjbe	58	23	≤5	≤5	NNP
cord-284008-vlwdtjbe	58	24	g	g	NNP
cord-284008-vlwdtjbe	58	25	and	and	CC
cord-284008-vlwdtjbe	58	26	the	the	DT
cord-284008-vlwdtjbe	58	27	treatment	treatment	NN
cord-284008-vlwdtjbe	58	28	duration	duration	NN
cord-284008-vlwdtjbe	58	29	was	be	VBD
cord-284008-vlwdtjbe	58	30	＜30	＜30	CD
cord-284008-vlwdtjbe	58	31	days	day	NNS
cord-284008-vlwdtjbe	58	32	.	.	.
cord-284008-vlwdtjbe	59	1	Chen	Chen	NNP
cord-284008-vlwdtjbe	59	2	et	et	NNP
cord-284008-vlwdtjbe	59	3	al	al	NNP
cord-284008-vlwdtjbe	59	4	.	.	.
cord-284008-vlwdtjbe	60	1	[	[	-LRB-
cord-284008-vlwdtjbe	60	2	17	17	CD
cord-284008-vlwdtjbe	60	3	]	]	-RRB-
cord-284008-vlwdtjbe	60	4	reviewed	review	VBN
cord-284008-vlwdtjbe	60	5	401	401	CD
cord-284008-vlwdtjbe	60	6	SARS	SARS	NNP
cord-284008-vlwdtjbe	60	7	cases	case	NNS
cord-284008-vlwdtjbe	60	8	confirmed	confirm	VBN
cord-284008-vlwdtjbe	60	9	by	by	IN
cord-284008-vlwdtjbe	60	10	virology	virology	NN
cord-284008-vlwdtjbe	60	11	in	in	IN
cord-284008-vlwdtjbe	60	12	Guangzhou	Guangzhou	NNP
cord-284008-vlwdtjbe	60	13	,	,	,
cord-284008-vlwdtjbe	60	14	Guangdong	Guangdong	NNP
cord-284008-vlwdtjbe	60	15	Province	Province	NNP
cord-284008-vlwdtjbe	60	16	of	of	IN
cord-284008-vlwdtjbe	60	17	China	China	NNP
cord-284008-vlwdtjbe	60	18	,	,	,
cord-284008-vlwdtjbe	60	19	to	to	TO
cord-284008-vlwdtjbe	60	20	evaluate	evaluate	VB
cord-284008-vlwdtjbe	60	21	the	the	DT
cord-284008-vlwdtjbe	60	22	efficacy	efficacy	NN
cord-284008-vlwdtjbe	60	23	and	and	CC
cord-284008-vlwdtjbe	60	24	safety	safety	NN
cord-284008-vlwdtjbe	60	25	of	of	IN
cord-284008-vlwdtjbe	60	26	steroid	steroid	NN
cord-284008-vlwdtjbe	60	27	therapy	therapy	NN
cord-284008-vlwdtjbe	60	28	.	.	.
cord-284008-vlwdtjbe	61	1	Their	-PRON-	PRP$
cord-284008-vlwdtjbe	61	2	study	study	NN
cord-284008-vlwdtjbe	61	3	revealed	reveal	VBD
cord-284008-vlwdtjbe	61	4	that	that	IN
cord-284008-vlwdtjbe	61	5	proper	proper	JJ
cord-284008-vlwdtjbe	61	6	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	61	7	treatment	treatment	NN
cord-284008-vlwdtjbe	61	8	resulted	result	VBD
cord-284008-vlwdtjbe	61	9	in	in	IN
cord-284008-vlwdtjbe	61	10	lower	low	JJR
cord-284008-vlwdtjbe	61	11	mortality	mortality	NN
cord-284008-vlwdtjbe	61	12	and	and	CC
cord-284008-vlwdtjbe	61	13	shorter	short	JJR
cord-284008-vlwdtjbe	61	14	hospitalization	hospitalization	NN
cord-284008-vlwdtjbe	61	15	stay	stay	VBP
cord-284008-vlwdtjbe	61	16	in	in	IN
cord-284008-vlwdtjbe	61	17	patients	patient	NNS
cord-284008-vlwdtjbe	61	18	with	with	IN
cord-284008-vlwdtjbe	61	19	critical	critical	JJ
cord-284008-vlwdtjbe	61	20	SARS	SARS	NNP
cord-284008-vlwdtjbe	61	21	with	with	IN
cord-284008-vlwdtjbe	61	22	an	an	DT
cord-284008-vlwdtjbe	61	23	oxygenation	oxygenation	NN
cord-284008-vlwdtjbe	61	24	index	index	NN
cord-284008-vlwdtjbe	61	25	(	(	-LRB-
cord-284008-vlwdtjbe	61	26	OI	OI	NNP
cord-284008-vlwdtjbe	61	27	)	)	-RRB-
cord-284008-vlwdtjbe	61	28	of	of	IN
cord-284008-vlwdtjbe	61	29	<	<	$
cord-284008-vlwdtjbe	61	30	300	300	CD
cord-284008-vlwdtjbe	61	31	mm	mm	CD
cord-284008-vlwdtjbe	61	32	Hg	Hg	NNP
cord-284008-vlwdtjbe	61	33	,	,	,
cord-284008-vlwdtjbe	61	34	and	and	CC
cord-284008-vlwdtjbe	61	35	it	-PRON-	PRP
cord-284008-vlwdtjbe	61	36	was	be	VBD
cord-284008-vlwdtjbe	61	37	not	not	RB
cord-284008-vlwdtjbe	61	38	associated	associate	VBN
cord-284008-vlwdtjbe	61	39	with	with	IN
cord-284008-vlwdtjbe	61	40	significant	significant	JJ
cord-284008-vlwdtjbe	61	41	secondary	secondary	JJ
cord-284008-vlwdtjbe	61	42	lower	low	JJR
cord-284008-vlwdtjbe	61	43	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	61	44	infection	infection	NN
cord-284008-vlwdtjbe	61	45	and	and	CC
cord-284008-vlwdtjbe	61	46	other	other	JJ
cord-284008-vlwdtjbe	61	47	complications	complication	NNS
cord-284008-vlwdtjbe	61	48	.	.	.
cord-284008-vlwdtjbe	62	1	Arabi	Arabi	NNP
cord-284008-vlwdtjbe	62	2	et	et	NNP
cord-284008-vlwdtjbe	62	3	al	al	NNP
cord-284008-vlwdtjbe	62	4	.	.	.
cord-284008-vlwdtjbe	63	1	[	[	-LRB-
cord-284008-vlwdtjbe	63	2	18	18	CD
cord-284008-vlwdtjbe	63	3	]	]	-RRB-
cord-284008-vlwdtjbe	63	4	used	use	VBN
cord-284008-vlwdtjbe	63	5	marginal	marginal	JJ
cord-284008-vlwdtjbe	63	6	structural	structural	JJ
cord-284008-vlwdtjbe	63	7	models	model	NNS
cord-284008-vlwdtjbe	63	8	to	to	TO
cord-284008-vlwdtjbe	63	9	adjust	adjust	VB
cord-284008-vlwdtjbe	63	10	for	for	IN
cord-284008-vlwdtjbe	63	11	baseline	baseline	NN
cord-284008-vlwdtjbe	63	12	and	and	CC
cord-284008-vlwdtjbe	63	13	time	time	NN
cord-284008-vlwdtjbe	63	14	-	-	HYPH
cord-284008-vlwdtjbe	63	15	varying	vary	VBG
cord-284008-vlwdtjbe	63	16	confounders	confounder	NNS
cord-284008-vlwdtjbe	63	17	to	to	TO
cord-284008-vlwdtjbe	63	18	investigate	investigate	VB
cord-284008-vlwdtjbe	63	19	the	the	DT
cord-284008-vlwdtjbe	63	20	relationship	relationship	NN
cord-284008-vlwdtjbe	63	21	between	between	IN
cord-284008-vlwdtjbe	63	22	systemic	systemic	JJ
cord-284008-vlwdtjbe	63	23	corticosteroid	corticosteroid	JJ
cord-284008-vlwdtjbe	63	24	treatment	treatment	NN
cord-284008-vlwdtjbe	63	25	and	and	CC
cord-284008-vlwdtjbe	63	26	90-day	90-day	CD
cord-284008-vlwdtjbe	63	27	mortality	mortality	NN
cord-284008-vlwdtjbe	63	28	in	in	IN
cord-284008-vlwdtjbe	63	29	patients	patient	NNS
cord-284008-vlwdtjbe	63	30	with	with	IN
cord-284008-vlwdtjbe	63	31	MERS	MERS	NNPS
cord-284008-vlwdtjbe	63	32	admitted	admit	VBD
cord-284008-vlwdtjbe	63	33	to	to	IN
cord-284008-vlwdtjbe	63	34	ICU	ICU	NNP
cord-284008-vlwdtjbe	63	35	.	.	.
cord-284008-vlwdtjbe	64	1	They	-PRON-	PRP
cord-284008-vlwdtjbe	64	2	found	find	VBD
cord-284008-vlwdtjbe	64	3	that	that	IN
cord-284008-vlwdtjbe	64	4	the	the	DT
cord-284008-vlwdtjbe	64	5	dose	dose	NN
cord-284008-vlwdtjbe	64	6	and	and	CC
cord-284008-vlwdtjbe	64	7	time	time	NN
cord-284008-vlwdtjbe	64	8	of	of	IN
cord-284008-vlwdtjbe	64	9	initiation	initiation	NN
cord-284008-vlwdtjbe	64	10	of	of	IN
cord-284008-vlwdtjbe	64	11	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	64	12	therapy	therapy	NN
cord-284008-vlwdtjbe	64	13	had	have	VBD
cord-284008-vlwdtjbe	64	14	no	no	DT
cord-284008-vlwdtjbe	64	15	impact	impact	NN
cord-284008-vlwdtjbe	64	16	on	on	IN
cord-284008-vlwdtjbe	64	17	90-day	90-day	CD
cord-284008-vlwdtjbe	64	18	mortality	mortality	NN
cord-284008-vlwdtjbe	64	19	.	.	.
cord-284008-vlwdtjbe	65	1	But	but	CC
cord-284008-vlwdtjbe	65	2	early	early	JJ
cord-284008-vlwdtjbe	65	3	initiation	initiation	NN
cord-284008-vlwdtjbe	65	4	of	of	IN
cord-284008-vlwdtjbe	65	5	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	65	6	therapy	therapy	NN
cord-284008-vlwdtjbe	65	7	was	be	VBD
cord-284008-vlwdtjbe	65	8	associated	associate	VBN
cord-284008-vlwdtjbe	65	9	with	with	IN
cord-284008-vlwdtjbe	65	10	delayed	delay	VBN
cord-284008-vlwdtjbe	65	11	MERS	MERS	NNP
cord-284008-vlwdtjbe	65	12	coronavirus	coronavirus	NN
cord-284008-vlwdtjbe	65	13	RNA	rna	NN
cord-284008-vlwdtjbe	65	14	clearance	clearance	NN
cord-284008-vlwdtjbe	65	15	.	.	.
cord-284008-vlwdtjbe	66	1	Arabi	Arabi	NNP
cord-284008-vlwdtjbe	66	2	et	et	NNP
cord-284008-vlwdtjbe	66	3	al	al	NNP
cord-284008-vlwdtjbe	66	4	.	.	.
cord-284008-vlwdtjbe	67	1	also	also	RB
cord-284008-vlwdtjbe	67	2	mentioned	mention	VBD
cord-284008-vlwdtjbe	67	3	that	that	IN
cord-284008-vlwdtjbe	67	4	persistent	persistent	JJ
cord-284008-vlwdtjbe	67	5	positivity	positivity	NN
cord-284008-vlwdtjbe	67	6	of	of	IN
cord-284008-vlwdtjbe	67	7	MERS	MERS	NNP
cord-284008-vlwdtjbe	67	8	-	-	HYPH
cord-284008-vlwdtjbe	67	9	CoV	CoV	NNP
cord-284008-vlwdtjbe	67	10	RNA	RNA	NNP
cord-284008-vlwdtjbe	67	11	did	do	VBD
cord-284008-vlwdtjbe	67	12	not	not	RB
cord-284008-vlwdtjbe	67	13	necessarily	necessarily	RB
cord-284008-vlwdtjbe	67	14	mean	mean	VB
cord-284008-vlwdtjbe	67	15	persistent	persistent	JJ
cord-284008-vlwdtjbe	67	16	shedding	shedding	NN
cord-284008-vlwdtjbe	67	17	of	of	IN
cord-284008-vlwdtjbe	67	18	live	live	JJ
cord-284008-vlwdtjbe	67	19	virus	virus	NN
cord-284008-vlwdtjbe	67	20	.	.	.
cord-284008-vlwdtjbe	68	1	Alfaraj	Alfaraj	NNP
cord-284008-vlwdtjbe	68	2	et	et	NNP
cord-284008-vlwdtjbe	68	3	al	al	NNP
cord-284008-vlwdtjbe	68	4	.	.	.
cord-284008-vlwdtjbe	69	1	[	[	-LRB-
cord-284008-vlwdtjbe	69	2	19	19	CD
cord-284008-vlwdtjbe	69	3	]	]	-RRB-
cord-284008-vlwdtjbe	69	4	performed	perform	VBD
cord-284008-vlwdtjbe	69	5	a	a	DT
cord-284008-vlwdtjbe	69	6	cohort	cohort	NN
cord-284008-vlwdtjbe	69	7	study	study	NN
cord-284008-vlwdtjbe	69	8	and	and	CC
cord-284008-vlwdtjbe	69	9	examined	examine	VBD
cord-284008-vlwdtjbe	69	10	clinical	clinical	JJ
cord-284008-vlwdtjbe	69	11	predictors	predictor	NNS
cord-284008-vlwdtjbe	69	12	of	of	IN
cord-284008-vlwdtjbe	69	13	the	the	DT
cord-284008-vlwdtjbe	69	14	mortality	mortality	NN
cord-284008-vlwdtjbe	69	15	of	of	IN
cord-284008-vlwdtjbe	69	16	MERS	MERS	NNP
cord-284008-vlwdtjbe	69	17	infection	infection	NN
cord-284008-vlwdtjbe	69	18	.	.	.
cord-284008-vlwdtjbe	70	1	This	this	DT
cord-284008-vlwdtjbe	70	2	study	study	NN
cord-284008-vlwdtjbe	70	3	found	find	VBD
cord-284008-vlwdtjbe	70	4	that	that	IN
cord-284008-vlwdtjbe	70	5	advanced	advanced	JJ
cord-284008-vlwdtjbe	70	6	age	age	NN
cord-284008-vlwdtjbe	70	7	,	,	,
cord-284008-vlwdtjbe	70	8	increased	increase	VBD
cord-284008-vlwdtjbe	70	9	WBC	WBC	NNP
cord-284008-vlwdtjbe	70	10	and	and	CC
cord-284008-vlwdtjbe	70	11	neutrophil	neutrophil	NN
cord-284008-vlwdtjbe	70	12	count	count	NN
cord-284008-vlwdtjbe	70	13	,	,	,
cord-284008-vlwdtjbe	70	14	lower	low	JJR
cord-284008-vlwdtjbe	70	15	serum	serum	NN
cord-284008-vlwdtjbe	70	16	albumin	albumin	NN
cord-284008-vlwdtjbe	70	17	level	level	NN
cord-284008-vlwdtjbe	70	18	,	,	,
cord-284008-vlwdtjbe	70	19	use	use	NN
cord-284008-vlwdtjbe	70	20	of	of	IN
cord-284008-vlwdtjbe	70	21	CRRT	CRRT	NNP
cord-284008-vlwdtjbe	70	22	,	,	,
cord-284008-vlwdtjbe	70	23	and	and	CC
cord-284008-vlwdtjbe	70	24	use	use	NN
cord-284008-vlwdtjbe	70	25	of	of	IN
cord-284008-vlwdtjbe	70	26	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	70	27	were	be	VBD
cord-284008-vlwdtjbe	70	28	associated	associate	VBN
cord-284008-vlwdtjbe	70	29	with	with	IN
cord-284008-vlwdtjbe	70	30	increased	increase	VBN
cord-284008-vlwdtjbe	70	31	mortality	mortality	NN
cord-284008-vlwdtjbe	70	32	.	.	.
cord-284008-vlwdtjbe	71	1	The	the	DT
cord-284008-vlwdtjbe	71	2	odd	odd	JJ
cord-284008-vlwdtjbe	71	3	ratio	ratio	NN
cord-284008-vlwdtjbe	71	4	for	for	IN
cord-284008-vlwdtjbe	71	5	mortality	mortality	NN
cord-284008-vlwdtjbe	71	6	was	be	VBD
cord-284008-vlwdtjbe	71	7	second	second	RB
cord-284008-vlwdtjbe	71	8	highest	high	JJS
cord-284008-vlwdtjbe	71	9	for	for	IN
cord-284008-vlwdtjbe	71	10	the	the	DT
cord-284008-vlwdtjbe	71	11	use	use	NN
cord-284008-vlwdtjbe	71	12	of	of	IN
cord-284008-vlwdtjbe	71	13	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	71	14	.	.	.
cord-284008-vlwdtjbe	72	1	Confuse	confuse	VB
cord-284008-vlwdtjbe	72	2	factor	factor	NN
cord-284008-vlwdtjbe	72	3	disturbance	disturbance	NN
cord-284008-vlwdtjbe	72	4	in	in	IN
cord-284008-vlwdtjbe	72	5	this	this	DT
cord-284008-vlwdtjbe	72	6	study	study	NN
cord-284008-vlwdtjbe	72	7	was	be	VBD
cord-284008-vlwdtjbe	72	8	not	not	RB
cord-284008-vlwdtjbe	72	9	removed	remove	VBN
cord-284008-vlwdtjbe	72	10	,	,	,
cord-284008-vlwdtjbe	72	11	and	and	CC
cord-284008-vlwdtjbe	72	12	they	-PRON-	PRP
cord-284008-vlwdtjbe	72	13	did	do	VBD
cord-284008-vlwdtjbe	72	14	not	not	RB
cord-284008-vlwdtjbe	72	15	know	know	VB
cord-284008-vlwdtjbe	72	16	whether	whether	IN
cord-284008-vlwdtjbe	72	17	all	all	DT
cord-284008-vlwdtjbe	72	18	factors	factor	NNS
cord-284008-vlwdtjbe	72	19	contributed	contribute	VBD
cord-284008-vlwdtjbe	72	20	to	to	IN
cord-284008-vlwdtjbe	72	21	mortality	mortality	NN
cord-284008-vlwdtjbe	72	22	.	.	.
cord-284008-vlwdtjbe	73	1	A	a	DT
cord-284008-vlwdtjbe	73	2	systematic	systematic	JJ
cord-284008-vlwdtjbe	73	3	review	review	NN
cord-284008-vlwdtjbe	73	4	and	and	CC
cord-284008-vlwdtjbe	73	5	meta	meta	NNP
cord-284008-vlwdtjbe	73	6	-	-	HYPH
cord-284008-vlwdtjbe	73	7	analysis	analysis	NN
cord-284008-vlwdtjbe	73	8	were	be	VBD
cord-284008-vlwdtjbe	73	9	conducted	conduct	VBN
cord-284008-vlwdtjbe	73	10	to	to	TO
cord-284008-vlwdtjbe	73	11	provide	provide	VB
cord-284008-vlwdtjbe	73	12	evidence	evidence	NN
cord-284008-vlwdtjbe	73	13	regarding	regard	VBG
cord-284008-vlwdtjbe	73	14	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	73	15	in	in	IN
cord-284008-vlwdtjbe	73	16	the	the	DT
cord-284008-vlwdtjbe	73	17	treatment	treatment	NN
cord-284008-vlwdtjbe	73	18	of	of	IN
cord-284008-vlwdtjbe	73	19	influenza	influenza	NN
cord-284008-vlwdtjbe	73	20	.	.	.
cord-284008-vlwdtjbe	74	1	The	the	DT
cord-284008-vlwdtjbe	74	2	result	result	NN
cord-284008-vlwdtjbe	74	3	of	of	IN
cord-284008-vlwdtjbe	74	4	this	this	DT
cord-284008-vlwdtjbe	74	5	meta	meta	NNP
cord-284008-vlwdtjbe	74	6	-	-	HYPH
cord-284008-vlwdtjbe	74	7	analysis	analysis	NN
cord-284008-vlwdtjbe	74	8	suggested	suggest	VBD
cord-284008-vlwdtjbe	74	9	that	that	IN
cord-284008-vlwdtjbe	74	10	the	the	DT
cord-284008-vlwdtjbe	74	11	use	use	NN
cord-284008-vlwdtjbe	74	12	of	of	IN
cord-284008-vlwdtjbe	74	13	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	74	14	increased	increase	VBD
cord-284008-vlwdtjbe	74	15	the	the	DT
cord-284008-vlwdtjbe	74	16	risk	risk	NN
cord-284008-vlwdtjbe	74	17	of	of	IN
cord-284008-vlwdtjbe	74	18	mortality	mortality	NN
cord-284008-vlwdtjbe	74	19	and	and	CC
cord-284008-vlwdtjbe	74	20	hospital	hospital	NN
cord-284008-vlwdtjbe	74	21	-	-	HYPH
cord-284008-vlwdtjbe	74	22	acquired	acquire	VBN
cord-284008-vlwdtjbe	74	23	infection	infection	NN
cord-284008-vlwdtjbe	74	24	.	.	.
cord-284008-vlwdtjbe	75	1	Patients	patient	NNS
cord-284008-vlwdtjbe	75	2	in	in	IN
cord-284008-vlwdtjbe	75	3	this	this	DT
cord-284008-vlwdtjbe	75	4	study	study	NN
cord-284008-vlwdtjbe	75	5	mainly	mainly	RB
cord-284008-vlwdtjbe	75	6	received	receive	VBD
cord-284008-vlwdtjbe	75	7	high	high	JJ
cord-284008-vlwdtjbe	75	8	doses	dose	NNS
cord-284008-vlwdtjbe	75	9	of	of	IN
cord-284008-vlwdtjbe	75	10	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	75	11	,	,	,
cord-284008-vlwdtjbe	75	12	and	and	CC
cord-284008-vlwdtjbe	75	13	the	the	DT
cord-284008-vlwdtjbe	75	14	evidence	evidence	NN
cord-284008-vlwdtjbe	75	15	was	be	VBD
cord-284008-vlwdtjbe	75	16	of	of	IN
cord-284008-vlwdtjbe	75	17	low	low	JJ
cord-284008-vlwdtjbe	75	18	quality	quality	NN
cord-284008-vlwdtjbe	75	19	with	with	IN
cord-284008-vlwdtjbe	75	20	potential	potential	JJ
cord-284008-vlwdtjbe	75	21	confounding	confounding	NN
cord-284008-vlwdtjbe	75	22	.	.	.
cord-284008-vlwdtjbe	76	1	[	[	-LRB-
cord-284008-vlwdtjbe	76	2	20	20	CD
cord-284008-vlwdtjbe	76	3	]	]	-RRB-
cord-284008-vlwdtjbe	76	4	Li	Li	NNP
cord-284008-vlwdtjbe	76	5	et	et	NNP
cord-284008-vlwdtjbe	76	6	al	al	NNP
cord-284008-vlwdtjbe	76	7	.	.	.
cord-284008-vlwdtjbe	77	1	[	[	-LRB-
cord-284008-vlwdtjbe	77	2	21	21	CD
cord-284008-vlwdtjbe	77	3	]	]	-RRB-
cord-284008-vlwdtjbe	77	4	described	describe	VBD
cord-284008-vlwdtjbe	77	5	the	the	DT
cord-284008-vlwdtjbe	77	6	effect	effect	NN
cord-284008-vlwdtjbe	77	7	of	of	IN
cord-284008-vlwdtjbe	77	8	different	different	JJ
cord-284008-vlwdtjbe	77	9	doses	dose	NNS
cord-284008-vlwdtjbe	77	10	of	of	IN
cord-284008-vlwdtjbe	77	11	adjuvant	adjuvant	NN
cord-284008-vlwdtjbe	77	12	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	77	13	therapy	therapy	NN
cord-284008-vlwdtjbe	77	14	on	on	IN
cord-284008-vlwdtjbe	77	15	30-or	30-or	$
cord-284008-vlwdtjbe	77	16	60-day	60-day	CD
cord-284008-vlwdtjbe	77	17	mortality	mortality	NN
cord-284008-vlwdtjbe	77	18	of	of	IN
cord-284008-vlwdtjbe	77	19	patients	patient	NNS
cord-284008-vlwdtjbe	77	20	with	with	IN
cord-284008-vlwdtjbe	77	21	influenza	influenza	NN
cord-284008-vlwdtjbe	77	22	A	a	NN
cord-284008-vlwdtjbe	77	23	(	(	-LRB-
cord-284008-vlwdtjbe	77	24	H1N1	H1N1	NNP
cord-284008-vlwdtjbe	77	25	)	)	-RRB-
cord-284008-vlwdtjbe	77	26	pdm09	pdm09	NFP
cord-284008-vlwdtjbe	77	27	viral	viral	JJ
cord-284008-vlwdtjbe	77	28	pneumonia	pneumonia	NN
cord-284008-vlwdtjbe	77	29	through	through	IN
cord-284008-vlwdtjbe	77	30	a	a	DT
cord-284008-vlwdtjbe	77	31	retrospective	retrospective	JJ
cord-284008-vlwdtjbe	77	32	analysis	analysis	NN
cord-284008-vlwdtjbe	77	33	.	.	.
cord-284008-vlwdtjbe	78	1	A	a	DT
cord-284008-vlwdtjbe	78	2	total	total	NN
cord-284008-vlwdtjbe	78	3	of	of	IN
cord-284008-vlwdtjbe	78	4	2141	2141	CD
cord-284008-vlwdtjbe	78	5	hospitalized	hospitalize	VBN
cord-284008-vlwdtjbe	78	6	adolescent	adolescent	JJ
cord-284008-vlwdtjbe	78	7	and	and	CC
cord-284008-vlwdtjbe	78	8	adult	adult	NN
cord-284008-vlwdtjbe	78	9	patients	patient	NNS
cord-284008-vlwdtjbe	78	10	were	be	VBD
cord-284008-vlwdtjbe	78	11	included	include	VBN
cord-284008-vlwdtjbe	78	12	in	in	IN
cord-284008-vlwdtjbe	78	13	the	the	DT
cord-284008-vlwdtjbe	78	14	study	study	NN
cord-284008-vlwdtjbe	78	15	.	.	.
cord-284008-vlwdtjbe	79	1	The	the	DT
cord-284008-vlwdtjbe	79	2	results	result	NNS
cord-284008-vlwdtjbe	79	3	of	of	IN
cord-284008-vlwdtjbe	79	4	stratified	stratified	JJ
cord-284008-vlwdtjbe	79	5	analysis	analysis	NN
cord-284008-vlwdtjbe	79	6	based	base	VBN
cord-284008-vlwdtjbe	79	7	on	on	IN
cord-284008-vlwdtjbe	79	8	the	the	DT
cord-284008-vlwdtjbe	79	9	doses	dose	NNS
cord-284008-vlwdtjbe	79	10	of	of	IN
cord-284008-vlwdtjbe	79	11	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	79	12	showed	show	VBD
cord-284008-vlwdtjbe	79	13	that	that	IN
cord-284008-vlwdtjbe	79	14	only	only	JJ
cord-284008-vlwdtjbe	79	15	treatment	treatment	NN
cord-284008-vlwdtjbe	79	16	with	with	IN
cord-284008-vlwdtjbe	79	17	low	low	JJ
cord-284008-vlwdtjbe	79	18	-	-	HYPH
cord-284008-vlwdtjbe	79	19	to	to	TO
cord-284008-vlwdtjbe	79	20	moderate	moderate	JJ
cord-284008-vlwdtjbe	79	21	-	-	HYPH
cord-284008-vlwdtjbe	79	22	dose	dose	NN
cord-284008-vlwdtjbe	79	23	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	79	24	could	could	MD
cord-284008-vlwdtjbe	79	25	reduce	reduce	VB
cord-284008-vlwdtjbe	79	26	30-and	30-and	CD
cord-284008-vlwdtjbe	79	27	60-day	60-day	CD
cord-284008-vlwdtjbe	79	28	mortality	mortality	NN
cord-284008-vlwdtjbe	79	29	of	of	IN
cord-284008-vlwdtjbe	79	30	patients	patient	NNS
cord-284008-vlwdtjbe	79	31	with	with	IN
cord-284008-vlwdtjbe	79	32	severe	severe	JJ
cord-284008-vlwdtjbe	79	33	infection	infection	NN
cord-284008-vlwdtjbe	79	34	with	with	IN
cord-284008-vlwdtjbe	79	35	PaO2	PaO2	NNS
cord-284008-vlwdtjbe	79	36	/	/	SYM
cord-284008-vlwdtjbe	79	37	FiO2	FiO2	NNS
cord-284008-vlwdtjbe	79	38	<	<	XX
cord-284008-vlwdtjbe	80	1	300	300	CD
cord-284008-vlwdtjbe	80	2	mm	mm	CD
cord-284008-vlwdtjbe	80	3	Hg	Hg	NNS
cord-284008-vlwdtjbe	80	4	.	.	.
cord-284008-vlwdtjbe	81	1	However	however	RB
cord-284008-vlwdtjbe	81	2	,	,	,
cord-284008-vlwdtjbe	81	3	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	81	4	at	at	IN
cord-284008-vlwdtjbe	81	5	any	any	DT
cord-284008-vlwdtjbe	81	6	dose	dose	NN
cord-284008-vlwdtjbe	81	7	increased	increase	VBD
cord-284008-vlwdtjbe	81	8	the	the	DT
cord-284008-vlwdtjbe	81	9	60-day	60-day	CD
cord-284008-vlwdtjbe	81	10	mortality	mortality	NN
cord-284008-vlwdtjbe	81	11	of	of	IN
cord-284008-vlwdtjbe	81	12	patients	patient	NNS
cord-284008-vlwdtjbe	81	13	with	with	IN
cord-284008-vlwdtjbe	81	14	mild	mild	JJ
cord-284008-vlwdtjbe	81	15	infection	infection	NN
cord-284008-vlwdtjbe	81	16	with	with	IN
cord-284008-vlwdtjbe	81	17	PaO2	PaO2	NNS
cord-284008-vlwdtjbe	81	18	/	/	SYM
cord-284008-vlwdtjbe	81	19	FiO2	FiO2	NNS
cord-284008-vlwdtjbe	81	20	>	>	XX
cord-284008-vlwdtjbe	82	1	300	300	CD
cord-284008-vlwdtjbe	82	2	mm	mm	NN
cord-284008-vlwdtjbe	83	1	Hg	Hg	NNP
cord-284008-vlwdtjbe	83	2	.	.	.
cord-284008-vlwdtjbe	84	1	Cao	Cao	NNP
cord-284008-vlwdtjbe	84	2	et	et	NNP
cord-284008-vlwdtjbe	84	3	al	al	NNP
cord-284008-vlwdtjbe	84	4	.	.	.
cord-284008-vlwdtjbe	85	1	[	[	-LRB-
cord-284008-vlwdtjbe	85	2	22	22	CD
cord-284008-vlwdtjbe	85	3	]	]	-RRB-
cord-284008-vlwdtjbe	85	4	screened	screen	VBN
cord-284008-vlwdtjbe	85	5	patients	patient	NNS
cord-284008-vlwdtjbe	85	6	aged	age	VBN
cord-284008-vlwdtjbe	85	7	>	>	XX
cord-284008-vlwdtjbe	86	1	14	14	CD
cord-284008-vlwdtjbe	86	2	years	year	NNS
cord-284008-vlwdtjbe	86	3	with	with	IN
cord-284008-vlwdtjbe	86	4	severe	severe	JJ
cord-284008-vlwdtjbe	86	5	influenza	influenza	NN
cord-284008-vlwdtjbe	86	6	A	a	NN
cord-284008-vlwdtjbe	86	7	(	(	-LRB-
cord-284008-vlwdtjbe	86	8	H7N9	H7N9	NNP
cord-284008-vlwdtjbe	86	9	)	)	-RRB-
cord-284008-vlwdtjbe	86	10	virus	virus	NN
cord-284008-vlwdtjbe	86	11	infections	infection	NNS
cord-284008-vlwdtjbe	86	12	from	from	IN
cord-284008-vlwdtjbe	86	13	April	April	NNP
cord-284008-vlwdtjbe	86	14	2013	2013	CD
cord-284008-vlwdtjbe	86	15	to	to	IN
cord-284008-vlwdtjbe	86	16	March	March	NNP
cord-284008-vlwdtjbe	86	17	2015	2015	CD
cord-284008-vlwdtjbe	86	18	to	to	TO
cord-284008-vlwdtjbe	86	19	determine	determine	VB
cord-284008-vlwdtjbe	86	20	the	the	DT
cord-284008-vlwdtjbe	86	21	impact	impact	NN
cord-284008-vlwdtjbe	86	22	of	of	IN
cord-284008-vlwdtjbe	86	23	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	86	24	.	.	.
cord-284008-vlwdtjbe	87	1	They	-PRON-	PRP
cord-284008-vlwdtjbe	87	2	found	find	VBD
cord-284008-vlwdtjbe	87	3	that	that	IN
cord-284008-vlwdtjbe	87	4	high	high	JJ
cord-284008-vlwdtjbe	87	5	-	-	HYPH
cord-284008-vlwdtjbe	87	6	dose	dose	NN
cord-284008-vlwdtjbe	87	7	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	87	8	therapy	therapy	NN
cord-284008-vlwdtjbe	87	9	(	(	-LRB-
cord-284008-vlwdtjbe	87	10	>	>	NFP
cord-284008-vlwdtjbe	87	11	150	150	CD
cord-284008-vlwdtjbe	87	12	mg	mg	NNP
cord-284008-vlwdtjbe	87	13	/	/	SYM
cord-284008-vlwdtjbe	87	14	d	d	NN
cord-284008-vlwdtjbe	87	15	methylprednisolone	methylprednisolone	NN
cord-284008-vlwdtjbe	87	16	or	or	CC
cord-284008-vlwdtjbe	87	17	equivalent	equivalent	NN
cord-284008-vlwdtjbe	87	18	)	)	-RRB-
cord-284008-vlwdtjbe	87	19	was	be	VBD
cord-284008-vlwdtjbe	87	20	associated	associate	VBN
cord-284008-vlwdtjbe	87	21	with	with	IN
cord-284008-vlwdtjbe	87	22	longer	long	JJR
cord-284008-vlwdtjbe	87	23	viral	viral	JJ
cord-284008-vlwdtjbe	87	24	shedding	shedding	NN
cord-284008-vlwdtjbe	87	25	and	and	CC
cord-284008-vlwdtjbe	87	26	significantly	significantly	RB
cord-284008-vlwdtjbe	87	27	increased	increase	VBD
cord-284008-vlwdtjbe	87	28	both	both	DT
cord-284008-vlwdtjbe	87	29	30and	30and	NN
cord-284008-vlwdtjbe	87	30	60-day	60-day	CD
cord-284008-vlwdtjbe	87	31	mortality	mortality	NN
cord-284008-vlwdtjbe	87	32	.	.	.
cord-284008-vlwdtjbe	88	1	On	on	IN
cord-284008-vlwdtjbe	88	2	the	the	DT
cord-284008-vlwdtjbe	88	3	whole	whole	JJ
cord-284008-vlwdtjbe	88	4	,	,	,
cord-284008-vlwdtjbe	88	5	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	88	6	therapy	therapy	NN
cord-284008-vlwdtjbe	88	7	seemed	seem	VBD
cord-284008-vlwdtjbe	88	8	to	to	TO
cord-284008-vlwdtjbe	88	9	be	be	VB
cord-284008-vlwdtjbe	88	10	a	a	DT
cord-284008-vlwdtjbe	88	11	double	double	RB
cord-284008-vlwdtjbe	88	12	-	-	HYPH
cord-284008-vlwdtjbe	88	13	edged	edged	JJ
cord-284008-vlwdtjbe	88	14	sword	sword	NN
cord-284008-vlwdtjbe	88	15	in	in	IN
cord-284008-vlwdtjbe	88	16	these	these	DT
cord-284008-vlwdtjbe	88	17	infectious	infectious	JJ
cord-284008-vlwdtjbe	88	18	diseases	disease	NNS
cord-284008-vlwdtjbe	88	19	.	.	.
cord-284008-vlwdtjbe	89	1	So	so	RB
cord-284008-vlwdtjbe	89	2	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	89	3	,	,	,
cord-284008-vlwdtjbe	89	4	especially	especially	RB
cord-284008-vlwdtjbe	89	5	high	high	JJ
cord-284008-vlwdtjbe	89	6	-	-	HYPH
cord-284008-vlwdtjbe	89	7	dose	dose	NN
cord-284008-vlwdtjbe	89	8	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	89	9	,	,	,
cord-284008-vlwdtjbe	89	10	should	should	MD
cord-284008-vlwdtjbe	89	11	be	be	VB
cord-284008-vlwdtjbe	89	12	used	use	VBN
cord-284008-vlwdtjbe	89	13	in	in	IN
cord-284008-vlwdtjbe	89	14	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	89	15	more	more	RBR
cord-284008-vlwdtjbe	89	16	cautiously	cautiously	RB
cord-284008-vlwdtjbe	89	17	.	.	.
cord-284008-vlwdtjbe	90	1	Of	of	RB
cord-284008-vlwdtjbe	90	2	course	course	RB
cord-284008-vlwdtjbe	90	3	,	,	,
cord-284008-vlwdtjbe	90	4	it	-PRON-	PRP
cord-284008-vlwdtjbe	90	5	would	would	MD
cord-284008-vlwdtjbe	90	6	be	be	VB
cord-284008-vlwdtjbe	90	7	better	well	JJR
cord-284008-vlwdtjbe	90	8	if	if	IN
cord-284008-vlwdtjbe	90	9	supported	support	VBN
cord-284008-vlwdtjbe	90	10	by	by	IN
cord-284008-vlwdtjbe	90	11	high	high	JJ
cord-284008-vlwdtjbe	90	12	-	-	HYPH
cord-284008-vlwdtjbe	90	13	quality	quality	NN
cord-284008-vlwdtjbe	90	14	randomized	randomize	VBN
cord-284008-vlwdtjbe	90	15	controlled	control	VBN
cord-284008-vlwdtjbe	90	16	trials	trial	NNS
cord-284008-vlwdtjbe	90	17	when	when	WRB
cord-284008-vlwdtjbe	90	18	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	90	19	are	be	VBP
cord-284008-vlwdtjbe	90	20	used	use	VBN
cord-284008-vlwdtjbe	90	21	.	.	.
cord-284008-vlwdtjbe	91	1	As	as	IN
cord-284008-vlwdtjbe	91	2	there	there	EX
cord-284008-vlwdtjbe	91	3	is	be	VBZ
cord-284008-vlwdtjbe	91	4	no	no	DT
cord-284008-vlwdtjbe	91	5	strong	strong	JJ
cord-284008-vlwdtjbe	91	6	clinical	clinical	JJ
cord-284008-vlwdtjbe	91	7	evidence	evidence	NN
cord-284008-vlwdtjbe	91	8	that	that	IN
cord-284008-vlwdtjbe	91	9	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	91	10	can	can	MD
cord-284008-vlwdtjbe	91	11	benefit	benefit	VB
cord-284008-vlwdtjbe	91	12	patients	patient	NNS
cord-284008-vlwdtjbe	91	13	with	with	IN
cord-284008-vlwdtjbe	91	14	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	91	15	,	,	,
cord-284008-vlwdtjbe	91	16	and	and	CC
cord-284008-vlwdtjbe	91	17	worrying	worry	VBG
cord-284008-vlwdtjbe	91	18	about	about	IN
cord-284008-vlwdtjbe	91	19	the	the	DT
cord-284008-vlwdtjbe	91	20	possible	possible	JJ
cord-284008-vlwdtjbe	91	21	harm	harm	NN
cord-284008-vlwdtjbe	91	22	,	,	,
cord-284008-vlwdtjbe	91	23	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	91	24	are	be	VBP
cord-284008-vlwdtjbe	91	25	not	not	RB
cord-284008-vlwdtjbe	91	26	widely	widely	RB
cord-284008-vlwdtjbe	91	27	used	use	VBN
cord-284008-vlwdtjbe	91	28	in	in	IN
cord-284008-vlwdtjbe	91	29	the	the	DT
cord-284008-vlwdtjbe	91	30	treatment	treatment	NN
cord-284008-vlwdtjbe	91	31	of	of	IN
cord-284008-vlwdtjbe	91	32	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	91	33	.	.	.
cord-284008-vlwdtjbe	92	1	For	for	IN
cord-284008-vlwdtjbe	92	2	the	the	DT
cord-284008-vlwdtjbe	92	3	above	above	JJ
cord-284008-vlwdtjbe	92	4	reasons	reason	NNS
cord-284008-vlwdtjbe	92	5	,	,	,
cord-284008-vlwdtjbe	92	6	Clark	Clark	NNP
cord-284008-vlwdtjbe	92	7	Russell	Russell	NNP
cord-284008-vlwdtjbe	92	8	and	and	CC
cord-284008-vlwdtjbe	92	9	colleagues	colleague	NNS
cord-284008-vlwdtjbe	92	10	concluded	conclude	VBD
cord-284008-vlwdtjbe	92	11	that	that	IN
cord-284008-vlwdtjbe	92	12	COVID-19related	COVID-19related	NNP
cord-284008-vlwdtjbe	92	13	lung	lung	NN
cord-284008-vlwdtjbe	92	14	injury	injury	NN
cord-284008-vlwdtjbe	92	15	or	or	CC
cord-284008-vlwdtjbe	92	16	shock	shock	NN
cord-284008-vlwdtjbe	92	17	should	should	MD
cord-284008-vlwdtjbe	92	18	not	not	RB
cord-284008-vlwdtjbe	92	19	be	be	VB
cord-284008-vlwdtjbe	92	20	treated	treat	VBN
cord-284008-vlwdtjbe	92	21	with	with	IN
cord-284008-vlwdtjbe	92	22	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	92	23	except	except	IN
cord-284008-vlwdtjbe	92	24	for	for	IN
cord-284008-vlwdtjbe	92	25	clinical	clinical	JJ
cord-284008-vlwdtjbe	92	26	trials	trial	NNS
cord-284008-vlwdtjbe	92	27	.	.	.
cord-284008-vlwdtjbe	93	1	[	[	-LRB-
cord-284008-vlwdtjbe	93	2	23	23	CD
cord-284008-vlwdtjbe	93	3	]	]	-RRB-
cord-284008-vlwdtjbe	94	1	Although	although	IN
cord-284008-vlwdtjbe	94	2	the	the	DT
cord-284008-vlwdtjbe	94	3	Lancet	Lancet	NNP
cord-284008-vlwdtjbe	94	4	published	publish	VBD
cord-284008-vlwdtjbe	94	5	the	the	DT
cord-284008-vlwdtjbe	94	6	world	world	NN
cord-284008-vlwdtjbe	94	7	's	's	POS
cord-284008-vlwdtjbe	94	8	first	first	JJ
cord-284008-vlwdtjbe	94	9	pathological	pathological	JJ
cord-284008-vlwdtjbe	94	10	results	result	NNS
cord-284008-vlwdtjbe	94	11	of	of	IN
cord-284008-vlwdtjbe	94	12	a	a	DT
cord-284008-vlwdtjbe	94	13	patient	patient	NN
cord-284008-vlwdtjbe	94	14	with	with	IN
cord-284008-vlwdtjbe	94	15	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	94	16	on	on	IN
cord-284008-vlwdtjbe	94	17	February	February	NNP
cord-284008-vlwdtjbe	94	18	17	17	CD
cord-284008-vlwdtjbe	94	19	,	,	,
cord-284008-vlwdtjbe	94	20	2020	2020	CD
cord-284008-vlwdtjbe	94	21	.	.	.
cord-284008-vlwdtjbe	95	1	The	the	DT
cord-284008-vlwdtjbe	95	2	patient	patient	NN
cord-284008-vlwdtjbe	95	3	's	's	POS
cord-284008-vlwdtjbe	95	4	lungs	lung	NNS
cord-284008-vlwdtjbe	95	5	showed	show	VBD
cord-284008-vlwdtjbe	95	6	diffuse	diffuse	JJ
cord-284008-vlwdtjbe	95	7	alveolar	alveolar	JJ
cord-284008-vlwdtjbe	95	8	injury	injury	NN
cord-284008-vlwdtjbe	95	9	and	and	CC
cord-284008-vlwdtjbe	95	10	pulmonary	pulmonary	JJ
cord-284008-vlwdtjbe	95	11	hyaline	hyaline	JJ
cord-284008-vlwdtjbe	95	12	membrane	membrane	NN
cord-284008-vlwdtjbe	95	13	formation	formation	NN
cord-284008-vlwdtjbe	95	14	consistent	consistent	JJ
cord-284008-vlwdtjbe	95	15	with	with	IN
cord-284008-vlwdtjbe	95	16	the	the	DT
cord-284008-vlwdtjbe	95	17	performance	performance	NN
cord-284008-vlwdtjbe	95	18	of	of	IN
cord-284008-vlwdtjbe	95	19	ARDS	ARDS	NNP
cord-284008-vlwdtjbe	95	20	,	,	,
cord-284008-vlwdtjbe	95	21	suggesting	suggest	VBG
cord-284008-vlwdtjbe	95	22	that	that	IN
cord-284008-vlwdtjbe	95	23	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	95	24	should	should	MD
cord-284008-vlwdtjbe	95	25	be	be	VB
cord-284008-vlwdtjbe	95	26	provided	provide	VBN
cord-284008-vlwdtjbe	95	27	timely	timely	RB
cord-284008-vlwdtjbe	95	28	and	and	CC
cord-284008-vlwdtjbe	95	29	appropriately	appropriately	RB
cord-284008-vlwdtjbe	95	30	.	.	.
cord-284008-vlwdtjbe	96	1	[	[	-LRB-
cord-284008-vlwdtjbe	96	2	24	24	CD
cord-284008-vlwdtjbe	96	3	]	]	-RRB-
cord-284008-vlwdtjbe	96	4	So	so	RB
cord-284008-vlwdtjbe	96	5	far	far	RB
cord-284008-vlwdtjbe	96	6	,	,	,
cord-284008-vlwdtjbe	96	7	whether	whether	IN
cord-284008-vlwdtjbe	96	8	the	the	DT
cord-284008-vlwdtjbe	96	9	patients	patient	NNS
cord-284008-vlwdtjbe	96	10	with	with	IN
cord-284008-vlwdtjbe	96	11	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	96	12	could	could	MD
cord-284008-vlwdtjbe	96	13	benefit	benefit	VB
cord-284008-vlwdtjbe	96	14	from	from	IN
cord-284008-vlwdtjbe	96	15	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	96	16	therapy	therapy	NN
cord-284008-vlwdtjbe	96	17	is	be	VBZ
cord-284008-vlwdtjbe	96	18	not	not	RB
cord-284008-vlwdtjbe	96	19	clear	clear	JJ
cord-284008-vlwdtjbe	96	20	.	.	.
cord-284008-vlwdtjbe	97	1	At	at	IN
cord-284008-vlwdtjbe	97	2	this	this	DT
cord-284008-vlwdtjbe	97	3	time	time	NN
cord-284008-vlwdtjbe	97	4	,	,	,
cord-284008-vlwdtjbe	97	5	it	-PRON-	PRP
cord-284008-vlwdtjbe	97	6	is	be	VBZ
cord-284008-vlwdtjbe	97	7	important	important	JJ
cord-284008-vlwdtjbe	97	8	to	to	TO
cord-284008-vlwdtjbe	97	9	summarize	summarize	VB
cord-284008-vlwdtjbe	97	10	the	the	DT
cord-284008-vlwdtjbe	97	11	advantages	advantage	NNS
cord-284008-vlwdtjbe	97	12	and	and	CC
cord-284008-vlwdtjbe	97	13	disadvantages	disadvantage	NNS
cord-284008-vlwdtjbe	97	14	of	of	IN
cord-284008-vlwdtjbe	97	15	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	97	16	therapy	therapy	NN
cord-284008-vlwdtjbe	97	17	in	in	IN
cord-284008-vlwdtjbe	97	18	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	97	19	.	.	.
cord-284008-vlwdtjbe	98	1	On	on	IN
cord-284008-vlwdtjbe	98	2	the	the	DT
cord-284008-vlwdtjbe	98	3	negative	negative	JJ
cord-284008-vlwdtjbe	98	4	side	side	NN
cord-284008-vlwdtjbe	98	5	,	,	,
cord-284008-vlwdtjbe	98	6	Liu	Liu	NNP
cord-284008-vlwdtjbe	98	7	et	et	NNP
cord-284008-vlwdtjbe	98	8	al	al	NNP
cord-284008-vlwdtjbe	98	9	.	.	.
cord-284008-vlwdtjbe	99	1	[	[	-LRB-
cord-284008-vlwdtjbe	99	2	25	25	CD
cord-284008-vlwdtjbe	99	3	]	]	-RRB-
cord-284008-vlwdtjbe	99	4	reported	report	VBD
cord-284008-vlwdtjbe	99	5	the	the	DT
cord-284008-vlwdtjbe	99	6	clinical	clinical	JJ
cord-284008-vlwdtjbe	99	7	characteristics	characteristic	NNS
cord-284008-vlwdtjbe	99	8	and	and	CC
cord-284008-vlwdtjbe	99	9	treatment	treatment	NN
cord-284008-vlwdtjbe	99	10	of	of	IN
cord-284008-vlwdtjbe	99	11	patients	patient	NNS
cord-284008-vlwdtjbe	99	12	with	with	IN
cord-284008-vlwdtjbe	99	13	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	99	14	with	with	IN
cord-284008-vlwdtjbe	99	15	ARDS	ARDS	NNP
cord-284008-vlwdtjbe	99	16	in	in	IN
cord-284008-vlwdtjbe	99	17	a	a	DT
cord-284008-vlwdtjbe	99	18	study	study	NN
cord-284008-vlwdtjbe	99	19	available	available	JJ
cord-284008-vlwdtjbe	99	20	on	on	IN
cord-284008-vlwdtjbe	99	21	the	the	DT
cord-284008-vlwdtjbe	99	22	medRxiv	medRxiv	NNP
cord-284008-vlwdtjbe	99	23	preprint	preprint	NN
cord-284008-vlwdtjbe	99	24	server	server	NN
cord-284008-vlwdtjbe	99	25	.	.	.
cord-284008-vlwdtjbe	100	1	This	this	DT
cord-284008-vlwdtjbe	100	2	study	study	NN
cord-284008-vlwdtjbe	100	3	enrolled	enrol	VBD
cord-284008-vlwdtjbe	100	4	109	109	CD
cord-284008-vlwdtjbe	100	5	patients	patient	NNS
cord-284008-vlwdtjbe	100	6	in	in	IN
cord-284008-vlwdtjbe	100	7	Wuhan	Wuhan	NNP
cord-284008-vlwdtjbe	100	8	,	,	,
cord-284008-vlwdtjbe	100	9	China	China	NNP
cord-284008-vlwdtjbe	100	10	,	,	,
cord-284008-vlwdtjbe	100	11	from	from	IN
cord-284008-vlwdtjbe	100	12	January	January	NNP
cord-284008-vlwdtjbe	100	13	2	2	CD
cord-284008-vlwdtjbe	100	14	to	to	IN
cord-284008-vlwdtjbe	100	15	February	February	NNP
cord-284008-vlwdtjbe	100	16	1	1	CD
cord-284008-vlwdtjbe	100	17	,	,	,
cord-284008-vlwdtjbe	100	18	2020	2020	CD
cord-284008-vlwdtjbe	100	19	.	.	.
cord-284008-vlwdtjbe	101	1	They	-PRON-	PRP
cord-284008-vlwdtjbe	101	2	concluded	conclude	VBD
cord-284008-vlwdtjbe	101	3	that	that	IN
cord-284008-vlwdtjbe	101	4	patients	patient	NNS
cord-284008-vlwdtjbe	101	5	with	with	IN
cord-284008-vlwdtjbe	101	6	moderate	moderate	JJ
cord-284008-vlwdtjbe	101	7	or	or	CC
cord-284008-vlwdtjbe	101	8	severe	severe	JJ
cord-284008-vlwdtjbe	101	9	ARDS	ARDS	NNP
cord-284008-vlwdtjbe	101	10	were	be	VBD
cord-284008-vlwdtjbe	101	11	more	more	RBR
cord-284008-vlwdtjbe	101	12	likely	likely	JJ
cord-284008-vlwdtjbe	101	13	to	to	TO
cord-284008-vlwdtjbe	101	14	receive	receive	VB
cord-284008-vlwdtjbe	101	15	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	101	16	,	,	,
cord-284008-vlwdtjbe	101	17	but	but	CC
cord-284008-vlwdtjbe	101	18	the	the	DT
cord-284008-vlwdtjbe	101	19	effects	effect	NNS
cord-284008-vlwdtjbe	101	20	of	of	IN
cord-284008-vlwdtjbe	101	21	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	101	22	treatment	treatment	NN
cord-284008-vlwdtjbe	101	23	on	on	IN
cord-284008-vlwdtjbe	101	24	the	the	DT
cord-284008-vlwdtjbe	101	25	survival	survival	NN
cord-284008-vlwdtjbe	101	26	were	be	VBD
cord-284008-vlwdtjbe	101	27	not	not	RB
cord-284008-vlwdtjbe	101	28	satisfactory	satisfactory	JJ
cord-284008-vlwdtjbe	101	29	.	.	.
cord-284008-vlwdtjbe	102	1	Similarly	similarly	RB
cord-284008-vlwdtjbe	102	2	,	,	,
cord-284008-vlwdtjbe	102	3	Feng	Feng	NNP
cord-284008-vlwdtjbe	102	4	et	et	FW
cord-284008-vlwdtjbe	102	5	al	al	NNP
cord-284008-vlwdtjbe	102	6	.	.	.
cord-284008-vlwdtjbe	103	1	[	[	-LRB-
cord-284008-vlwdtjbe	103	2	26	26	CD
cord-284008-vlwdtjbe	103	3	]	]	-RRB-
cord-284008-vlwdtjbe	103	4	found	find	VBD
cord-284008-vlwdtjbe	103	5	that	that	IN
cord-284008-vlwdtjbe	103	6	more	more	JJR
cord-284008-vlwdtjbe	103	7	patients	patient	NNS
cord-284008-vlwdtjbe	103	8	received	receive	VBD
cord-284008-vlwdtjbe	103	9	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	103	10	in	in	IN
cord-284008-vlwdtjbe	103	11	the	the	DT
cord-284008-vlwdtjbe	103	12	critical	critical	JJ
cord-284008-vlwdtjbe	103	13	and	and	CC
cord-284008-vlwdtjbe	103	14	severe	severe	JJ
cord-284008-vlwdtjbe	103	15	groups	group	NNS
cord-284008-vlwdtjbe	103	16	.	.	.
cord-284008-vlwdtjbe	104	1	Although	although	IN
cord-284008-vlwdtjbe	104	2	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	104	3	therapy	therapy	NN
cord-284008-vlwdtjbe	104	4	did	do	VBD
cord-284008-vlwdtjbe	104	5	not	not	RB
cord-284008-vlwdtjbe	104	6	have	have	VB
cord-284008-vlwdtjbe	104	7	any	any	DT
cord-284008-vlwdtjbe	104	8	association	association	NN
cord-284008-vlwdtjbe	104	9	with	with	IN
cord-284008-vlwdtjbe	104	10	disease	disease	NN
cord-284008-vlwdtjbe	104	11	progression	progression	NN
cord-284008-vlwdtjbe	104	12	to	to	IN
cord-284008-vlwdtjbe	104	13	death	death	NN
cord-284008-vlwdtjbe	104	14	or	or	CC
cord-284008-vlwdtjbe	104	15	mechanical	mechanical	JJ
cord-284008-vlwdtjbe	104	16	ventilation	ventilation	NN
cord-284008-vlwdtjbe	104	17	,	,	,
cord-284008-vlwdtjbe	104	18	receiving	receive	VBG
cord-284008-vlwdtjbe	104	19	no	no	DT
cord-284008-vlwdtjbe	104	20	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	104	21	in	in	IN
cord-284008-vlwdtjbe	104	22	the	the	DT
cord-284008-vlwdtjbe	104	23	critical	critical	JJ
cord-284008-vlwdtjbe	104	24	group	group	NN
cord-284008-vlwdtjbe	104	25	was	be	VBD
cord-284008-vlwdtjbe	104	26	associated	associate	VBN
cord-284008-vlwdtjbe	104	27	with	with	IN
cord-284008-vlwdtjbe	104	28	good	good	JJ
cord-284008-vlwdtjbe	104	29	prognosis	prognosis	NN
cord-284008-vlwdtjbe	104	30	.	.	.
cord-284008-vlwdtjbe	105	1	Shang	Shang	NNP
cord-284008-vlwdtjbe	105	2	et	et	NNP
cord-284008-vlwdtjbe	105	3	al	al	NNP
cord-284008-vlwdtjbe	105	4	.	.	.
cord-284008-vlwdtjbe	106	1	[	[	-LRB-
cord-284008-vlwdtjbe	106	2	27	27	CD
cord-284008-vlwdtjbe	106	3	]	]	-RRB-
cord-284008-vlwdtjbe	106	4	divided	divide	VBD
cord-284008-vlwdtjbe	106	5	416	416	CD
cord-284008-vlwdtjbe	106	6	patients	patient	NNS
cord-284008-vlwdtjbe	106	7	with	with	IN
cord-284008-vlwdtjbe	106	8	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	106	9	into	into	IN
cord-284008-vlwdtjbe	106	10	three	three	CD
cord-284008-vlwdtjbe	106	11	groups	group	NNS
cord-284008-vlwdtjbe	106	12	based	base	VBN
cord-284008-vlwdtjbe	106	13	on	on	IN
cord-284008-vlwdtjbe	106	14	clinical	clinical	JJ
cord-284008-vlwdtjbe	106	15	outcomes	outcome	NNS
cord-284008-vlwdtjbe	106	16	:	:	:
cord-284008-vlwdtjbe	106	17	the	the	DT
cord-284008-vlwdtjbe	106	18	common	common	JJ
cord-284008-vlwdtjbe	106	19	survivor	survivor	NN
cord-284008-vlwdtjbe	106	20	(	(	-LRB-
cord-284008-vlwdtjbe	106	21	not	not	RB
cord-284008-vlwdtjbe	106	22	severe/	severe/	CD
cord-284008-vlwdtjbe	106	23	critical	critical	JJ
cord-284008-vlwdtjbe	106	24	)	)	-RRB-
cord-284008-vlwdtjbe	106	25	group	group	NN
cord-284008-vlwdtjbe	106	26	,	,	,
cord-284008-vlwdtjbe	106	27	the	the	DT
cord-284008-vlwdtjbe	106	28	severe	severe	JJ
cord-284008-vlwdtjbe	106	29	/	/	SYM
cord-284008-vlwdtjbe	106	30	critical	critical	JJ
cord-284008-vlwdtjbe	106	31	survivor	survivor	NN
cord-284008-vlwdtjbe	106	32	group	group	NN
cord-284008-vlwdtjbe	106	33	,	,	,
cord-284008-vlwdtjbe	106	34	and	and	CC
cord-284008-vlwdtjbe	106	35	the	the	DT
cord-284008-vlwdtjbe	106	36	death	death	NN
cord-284008-vlwdtjbe	106	37	group	group	NN
cord-284008-vlwdtjbe	106	38	.	.	.
cord-284008-vlwdtjbe	107	1	The	the	DT
cord-284008-vlwdtjbe	107	2	comparison	comparison	NN
cord-284008-vlwdtjbe	107	3	of	of	IN
cord-284008-vlwdtjbe	107	4	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	107	5	therapy	therapy	NN
cord-284008-vlwdtjbe	107	6	among	among	IN
cord-284008-vlwdtjbe	107	7	different	different	JJ
cord-284008-vlwdtjbe	107	8	groups	group	NNS
cord-284008-vlwdtjbe	107	9	showed	show	VBD
cord-284008-vlwdtjbe	107	10	that	that	IN
cord-284008-vlwdtjbe	107	11	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	107	12	therapy	therapy	NN
cord-284008-vlwdtjbe	107	13	prolonged	prolong	VBD
cord-284008-vlwdtjbe	107	14	the	the	DT
cord-284008-vlwdtjbe	107	15	hospitalization	hospitalization	NN
cord-284008-vlwdtjbe	107	16	days	day	NNS
cord-284008-vlwdtjbe	107	17	for	for	IN
cord-284008-vlwdtjbe	107	18	the	the	DT
cord-284008-vlwdtjbe	107	19	patients	patient	NNS
cord-284008-vlwdtjbe	107	20	in	in	IN
cord-284008-vlwdtjbe	107	21	the	the	DT
cord-284008-vlwdtjbe	107	22	common	common	JJ
cord-284008-vlwdtjbe	107	23	and	and	CC
cord-284008-vlwdtjbe	107	24	severe	severe	JJ
cord-284008-vlwdtjbe	107	25	/	/	SYM
cord-284008-vlwdtjbe	107	26	critical	critical	JJ
cord-284008-vlwdtjbe	107	27	survivor	survivor	NN
cord-284008-vlwdtjbe	107	28	groups	group	NNS
cord-284008-vlwdtjbe	107	29	.	.	.
cord-284008-vlwdtjbe	108	1	Patients	patient	NNS
cord-284008-vlwdtjbe	108	2	in	in	IN
cord-284008-vlwdtjbe	108	3	the	the	DT
cord-284008-vlwdtjbe	108	4	two	two	CD
cord-284008-vlwdtjbe	108	5	survivor	survivor	NN
cord-284008-vlwdtjbe	108	6	groups	group	NNS
cord-284008-vlwdtjbe	108	7	who	who	WP
cord-284008-vlwdtjbe	108	8	received	receive	VBD
cord-284008-vlwdtjbe	108	9	corticosteroid	corticosteroid	JJ
cord-284008-vlwdtjbe	108	10	treatment	treatment	NN
cord-284008-vlwdtjbe	108	11	had	have	VBD
cord-284008-vlwdtjbe	108	12	lower	low	JJR
cord-284008-vlwdtjbe	108	13	lymphocyte	lymphocyte	NN
cord-284008-vlwdtjbe	108	14	counts	count	NNS
cord-284008-vlwdtjbe	108	15	and	and	CC
cord-284008-vlwdtjbe	108	16	the	the	DT
cord-284008-vlwdtjbe	108	17	median	median	JJ
cord-284008-vlwdtjbe	108	18	percentage	percentage	NN
cord-284008-vlwdtjbe	108	19	of	of	IN
cord-284008-vlwdtjbe	108	20	lymphocytes	lymphocyte	NNS
cord-284008-vlwdtjbe	108	21	was	be	VBD
cord-284008-vlwdtjbe	108	22	reduced	reduce	VBN
cord-284008-vlwdtjbe	108	23	after	after	IN
cord-284008-vlwdtjbe	108	24	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	108	25	therapy	therapy	NN
cord-284008-vlwdtjbe	108	26	in	in	IN
cord-284008-vlwdtjbe	108	27	the	the	DT
cord-284008-vlwdtjbe	108	28	death	death	NN
cord-284008-vlwdtjbe	108	29	group	group	NN
cord-284008-vlwdtjbe	108	30	.	.	.
cord-284008-vlwdtjbe	109	1	It	-PRON-	PRP
cord-284008-vlwdtjbe	109	2	is	be	VBZ
cord-284008-vlwdtjbe	109	3	better	well	JJR
cord-284008-vlwdtjbe	109	4	to	to	TO
cord-284008-vlwdtjbe	109	5	analyze	analyze	VB
cord-284008-vlwdtjbe	109	6	more	more	JJR
cord-284008-vlwdtjbe	109	7	cases	case	NNS
cord-284008-vlwdtjbe	109	8	in	in	IN
cord-284008-vlwdtjbe	109	9	this	this	DT
cord-284008-vlwdtjbe	109	10	retrospective	retrospective	JJ
cord-284008-vlwdtjbe	109	11	observational	observational	JJ
cord-284008-vlwdtjbe	109	12	study	study	NN
cord-284008-vlwdtjbe	109	13	.	.	.
cord-284008-vlwdtjbe	110	1	What	what	WP
cord-284008-vlwdtjbe	110	2	are	be	VBP
cord-284008-vlwdtjbe	110	3	the	the	DT
cord-284008-vlwdtjbe	110	4	positive	positive	JJ
cord-284008-vlwdtjbe	110	5	effects	effect	NNS
cord-284008-vlwdtjbe	110	6	of	of	IN
cord-284008-vlwdtjbe	110	7	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	110	8	?	?	.
cord-284008-vlwdtjbe	111	1	The	the	DT
cord-284008-vlwdtjbe	111	2	efficacy	efficacy	NN
cord-284008-vlwdtjbe	111	3	of	of	IN
cord-284008-vlwdtjbe	111	4	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	111	5	for	for	IN
cord-284008-vlwdtjbe	111	6	severe	severe	JJ
cord-284008-vlwdtjbe	111	7	or	or	CC
cord-284008-vlwdtjbe	111	8	fatal	fatal	JJ
cord-284008-vlwdtjbe	111	9	cases	case	NNS
cord-284008-vlwdtjbe	111	10	with	with	IN
cord-284008-vlwdtjbe	111	11	COVID-19	covid-19	CD
cord-284008-vlwdtjbe	111	12	in	in	IN
cord-284008-vlwdtjbe	111	13	Wuhan	Wuhan	NNP
cord-284008-vlwdtjbe	111	14	was	be	VBD
cord-284008-vlwdtjbe	111	15	evaluated	evaluate	VBN
cord-284008-vlwdtjbe	111	16	.	.	.
cord-284008-vlwdtjbe	112	1	The	the	DT
cord-284008-vlwdtjbe	112	2	results	result	NNS
cord-284008-vlwdtjbe	112	3	showed	show	VBD
cord-284008-vlwdtjbe	112	4	that	that	IN
cord-284008-vlwdtjbe	112	5	although	although	IN
cord-284008-vlwdtjbe	112	6	low	low	JJ
cord-284008-vlwdtjbe	112	7	-	-	HYPH
cord-284008-vlwdtjbe	112	8	dose	dose	NN
cord-284008-vlwdtjbe	112	9	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	112	10	might	may	MD
cord-284008-vlwdtjbe	112	11	not	not	RB
cord-284008-vlwdtjbe	112	12	improve	improve	VB
cord-284008-vlwdtjbe	112	13	ICU	ICU	NNP
cord-284008-vlwdtjbe	112	14	mortality	mortality	NN
cord-284008-vlwdtjbe	112	15	,	,	,
cord-284008-vlwdtjbe	112	16	it	-PRON-	PRP
cord-284008-vlwdtjbe	112	17	suppressed	suppress	VBD
cord-284008-vlwdtjbe	112	18	the	the	DT
cord-284008-vlwdtjbe	112	19	cytokine	cytokine	NN
cord-284008-vlwdtjbe	112	20	storm	storm	NN
cord-284008-vlwdtjbe	112	21	in	in	IN
cord-284008-vlwdtjbe	112	22	the	the	DT
cord-284008-vlwdtjbe	112	23	phase	phase	NN
cord-284008-vlwdtjbe	112	24	of	of	IN
cord-284008-vlwdtjbe	112	25	ARDS	ARDS	NNP
cord-284008-vlwdtjbe	112	26	and	and	CC
cord-284008-vlwdtjbe	112	27	effectively	effectively	RB
cord-284008-vlwdtjbe	112	28	improved	improve	VBD
cord-284008-vlwdtjbe	112	29	the	the	DT
cord-284008-vlwdtjbe	112	30	blood	blood	NN
cord-284008-vlwdtjbe	112	31	oxygen	oxygen	NN
cord-284008-vlwdtjbe	112	32	saturation	saturation	NN
cord-284008-vlwdtjbe	112	33	.	.	.
cord-284008-vlwdtjbe	113	1	This	this	DT
cord-284008-vlwdtjbe	113	2	result	result	NN
cord-284008-vlwdtjbe	113	3	implied	imply	VBD
cord-284008-vlwdtjbe	113	4	that	that	IN
cord-284008-vlwdtjbe	113	5	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	113	6	therapy	therapy	NN
cord-284008-vlwdtjbe	113	7	might	may	MD
cord-284008-vlwdtjbe	113	8	provide	provide	VB
cord-284008-vlwdtjbe	113	9	valuable	valuable	JJ
cord-284008-vlwdtjbe	113	10	time	time	NN
cord-284008-vlwdtjbe	113	11	for	for	IN
cord-284008-vlwdtjbe	113	12	these	these	DT
cord-284008-vlwdtjbe	113	13	patients	patient	NNS
cord-284008-vlwdtjbe	113	14	in	in	IN
cord-284008-vlwdtjbe	113	15	controlling	control	VBG
cord-284008-vlwdtjbe	113	16	infection	infection	NN
cord-284008-vlwdtjbe	113	17	and	and	CC
cord-284008-vlwdtjbe	113	18	preventing	prevent	VBG
cord-284008-vlwdtjbe	113	19	secondary	secondary	JJ
cord-284008-vlwdtjbe	113	20	multiorgan	multiorgan	NN
cord-284008-vlwdtjbe	113	21	damage	damage	NN
cord-284008-vlwdtjbe	113	22	and	and	CC
cord-284008-vlwdtjbe	113	23	shock	shock	NN
cord-284008-vlwdtjbe	113	24	.	.	.
cord-284008-vlwdtjbe	114	1	An	an	DT
cord-284008-vlwdtjbe	114	2	accurate	accurate	JJ
cord-284008-vlwdtjbe	114	3	conclusion	conclusion	NN
cord-284008-vlwdtjbe	114	4	could	could	MD
cord-284008-vlwdtjbe	114	5	not	not	RB
cord-284008-vlwdtjbe	114	6	be	be	VB
cord-284008-vlwdtjbe	114	7	made	make	VBN
cord-284008-vlwdtjbe	114	8	because	because	IN
cord-284008-vlwdtjbe	114	9	of	of	IN
cord-284008-vlwdtjbe	114	10	the	the	DT
cord-284008-vlwdtjbe	114	11	deficiency	deficiency	NN
cord-284008-vlwdtjbe	114	12	of	of	IN
cord-284008-vlwdtjbe	114	13	sample	sample	NN
cord-284008-vlwdtjbe	114	14	size	size	NN
cord-284008-vlwdtjbe	114	15	and	and	CC
cord-284008-vlwdtjbe	114	16	the	the	DT
cord-284008-vlwdtjbe	114	17	lack	lack	NN
cord-284008-vlwdtjbe	114	18	of	of	IN
cord-284008-vlwdtjbe	114	19	matched	match	VBN
cord-284008-vlwdtjbe	114	20	control	control	NN
cord-284008-vlwdtjbe	114	21	groups	group	NNS
cord-284008-vlwdtjbe	114	22	.	.	.
cord-284008-vlwdtjbe	115	1	[	[	-LRB-
cord-284008-vlwdtjbe	115	2	28	28	CD
cord-284008-vlwdtjbe	115	3	]	]	-RRB-
cord-284008-vlwdtjbe	116	1	There	there	EX
cord-284008-vlwdtjbe	116	2	is	be	VBZ
cord-284008-vlwdtjbe	116	3	a	a	DT
cord-284008-vlwdtjbe	116	4	retrospective	retrospective	JJ
cord-284008-vlwdtjbe	116	5	cohort	cohort	NN
cord-284008-vlwdtjbe	116	6	study	study	NN
cord-284008-vlwdtjbe	116	7	of	of	IN
cord-284008-vlwdtjbe	116	8	201	201	CD
cord-284008-vlwdtjbe	116	9	patients	patient	NNS
cord-284008-vlwdtjbe	116	10	with	with	IN
cord-284008-vlwdtjbe	116	11	COVID-19	covid-19	JJ
cord-284008-vlwdtjbe	116	12	whose	whose	WP$
cord-284008-vlwdtjbe	116	13	median	median	JJ
cord-284008-vlwdtjbe	116	14	time	time	NN
cord-284008-vlwdtjbe	116	15	from	from	IN
cord-284008-vlwdtjbe	116	16	admission	admission	NN
cord-284008-vlwdtjbe	116	17	to	to	IN
cord-284008-vlwdtjbe	116	18	progression	progression	NN
cord-284008-vlwdtjbe	116	19	to	to	IN
cord-284008-vlwdtjbe	116	20	ARDS	ARDS	NNP
cord-284008-vlwdtjbe	116	21	was	be	VBD
cord-284008-vlwdtjbe	116	22	only	only	RB
cord-284008-vlwdtjbe	116	23	2	2	CD
cord-284008-vlwdtjbe	116	24	days	day	NNS
cord-284008-vlwdtjbe	116	25	.	.	.
cord-284008-vlwdtjbe	117	1	Among	among	IN
cord-284008-vlwdtjbe	117	2	the	the	DT
cord-284008-vlwdtjbe	117	3	patients	patient	NNS
cord-284008-vlwdtjbe	117	4	with	with	IN
cord-284008-vlwdtjbe	117	5	ARDS	ARDS	NNP
cord-284008-vlwdtjbe	117	6	,	,	,
cord-284008-vlwdtjbe	117	7	23	23	CD
cord-284008-vlwdtjbe	117	8	of	of	IN
cord-284008-vlwdtjbe	117	9	50	50	CD
cord-284008-vlwdtjbe	117	10	(	(	-LRB-
cord-284008-vlwdtjbe	117	11	46.0	46.0	CD
cord-284008-vlwdtjbe	117	12	%	%	NN
cord-284008-vlwdtjbe	117	13	)	)	-RRB-
cord-284008-vlwdtjbe	117	14	patients	patient	NNS
cord-284008-vlwdtjbe	117	15	receiving	receive	VBG
cord-284008-vlwdtjbe	117	16	methylprednisolone	methylprednisolone	NN
cord-284008-vlwdtjbe	117	17	and	and	CC
cord-284008-vlwdtjbe	117	18	21	21	CD
cord-284008-vlwdtjbe	117	19	of	of	IN
cord-284008-vlwdtjbe	117	20	34	34	CD
cord-284008-vlwdtjbe	117	21	(	(	-LRB-
cord-284008-vlwdtjbe	117	22	61.8	61.8	CD
cord-284008-vlwdtjbe	117	23	%	%	NN
cord-284008-vlwdtjbe	117	24	)	)	-RRB-
cord-284008-vlwdtjbe	117	25	patients	patient	NNS
cord-284008-vlwdtjbe	117	26	who	who	WP
cord-284008-vlwdtjbe	117	27	did	do	VBD
cord-284008-vlwdtjbe	117	28	not	not	RB
cord-284008-vlwdtjbe	117	29	receive	receive	VB
cord-284008-vlwdtjbe	117	30	methylprednisolone	methylprednisolone	NN
cord-284008-vlwdtjbe	117	31	died	die	VBD
cord-284008-vlwdtjbe	117	32	.	.	.
cord-284008-vlwdtjbe	118	1	These	these	DT
cord-284008-vlwdtjbe	118	2	data	datum	NNS
cord-284008-vlwdtjbe	118	3	suggested	suggest	VBD
cord-284008-vlwdtjbe	118	4	that	that	IN
cord-284008-vlwdtjbe	118	5	the	the	DT
cord-284008-vlwdtjbe	118	6	use	use	NN
cord-284008-vlwdtjbe	118	7	of	of	IN
cord-284008-vlwdtjbe	118	8	methylprednisolone	methylprednisolone	NN
cord-284008-vlwdtjbe	118	9	appeared	appear	VBD
cord-284008-vlwdtjbe	118	10	to	to	TO
cord-284008-vlwdtjbe	118	11	reduce	reduce	VB
cord-284008-vlwdtjbe	118	12	the	the	DT
cord-284008-vlwdtjbe	118	13	risk	risk	NN
cord-284008-vlwdtjbe	118	14	of	of	IN
cord-284008-vlwdtjbe	118	15	death	death	NN
cord-284008-vlwdtjbe	118	16	in	in	IN
cord-284008-vlwdtjbe	118	17	patients	patient	NNS
cord-284008-vlwdtjbe	118	18	with	with	IN
cord-284008-vlwdtjbe	118	19	ARDS	ARDS	NNP
cord-284008-vlwdtjbe	118	20	(	(	-LRB-
cord-284008-vlwdtjbe	118	21	HR	HR	NNP
cord-284008-vlwdtjbe	118	22	,	,	,
cord-284008-vlwdtjbe	118	23	0.38	0.38	CD
cord-284008-vlwdtjbe	118	24	;	;	:
cord-284008-vlwdtjbe	118	25	95	95	CD
cord-284008-vlwdtjbe	118	26	%	%	NN
cord-284008-vlwdtjbe	118	27	CI	ci	NN
cord-284008-vlwdtjbe	118	28	,	,	,
cord-284008-vlwdtjbe	118	29	0.20	0.20	CD
cord-284008-vlwdtjbe	118	30	-	-	HYPH
cord-284008-vlwdtjbe	118	31	0.72	0.72	CD
cord-284008-vlwdtjbe	118	32	)	)	-RRB-
cord-284008-vlwdtjbe	118	33	.	.	.
cord-284008-vlwdtjbe	119	1	[	[	-LRB-
cord-284008-vlwdtjbe	119	2	29	29	CD
cord-284008-vlwdtjbe	119	3	]	]	-RRB-
cord-284008-vlwdtjbe	120	1	Zhou	Zhou	NNP
cord-284008-vlwdtjbe	120	2	et	et	NNP
cord-284008-vlwdtjbe	120	3	al	al	NNP
cord-284008-vlwdtjbe	120	4	.	.	.
cord-284008-vlwdtjbe	121	1	[	[	-LRB-
cord-284008-vlwdtjbe	121	2	30	30	CD
cord-284008-vlwdtjbe	121	3	]	]	-RRB-
cord-284008-vlwdtjbe	121	4	analyzed	analyze	VBD
cord-284008-vlwdtjbe	121	5	the	the	DT
cord-284008-vlwdtjbe	121	6	clinical	clinical	JJ
cord-284008-vlwdtjbe	121	7	data	datum	NNS
cord-284008-vlwdtjbe	121	8	of	of	IN
cord-284008-vlwdtjbe	121	9	10	10	CD
cord-284008-vlwdtjbe	121	10	patients	patient	NNS
cord-284008-vlwdtjbe	121	11	with	with	IN
cord-284008-vlwdtjbe	121	12	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	121	13	and	and	CC
cord-284008-vlwdtjbe	121	14	found	find	VBD
cord-284008-vlwdtjbe	121	15	that	that	IN
cord-284008-vlwdtjbe	121	16	the	the	DT
cord-284008-vlwdtjbe	121	17	lymphocyte	lymphocyte	NN
cord-284008-vlwdtjbe	121	18	count	count	NN
cord-284008-vlwdtjbe	121	19	and	and	CC
cord-284008-vlwdtjbe	121	20	OI	OI	NNP
cord-284008-vlwdtjbe	121	21	of	of	IN
cord-284008-vlwdtjbe	121	22	these	these	DT
cord-284008-vlwdtjbe	121	23	patients	patient	NNS
cord-284008-vlwdtjbe	121	24	with	with	IN
cord-284008-vlwdtjbe	121	25	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	121	26	became	become	VBD
cord-284008-vlwdtjbe	121	27	more	more	RBR
cord-284008-vlwdtjbe	121	28	worrying	worrying	JJ
cord-284008-vlwdtjbe	121	29	after	after	IN
cord-284008-vlwdtjbe	121	30	the	the	DT
cord-284008-vlwdtjbe	121	31	treatment	treatment	NN
cord-284008-vlwdtjbe	121	32	with	with	IN
cord-284008-vlwdtjbe	121	33	a	a	DT
cord-284008-vlwdtjbe	121	34	combination	combination	NN
cord-284008-vlwdtjbe	121	35	of	of	IN
cord-284008-vlwdtjbe	121	36	low	low	JJ
cord-284008-vlwdtjbe	121	37	-	-	HYPH
cord-284008-vlwdtjbe	121	38	dose	dose	NN
cord-284008-vlwdtjbe	121	39	methylprednisolone	methylprednisolone	NN
cord-284008-vlwdtjbe	121	40	(	(	-LRB-
cord-284008-vlwdtjbe	121	41	80	80	CD
cord-284008-vlwdtjbe	121	42	mg	mg	NNP
cord-284008-vlwdtjbe	121	43	/	/	SYM
cord-284008-vlwdtjbe	121	44	d	d	NN
cord-284008-vlwdtjbe	121	45	)	)	-RRB-
cord-284008-vlwdtjbe	121	46	and	and	CC
cord-284008-vlwdtjbe	121	47	immunoglobulin	immunoglobulin	NN
cord-284008-vlwdtjbe	121	48	(	(	-LRB-
cord-284008-vlwdtjbe	121	49	10	10	CD
cord-284008-vlwdtjbe	121	50	g	g	NN
cord-284008-vlwdtjbe	121	51	/	/	SYM
cord-284008-vlwdtjbe	121	52	d	d	NN
cord-284008-vlwdtjbe	121	53	)	)	-RRB-
cord-284008-vlwdtjbe	121	54	,	,	,
cord-284008-vlwdtjbe	121	55	and	and	CC
cord-284008-vlwdtjbe	121	56	the	the	DT
cord-284008-vlwdtjbe	121	57	pulmonary	pulmonary	JJ
cord-284008-vlwdtjbe	121	58	CT	CT	NNP
cord-284008-vlwdtjbe	121	59	revealed	reveal	VBD
cord-284008-vlwdtjbe	121	60	that	that	IN
cord-284008-vlwdtjbe	121	61	the	the	DT
cord-284008-vlwdtjbe	121	62	lung	lung	NN
cord-284008-vlwdtjbe	121	63	lesions	lesion	NNS
cord-284008-vlwdtjbe	121	64	were	be	VBD
cord-284008-vlwdtjbe	121	65	significantly	significantly	RB
cord-284008-vlwdtjbe	121	66	worse	bad	JJR
cord-284008-vlwdtjbe	121	67	.	.	.
cord-284008-vlwdtjbe	122	1	However	however	RB
cord-284008-vlwdtjbe	122	2	,	,	,
cord-284008-vlwdtjbe	122	3	the	the	DT
cord-284008-vlwdtjbe	122	4	condition	condition	NN
cord-284008-vlwdtjbe	122	5	of	of	IN
cord-284008-vlwdtjbe	122	6	these	these	DT
cord-284008-vlwdtjbe	122	7	patients	patient	NNS
cord-284008-vlwdtjbe	122	8	significantly	significantly	RB
cord-284008-vlwdtjbe	122	9	improved	improve	VBD
cord-284008-vlwdtjbe	122	10	after	after	IN
cord-284008-vlwdtjbe	122	11	doctors	doctor	NNS
cord-284008-vlwdtjbe	122	12	increased	increase	VBD
cord-284008-vlwdtjbe	122	13	doses	dose	NNS
cord-284008-vlwdtjbe	122	14	of	of	IN
cord-284008-vlwdtjbe	122	15	methylprednisolone	methylprednisolone	NN
cord-284008-vlwdtjbe	122	16	and	and	CC
cord-284008-vlwdtjbe	122	17	immunoglobulin	immunoglobulin	NN
cord-284008-vlwdtjbe	122	18	to	to	IN
cord-284008-vlwdtjbe	122	19	160	160	CD
cord-284008-vlwdtjbe	122	20	and	and	CC
cord-284008-vlwdtjbe	122	21	20	20	CD
cord-284008-vlwdtjbe	122	22	g	g	NN
cord-284008-vlwdtjbe	122	23	/	/	SYM
cord-284008-vlwdtjbe	122	24	d	d	NN
cord-284008-vlwdtjbe	122	25	,	,	,
cord-284008-vlwdtjbe	122	26	respectively	respectively	RB
cord-284008-vlwdtjbe	122	27	.	.	.
cord-284008-vlwdtjbe	123	1	So	so	RB
cord-284008-vlwdtjbe	123	2	choosing	choose	VBG
cord-284008-vlwdtjbe	123	3	the	the	DT
cord-284008-vlwdtjbe	123	4	proper	proper	JJ
cord-284008-vlwdtjbe	123	5	doses	dose	NNS
cord-284008-vlwdtjbe	123	6	of	of	IN
cord-284008-vlwdtjbe	123	7	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	123	8	is	be	VBZ
cord-284008-vlwdtjbe	123	9	also	also	RB
cord-284008-vlwdtjbe	123	10	a	a	DT
cord-284008-vlwdtjbe	123	11	big	big	JJ
cord-284008-vlwdtjbe	123	12	challenge	challenge	NN
cord-284008-vlwdtjbe	123	13	.	.	.
cord-284008-vlwdtjbe	124	1	This	this	DT
cord-284008-vlwdtjbe	124	2	study	study	NN
cord-284008-vlwdtjbe	124	3	was	be	VBD
cord-284008-vlwdtjbe	124	4	limited	limit	VBN
cord-284008-vlwdtjbe	124	5	by	by	IN
cord-284008-vlwdtjbe	124	6	small	small	JJ
cord-284008-vlwdtjbe	124	7	sample	sample	NN
cord-284008-vlwdtjbe	124	8	size	size	NN
cord-284008-vlwdtjbe	124	9	and	and	CC
cord-284008-vlwdtjbe	124	10	short	short	JJ
cord-284008-vlwdtjbe	124	11	-	-	HYPH
cord-284008-vlwdtjbe	124	12	term	term	NN
cord-284008-vlwdtjbe	124	13	follow	follow	NN
cord-284008-vlwdtjbe	124	14	-	-	HYPH
cord-284008-vlwdtjbe	124	15	up	up	NN
cord-284008-vlwdtjbe	124	16	of	of	IN
cord-284008-vlwdtjbe	124	17	only	only	RB
cord-284008-vlwdtjbe	124	18	1	1	CD
cord-284008-vlwdtjbe	124	19	month	month	NN
cord-284008-vlwdtjbe	124	20	.	.	.
cord-284008-vlwdtjbe	125	1	Although	although	IN
cord-284008-vlwdtjbe	125	2	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	125	3	seemed	seem	VBD
cord-284008-vlwdtjbe	125	4	to	to	TO
cord-284008-vlwdtjbe	125	5	be	be	VB
cord-284008-vlwdtjbe	125	6	beneficial	beneficial	JJ
cord-284008-vlwdtjbe	125	7	for	for	IN
cord-284008-vlwdtjbe	125	8	some	some	DT
cord-284008-vlwdtjbe	125	9	patients	patient	NNS
cord-284008-vlwdtjbe	125	10	with	with	IN
cord-284008-vlwdtjbe	125	11	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	125	12	,	,	,
cord-284008-vlwdtjbe	125	13	the	the	DT
cord-284008-vlwdtjbe	125	14	sample	sample	NN
cord-284008-vlwdtjbe	125	15	sizes	size	NNS
cord-284008-vlwdtjbe	125	16	of	of	IN
cord-284008-vlwdtjbe	125	17	these	these	DT
cord-284008-vlwdtjbe	125	18	studies	study	NNS
cord-284008-vlwdtjbe	125	19	mentioned	mention	VBN
cord-284008-vlwdtjbe	125	20	above	above	RB
cord-284008-vlwdtjbe	125	21	were	be	VBD
cord-284008-vlwdtjbe	125	22	not	not	RB
cord-284008-vlwdtjbe	125	23	large	large	JJ
cord-284008-vlwdtjbe	125	24	,	,	,
cord-284008-vlwdtjbe	125	25	and	and	CC
cord-284008-vlwdtjbe	125	26	they	-PRON-	PRP
cord-284008-vlwdtjbe	125	27	were	be	VBD
cord-284008-vlwdtjbe	125	28	not	not	RB
cord-284008-vlwdtjbe	125	29	randomized	randomize	VBN
cord-284008-vlwdtjbe	125	30	controlled	control	VBN
cord-284008-vlwdtjbe	125	31	experiments	experiment	NNS
cord-284008-vlwdtjbe	125	32	.	.	.
cord-284008-vlwdtjbe	126	1	Professor	Professor	NNP
cord-284008-vlwdtjbe	126	2	Cao	Cao	NNP
cord-284008-vlwdtjbe	126	3	also	also	RB
cord-284008-vlwdtjbe	126	4	considered	consider	VBD
cord-284008-vlwdtjbe	126	5	that	that	IN
cord-284008-vlwdtjbe	126	6	it	-PRON-	PRP
cord-284008-vlwdtjbe	126	7	would	would	MD
cord-284008-vlwdtjbe	126	8	be	be	VB
cord-284008-vlwdtjbe	126	9	necessary	necessary	JJ
cord-284008-vlwdtjbe	126	10	to	to	TO
cord-284008-vlwdtjbe	126	11	carry	carry	VB
cord-284008-vlwdtjbe	126	12	out	out	RP
cord-284008-vlwdtjbe	126	13	the	the	DT
cord-284008-vlwdtjbe	126	14	highquality	highquality	JJ
cord-284008-vlwdtjbe	126	15	trials	trial	NNS
cord-284008-vlwdtjbe	126	16	in	in	IN
cord-284008-vlwdtjbe	126	17	the	the	DT
cord-284008-vlwdtjbe	126	18	future	future	NN
cord-284008-vlwdtjbe	126	19	.	.	.
cord-284008-vlwdtjbe	127	1	[	[	-LRB-
cord-284008-vlwdtjbe	127	2	31	31	CD
cord-284008-vlwdtjbe	127	3	]	]	-RRB-
cord-284008-vlwdtjbe	127	4	Now	now	RB
cord-284008-vlwdtjbe	127	5	it	-PRON-	PRP
cord-284008-vlwdtjbe	127	6	is	be	VBZ
cord-284008-vlwdtjbe	127	7	still	still	RB
cord-284008-vlwdtjbe	127	8	difficult	difficult	JJ
cord-284008-vlwdtjbe	127	9	to	to	TO
cord-284008-vlwdtjbe	127	10	draw	draw	VB
cord-284008-vlwdtjbe	127	11	any	any	DT
cord-284008-vlwdtjbe	127	12	firm	firm	JJ
cord-284008-vlwdtjbe	127	13	conclusions	conclusion	NNS
cord-284008-vlwdtjbe	127	14	.	.	.
cord-284008-vlwdtjbe	128	1	Following	follow	VBG
cord-284008-vlwdtjbe	128	2	the	the	DT
cord-284008-vlwdtjbe	128	3	guidance	guidance	NN
cord-284008-vlwdtjbe	128	4	provided	provide	VBN
cord-284008-vlwdtjbe	128	5	by	by	IN
cord-284008-vlwdtjbe	128	6	experts	expert	NNS
cord-284008-vlwdtjbe	128	7	is	be	VBZ
cord-284008-vlwdtjbe	128	8	a	a	DT
cord-284008-vlwdtjbe	128	9	good	good	JJ
cord-284008-vlwdtjbe	128	10	choice	choice	NN
cord-284008-vlwdtjbe	128	11	.	.	.
cord-284008-vlwdtjbe	129	1	A	a	DT
cord-284008-vlwdtjbe	129	2	report	report	NN
cord-284008-vlwdtjbe	129	3	published	publish	VBN
cord-284008-vlwdtjbe	129	4	by	by	IN
cord-284008-vlwdtjbe	129	5	the	the	DT
cord-284008-vlwdtjbe	129	6	China	China	NNP
cord-284008-vlwdtjbe	129	7	Medical	Medical	NNP
cord-284008-vlwdtjbe	129	8	Treatment	Treatment	NNP
cord-284008-vlwdtjbe	129	9	Expert	Expert	NNP
cord-284008-vlwdtjbe	129	10	Group	Group	NNP
cord-284008-vlwdtjbe	129	11	for	for	IN
cord-284008-vlwdtjbe	129	12	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	129	13	concluded	conclude	VBD
cord-284008-vlwdtjbe	129	14	that	that	IN
cord-284008-vlwdtjbe	129	15	18.6	18.6	CD
cord-284008-vlwdtjbe	129	16	%	%	NN
cord-284008-vlwdtjbe	129	17	of	of	IN
cord-284008-vlwdtjbe	129	18	1099	1099	CD
cord-284008-vlwdtjbe	129	19	patients	patient	NNS
cord-284008-vlwdtjbe	129	20	with	with	IN
cord-284008-vlwdtjbe	129	21	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	129	22	received	receive	VBN
cord-284008-vlwdtjbe	129	23	systemic	systemic	JJ
cord-284008-vlwdtjbe	129	24	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	129	25	,	,	,
cord-284008-vlwdtjbe	129	26	including	include	VBG
cord-284008-vlwdtjbe	129	27	77	77	CD
cord-284008-vlwdtjbe	129	28	of	of	IN
cord-284008-vlwdtjbe	129	29	173	173	CD
cord-284008-vlwdtjbe	129	30	patients	patient	NNS
cord-284008-vlwdtjbe	129	31	with	with	IN
cord-284008-vlwdtjbe	129	32	severe	severe	JJ
cord-284008-vlwdtjbe	129	33	infection	infection	NN
cord-284008-vlwdtjbe	129	34	or	or	CC
cord-284008-vlwdtjbe	129	35	critical	critical	JJ
cord-284008-vlwdtjbe	129	36	patients	patient	NNS
cord-284008-vlwdtjbe	129	37	.	.	.
cord-284008-vlwdtjbe	130	1	[	[	-LRB-
cord-284008-vlwdtjbe	130	2	32	32	CD
cord-284008-vlwdtjbe	130	3	]	]	-RRB-
cord-284008-vlwdtjbe	131	1	Corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	131	2	seemed	seem	VBD
cord-284008-vlwdtjbe	131	3	to	to	TO
cord-284008-vlwdtjbe	131	4	be	be	VB
cord-284008-vlwdtjbe	131	5	empirically	empirically	RB
cord-284008-vlwdtjbe	131	6	used	use	VBN
cord-284008-vlwdtjbe	131	7	by	by	IN
cord-284008-vlwdtjbe	131	8	clinicians	clinician	NNS
cord-284008-vlwdtjbe	131	9	.	.	.
cord-284008-vlwdtjbe	132	1	There	there	EX
cord-284008-vlwdtjbe	132	2	were	be	VBD
cord-284008-vlwdtjbe	132	3	different	different	JJ
cord-284008-vlwdtjbe	132	4	recommendations	recommendation	NNS
cord-284008-vlwdtjbe	132	5	about	about	IN
cord-284008-vlwdtjbe	132	6	the	the	DT
cord-284008-vlwdtjbe	132	7	use	use	NN
cord-284008-vlwdtjbe	132	8	of	of	IN
cord-284008-vlwdtjbe	132	9	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	132	10	in	in	IN
cord-284008-vlwdtjbe	132	11	guidelines	guideline	NNS
cord-284008-vlwdtjbe	132	12	for	for	IN
cord-284008-vlwdtjbe	132	13	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	132	14	.	.	.
cord-284008-vlwdtjbe	133	1	On	on	IN
cord-284008-vlwdtjbe	133	2	the	the	DT
cord-284008-vlwdtjbe	133	3	basis	basis	NN
cord-284008-vlwdtjbe	133	4	of	of	IN
cord-284008-vlwdtjbe	133	5	fully	fully	RB
cord-284008-vlwdtjbe	133	6	learning	learn	VBG
cord-284008-vlwdtjbe	133	7	from	from	IN
cord-284008-vlwdtjbe	133	8	the	the	DT
cord-284008-vlwdtjbe	133	9	treatment	treatment	NN
cord-284008-vlwdtjbe	133	10	experience	experience	NN
cord-284008-vlwdtjbe	133	11	of	of	IN
cord-284008-vlwdtjbe	133	12	their	-PRON-	PRP$
cord-284008-vlwdtjbe	133	13	counterparts	counterpart	NNS
cord-284008-vlwdtjbe	133	14	at	at	IN
cord-284008-vlwdtjbe	133	15	home	home	RB
cord-284008-vlwdtjbe	133	16	and	and	CC
cord-284008-vlwdtjbe	133	17	abroad	abroad	RB
cord-284008-vlwdtjbe	133	18	,	,	,
cord-284008-vlwdtjbe	133	19	the	the	DT
cord-284008-vlwdtjbe	133	20	Shanghai	Shanghai	NNP
cord-284008-vlwdtjbe	133	21	Clinical	Clinical	NNP
cord-284008-vlwdtjbe	133	22	Treatment	Treatment	NNP
cord-284008-vlwdtjbe	133	23	Expert	Expert	NNP
cord-284008-vlwdtjbe	133	24	Group	Group	NNP
cord-284008-vlwdtjbe	133	25	for	for	IN
cord-284008-vlwdtjbe	133	26	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	133	27	continued	continue	VBD
cord-284008-vlwdtjbe	133	28	to	to	TO
cord-284008-vlwdtjbe	133	29	optimize	optimize	VB
cord-284008-vlwdtjbe	133	30	and	and	CC
cord-284008-vlwdtjbe	133	31	refine	refine	VB
cord-284008-vlwdtjbe	133	32	the	the	DT
cord-284008-vlwdtjbe	133	33	treatment	treatment	NN
cord-284008-vlwdtjbe	133	34	plan	plan	NN
cord-284008-vlwdtjbe	133	35	for	for	IN
cord-284008-vlwdtjbe	133	36	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	133	37	and	and	CC
cord-284008-vlwdtjbe	133	38	formed	form	VBD
cord-284008-vlwdtjbe	133	39	an	an	DT
cord-284008-vlwdtjbe	133	40	expert	expert	JJ
cord-284008-vlwdtjbe	133	41	consensus	consensus	NN
cord-284008-vlwdtjbe	133	42	,	,	,
cord-284008-vlwdtjbe	133	43	commonly	commonly	RB
cord-284008-vlwdtjbe	133	44	known	know	VBN
cord-284008-vlwdtjbe	133	45	as	as	IN
cord-284008-vlwdtjbe	133	46	"	"	``
cord-284008-vlwdtjbe	133	47	Shanghai	Shanghai	NNP
cord-284008-vlwdtjbe	133	48	Plan	Plan	NNP
cord-284008-vlwdtjbe	133	49	.	.	.
cord-284008-vlwdtjbe	134	1	"	"	''
cord-284008-vlwdtjbe	135	1	The	the	DT
cord-284008-vlwdtjbe	135	2	plan	plan	NN
cord-284008-vlwdtjbe	135	3	suggested	suggest	VBD
cord-284008-vlwdtjbe	135	4	that	that	IN
cord-284008-vlwdtjbe	135	5	if	if	IN
cord-284008-vlwdtjbe	135	6	there	there	EX
cord-284008-vlwdtjbe	135	7	is	be	VBZ
cord-284008-vlwdtjbe	135	8	a	a	DT
cord-284008-vlwdtjbe	135	9	risk	risk	NN
cord-284008-vlwdtjbe	135	10	of	of	IN
cord-284008-vlwdtjbe	135	11	becoming	become	VBG
cord-284008-vlwdtjbe	135	12	severe	severe	JJ
cord-284008-vlwdtjbe	135	13	for	for	IN
cord-284008-vlwdtjbe	135	14	patients	patient	NNS
cord-284008-vlwdtjbe	135	15	with	with	IN
cord-284008-vlwdtjbe	135	16	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	135	17	,	,	,
cord-284008-vlwdtjbe	135	18	such	such	JJ
cord-284008-vlwdtjbe	135	19	as	as	IN
cord-284008-vlwdtjbe	135	20	significant	significant	JJ
cord-284008-vlwdtjbe	135	21	radiographic	radiographic	JJ
cord-284008-vlwdtjbe	135	22	progress	progress	NN
cord-284008-vlwdtjbe	135	23	in	in	IN
cord-284008-vlwdtjbe	135	24	pneumonia	pneumonia	NN
cord-284008-vlwdtjbe	135	25	,	,	,
cord-284008-vlwdtjbe	135	26	SaO2	sao2	NN
cord-284008-vlwdtjbe	135	27	of	of	IN
cord-284008-vlwdtjbe	135	28	patients	patient	NNS
cord-284008-vlwdtjbe	135	29	<	<	XX
cord-284008-vlwdtjbe	135	30	93	93	CD
cord-284008-vlwdtjbe	135	31	%	%	NN
cord-284008-vlwdtjbe	135	32	in	in	IN
cord-284008-vlwdtjbe	135	33	the	the	DT
cord-284008-vlwdtjbe	135	34	resting	rest	VBG
cord-284008-vlwdtjbe	135	35	state	state	NN
cord-284008-vlwdtjbe	135	36	without	without	IN
cord-284008-vlwdtjbe	135	37	oxygen	oxygen	NN
cord-284008-vlwdtjbe	135	38	therapy	therapy	NN
cord-284008-vlwdtjbe	135	39	,	,	,
cord-284008-vlwdtjbe	135	40	or	or	CC
cord-284008-vlwdtjbe	135	41	shortness	shortness	NN
cord-284008-vlwdtjbe	135	42	of	of	IN
cord-284008-vlwdtjbe	135	43	breath	breath	NN
cord-284008-vlwdtjbe	135	44	(	(	-LRB-
cord-284008-vlwdtjbe	135	45	breathing	breathing	NN
cord-284008-vlwdtjbe	135	46	frequency	frequency	NN
cord-284008-vlwdtjbe	135	47	≥30	≥30	WRB
cord-284008-vlwdtjbe	135	48	times	time	NNS
cord-284008-vlwdtjbe	135	49	/	/	SYM
cord-284008-vlwdtjbe	135	50	minute	minute	NN
cord-284008-vlwdtjbe	135	51	)	)	-RRB-
cord-284008-vlwdtjbe	135	52	,	,	,
cord-284008-vlwdtjbe	135	53	OI	OI	NNP
cord-284008-vlwdtjbe	135	54	≤300	≤300	NN
cord-284008-vlwdtjbe	135	55	mm	mm	NNP
cord-284008-vlwdtjbe	135	56	Hg	Hg	NNP
cord-284008-vlwdtjbe	135	57	,	,	,
cord-284008-vlwdtjbe	135	58	or	or	CC
cord-284008-vlwdtjbe	135	59	facing	face	VBG
cord-284008-vlwdtjbe	135	60	the	the	DT
cord-284008-vlwdtjbe	135	61	risk	risk	NN
cord-284008-vlwdtjbe	135	62	of	of	IN
cord-284008-vlwdtjbe	135	63	intubation	intubation	NN
cord-284008-vlwdtjbe	135	64	,	,	,
cord-284008-vlwdtjbe	135	65	low	low	JJ
cord-284008-vlwdtjbe	135	66	-	-	HYPH
cord-284008-vlwdtjbe	135	67	dose	dose	NN
cord-284008-vlwdtjbe	135	68	shortcourse	shortcourse	JJ
cord-284008-vlwdtjbe	135	69	glucocorticoids	glucocorticoid	NNS
cord-284008-vlwdtjbe	135	70	are	be	VBP
cord-284008-vlwdtjbe	135	71	recommended	recommend	VBN
cord-284008-vlwdtjbe	135	72	generally	generally	RB
cord-284008-vlwdtjbe	135	73	for	for	IN
cord-284008-vlwdtjbe	135	74	3	3	CD
cord-284008-vlwdtjbe	135	75	-	-	SYM
cord-284008-vlwdtjbe	135	76	6	6	CD
cord-284008-vlwdtjbe	135	77	days	day	NNS
cord-284008-vlwdtjbe	135	78	.	.	.
cord-284008-vlwdtjbe	136	1	[	[	-LRB-
cord-284008-vlwdtjbe	136	2	33	33	CD
cord-284008-vlwdtjbe	136	3	]	]	-RRB-
cord-284008-vlwdtjbe	137	1	Actually	actually	RB
cord-284008-vlwdtjbe	137	2	,	,	,
cord-284008-vlwdtjbe	137	3	early	early	RB
cord-284008-vlwdtjbe	137	4	in	in	IN
cord-284008-vlwdtjbe	137	5	the	the	DT
cord-284008-vlwdtjbe	137	6	epidemic	epidemic	NN
cord-284008-vlwdtjbe	137	7	,	,	,
cord-284008-vlwdtjbe	137	8	the	the	DT
cord-284008-vlwdtjbe	137	9	National	National	NNP
cord-284008-vlwdtjbe	137	10	Health	Health	NNP
cord-284008-vlwdtjbe	137	11	Commission	Commission	NNP
cord-284008-vlwdtjbe	137	12	of	of	IN
cord-284008-vlwdtjbe	137	13	China	China	NNP
cord-284008-vlwdtjbe	137	14	mentioned	mention	VBD
cord-284008-vlwdtjbe	137	15	that	that	IN
cord-284008-vlwdtjbe	137	16	glucocorticoids	glucocorticoid	NNS
cord-284008-vlwdtjbe	137	17	can	can	MD
cord-284008-vlwdtjbe	137	18	be	be	VB
cord-284008-vlwdtjbe	137	19	used	use	VBN
cord-284008-vlwdtjbe	137	20	for	for	IN
cord-284008-vlwdtjbe	137	21	a	a	DT
cord-284008-vlwdtjbe	137	22	short	short	JJ
cord-284008-vlwdtjbe	137	23	period	period	NN
cord-284008-vlwdtjbe	137	24	of	of	IN
cord-284008-vlwdtjbe	137	25	time	time	NN
cord-284008-vlwdtjbe	137	26	based	base	VBN
cord-284008-vlwdtjbe	137	27	on	on	IN
cord-284008-vlwdtjbe	137	28	the	the	DT
cord-284008-vlwdtjbe	137	29	degree	degree	NN
cord-284008-vlwdtjbe	137	30	of	of	IN
cord-284008-vlwdtjbe	137	31	dyspnea	dyspnea	NN
cord-284008-vlwdtjbe	137	32	and	and	CC
cord-284008-vlwdtjbe	137	33	chest	chest	NN
cord-284008-vlwdtjbe	137	34	radiographic	radiographic	JJ
cord-284008-vlwdtjbe	137	35	progress	progress	NN
cord-284008-vlwdtjbe	137	36	.	.	.
cord-284008-vlwdtjbe	138	1	The	the	DT
cord-284008-vlwdtjbe	138	2	recommended	recommend	VBN
cord-284008-vlwdtjbe	138	3	dose	dose	NN
cord-284008-vlwdtjbe	138	4	does	do	VBZ
cord-284008-vlwdtjbe	138	5	not	not	RB
cord-284008-vlwdtjbe	138	6	exceed	exceed	VB
cord-284008-vlwdtjbe	138	7	1	1	CD
cord-284008-vlwdtjbe	138	8	-	-	SYM
cord-284008-vlwdtjbe	138	9	2	2	CD
cord-284008-vlwdtjbe	138	10	mg	mg	NNP
cord-284008-vlwdtjbe	138	11	/	/	SYM
cord-284008-vlwdtjbe	138	12	kg	kg	NNP
cord-284008-vlwdtjbe	138	13	/	/	SYM
cord-284008-vlwdtjbe	138	14	d	d	NN
cord-284008-vlwdtjbe	138	15	.	.	.
cord-284008-vlwdtjbe	139	1	[	[	-LRB-
cord-284008-vlwdtjbe	139	2	34	34	CD
cord-284008-vlwdtjbe	139	3	]	]	-RRB-
cord-284008-vlwdtjbe	140	1	Subsequently	subsequently	RB
cord-284008-vlwdtjbe	140	2	,	,	,
cord-284008-vlwdtjbe	140	3	multiple	multiple	JJ
cord-284008-vlwdtjbe	140	4	Chinese	chinese	JJ
cord-284008-vlwdtjbe	140	5	physicians	physician	NNS
cord-284008-vlwdtjbe	140	6	developed	develop	VBD
cord-284008-vlwdtjbe	140	7	an	an	DT
cord-284008-vlwdtjbe	140	8	expert	expert	JJ
cord-284008-vlwdtjbe	140	9	consensus	consensus	NN
cord-284008-vlwdtjbe	140	10	as	as	IN
cord-284008-vlwdtjbe	140	11	a	a	DT
cord-284008-vlwdtjbe	140	12	supplement	supplement	NN
cord-284008-vlwdtjbe	140	13	to	to	IN
cord-284008-vlwdtjbe	140	14	this	this	DT
cord-284008-vlwdtjbe	140	15	above	above	JJ
cord-284008-vlwdtjbe	140	16	guideline	guideline	NN
cord-284008-vlwdtjbe	140	17	.	.	.
cord-284008-vlwdtjbe	141	1	The	the	DT
cord-284008-vlwdtjbe	141	2	indications	indication	NNS
cord-284008-vlwdtjbe	141	3	for	for	IN
cord-284008-vlwdtjbe	141	4	glucocorticoid	glucocorticoid	NN
cord-284008-vlwdtjbe	141	5	therapy	therapy	NN
cord-284008-vlwdtjbe	141	6	are	be	VBP
cord-284008-vlwdtjbe	141	7	similar	similar	JJ
cord-284008-vlwdtjbe	141	8	to	to	IN
cord-284008-vlwdtjbe	141	9	those	those	DT
cord-284008-vlwdtjbe	141	10	of	of	IN
cord-284008-vlwdtjbe	141	11	the	the	DT
cord-284008-vlwdtjbe	141	12	"	"	``
cord-284008-vlwdtjbe	141	13	Shanghai	Shanghai	NNP
cord-284008-vlwdtjbe	141	14	Plan	Plan	NNP
cord-284008-vlwdtjbe	141	15	,	,	,
cord-284008-vlwdtjbe	141	16	"	"	''
cord-284008-vlwdtjbe	141	17	and	and	CC
cord-284008-vlwdtjbe	141	18	it	-PRON-	PRP
cord-284008-vlwdtjbe	141	19	is	be	VBZ
cord-284008-vlwdtjbe	141	20	better	well	JJR
cord-284008-vlwdtjbe	141	21	to	to	TO
cord-284008-vlwdtjbe	141	22	follow	follow	VB
cord-284008-vlwdtjbe	141	23	these	these	DT
cord-284008-vlwdtjbe	141	24	principles	principle	NNS
cord-284008-vlwdtjbe	141	25	:	:	:
cord-284008-vlwdtjbe	141	26	(	(	-LRB-
cord-284008-vlwdtjbe	141	27	1	1	LS
cord-284008-vlwdtjbe	141	28	)	)	-RRB-
cord-284008-vlwdtjbe	141	29	never	never	RB
cord-284008-vlwdtjbe	141	30	use	use	VBP
cord-284008-vlwdtjbe	141	31	glucocorticoids	glucocorticoid	NNS
cord-284008-vlwdtjbe	141	32	to	to	TO
cord-284008-vlwdtjbe	141	33	relieve	relieve	VB
cord-284008-vlwdtjbe	141	34	the	the	DT
cord-284008-vlwdtjbe	141	35	fever	fever	NN
cord-284008-vlwdtjbe	141	36	;	;	,
cord-284008-vlwdtjbe	141	37	(	(	-LRB-
cord-284008-vlwdtjbe	141	38	2	2	LS
cord-284008-vlwdtjbe	141	39	)	)	-RRB-
cord-284008-vlwdtjbe	141	40	the	the	DT
cord-284008-vlwdtjbe	141	41	dosage	dosage	NN
cord-284008-vlwdtjbe	141	42	of	of	IN
cord-284008-vlwdtjbe	141	43	glucocorticoids	glucocorticoid	NNS
cord-284008-vlwdtjbe	141	44	should	should	MD
cord-284008-vlwdtjbe	141	45	be	be	VB
cord-284008-vlwdtjbe	141	46	individualized	individualize	VBN
cord-284008-vlwdtjbe	141	47	according	accord	VBG
cord-284008-vlwdtjbe	141	48	to	to	IN
cord-284008-vlwdtjbe	141	49	different	different	JJ
cord-284008-vlwdtjbe	141	50	patients	patient	NNS
cord-284008-vlwdtjbe	141	51	;	;	:
cord-284008-vlwdtjbe	141	52	and	and	CC
cord-284008-vlwdtjbe	141	53	(	(	-LRB-
cord-284008-vlwdtjbe	141	54	3	3	LS
cord-284008-vlwdtjbe	141	55	)	)	-RRB-
cord-284008-vlwdtjbe	141	56	if	if	IN
cord-284008-vlwdtjbe	141	57	the	the	DT
cord-284008-vlwdtjbe	141	58	situation	situation	NN
cord-284008-vlwdtjbe	141	59	of	of	IN
cord-284008-vlwdtjbe	141	60	hypoxemia	hypoxemia	NN
cord-284008-vlwdtjbe	141	61	has	have	VBZ
cord-284008-vlwdtjbe	141	62	already	already	RB
cord-284008-vlwdtjbe	141	63	existed	exist	VBN
cord-284008-vlwdtjbe	141	64	before	before	IN
cord-284008-vlwdtjbe	141	65	suffering	suffer	VBG
cord-284008-vlwdtjbe	141	66	from	from	IN
cord-284008-vlwdtjbe	141	67	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	141	68	,	,	,
cord-284008-vlwdtjbe	141	69	be	be	VB
cord-284008-vlwdtjbe	141	70	more	more	RBR
cord-284008-vlwdtjbe	141	71	cautious	cautious	JJ
cord-284008-vlwdtjbe	141	72	about	about	IN
cord-284008-vlwdtjbe	141	73	indications	indication	NNS
cord-284008-vlwdtjbe	141	74	of	of	IN
cord-284008-vlwdtjbe	141	75	glucocorticoid	glucocorticoid	NN
cord-284008-vlwdtjbe	141	76	therapy	therapy	NN
cord-284008-vlwdtjbe	141	77	.	.	.
cord-284008-vlwdtjbe	142	1	In	in	IN
cord-284008-vlwdtjbe	142	2	addition	addition	NN
cord-284008-vlwdtjbe	142	3	,	,	,
cord-284008-vlwdtjbe	142	4	the	the	DT
cord-284008-vlwdtjbe	142	5	recommended	recommend	VBN
cord-284008-vlwdtjbe	142	6	time	time	NN
cord-284008-vlwdtjbe	142	7	is	be	VBZ
cord-284008-vlwdtjbe	142	8	not	not	RB
cord-284008-vlwdtjbe	142	9	more	more	JJR
cord-284008-vlwdtjbe	142	10	than	than	IN
cord-284008-vlwdtjbe	142	11	7	7	CD
cord-284008-vlwdtjbe	142	12	days	day	NNS
cord-284008-vlwdtjbe	142	13	.	.	.
cord-284008-vlwdtjbe	143	1	[	[	-LRB-
cord-284008-vlwdtjbe	143	2	35	35	CD
cord-284008-vlwdtjbe	143	3	]	]	-RRB-
cord-284008-vlwdtjbe	143	4	With	with	IN
cord-284008-vlwdtjbe	143	5	the	the	DT
cord-284008-vlwdtjbe	143	6	accumulation	accumulation	NN
cord-284008-vlwdtjbe	143	7	of	of	IN
cord-284008-vlwdtjbe	143	8	more	more	JJR
cord-284008-vlwdtjbe	143	9	experience	experience	NN
cord-284008-vlwdtjbe	143	10	and	and	CC
cord-284008-vlwdtjbe	143	11	clinical	clinical	JJ
cord-284008-vlwdtjbe	143	12	data	datum	NNS
cord-284008-vlwdtjbe	143	13	,	,	,
cord-284008-vlwdtjbe	143	14	therapeutic	therapeutic	JJ
cord-284008-vlwdtjbe	143	15	methods	method	NNS
cord-284008-vlwdtjbe	143	16	of	of	IN
cord-284008-vlwdtjbe	143	17	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	143	18	will	will	MD
cord-284008-vlwdtjbe	143	19	be	be	VB
cord-284008-vlwdtjbe	143	20	continuously	continuously	RB
cord-284008-vlwdtjbe	143	21	improved	improve	VBN
cord-284008-vlwdtjbe	143	22	.	.	.
cord-284008-vlwdtjbe	144	1	In	in	IN
cord-284008-vlwdtjbe	144	2	general	general	JJ
cord-284008-vlwdtjbe	144	3	,	,	,
cord-284008-vlwdtjbe	144	4	there	there	EX
cord-284008-vlwdtjbe	144	5	are	be	VBP
cord-284008-vlwdtjbe	144	6	still	still	RB
cord-284008-vlwdtjbe	144	7	no	no	DT
cord-284008-vlwdtjbe	144	8	very	very	RB
cord-284008-vlwdtjbe	144	9	encouraging	encouraging	JJ
cord-284008-vlwdtjbe	144	10	results	result	NNS
cord-284008-vlwdtjbe	144	11	about	about	IN
cord-284008-vlwdtjbe	144	12	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	144	13	therapy	therapy	NN
cord-284008-vlwdtjbe	144	14	for	for	IN
cord-284008-vlwdtjbe	144	15	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	144	16	.	.	.
cord-284008-vlwdtjbe	145	1	However	however	RB
cord-284008-vlwdtjbe	145	2	,	,	,
cord-284008-vlwdtjbe	145	3	it	-PRON-	PRP
cord-284008-vlwdtjbe	145	4	is	be	VBZ
cord-284008-vlwdtjbe	145	5	difficult	difficult	JJ
cord-284008-vlwdtjbe	145	6	to	to	TO
cord-284008-vlwdtjbe	145	7	neglect	neglect	VB
cord-284008-vlwdtjbe	145	8	that	that	IN
cord-284008-vlwdtjbe	145	9	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	145	10	may	may	MD
cord-284008-vlwdtjbe	145	11	have	have	VB
cord-284008-vlwdtjbe	145	12	a	a	DT
cord-284008-vlwdtjbe	145	13	potential	potential	JJ
cord-284008-vlwdtjbe	145	14	role	role	NN
cord-284008-vlwdtjbe	145	15	in	in	IN
cord-284008-vlwdtjbe	145	16	the	the	DT
cord-284008-vlwdtjbe	145	17	treatment	treatment	NN
cord-284008-vlwdtjbe	145	18	of	of	IN
cord-284008-vlwdtjbe	145	19	patients	patient	NNS
cord-284008-vlwdtjbe	145	20	with	with	IN
cord-284008-vlwdtjbe	145	21	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	145	22	.	.	.
cord-284008-vlwdtjbe	146	1	Everything	everything	NN
cord-284008-vlwdtjbe	146	2	is	be	VBZ
cord-284008-vlwdtjbe	146	3	inconclusive	inconclusive	JJ
cord-284008-vlwdtjbe	146	4	and	and	CC
cord-284008-vlwdtjbe	146	5	we	-PRON-	PRP
cord-284008-vlwdtjbe	146	6	should	should	MD
cord-284008-vlwdtjbe	146	7	remain	remain	VB
cord-284008-vlwdtjbe	146	8	optimistic	optimistic	JJ
cord-284008-vlwdtjbe	146	9	.	.	.
cord-284008-vlwdtjbe	147	1	It	-PRON-	PRP
cord-284008-vlwdtjbe	147	2	is	be	VBZ
cord-284008-vlwdtjbe	147	3	necessary	necessary	JJ
cord-284008-vlwdtjbe	147	4	to	to	TO
cord-284008-vlwdtjbe	147	5	strictly	strictly	RB
cord-284008-vlwdtjbe	147	6	abide	abide	VB
cord-284008-vlwdtjbe	147	7	by	by	IN
cord-284008-vlwdtjbe	147	8	experts	expert	NNS
cord-284008-vlwdtjbe	147	9	'	'	POS
cord-284008-vlwdtjbe	147	10	advice	advice	NN
cord-284008-vlwdtjbe	147	11	and	and	CC
cord-284008-vlwdtjbe	147	12	start	start	VB
cord-284008-vlwdtjbe	147	13	or	or	CC
cord-284008-vlwdtjbe	147	14	stop	stop	VB
cord-284008-vlwdtjbe	147	15	the	the	DT
cord-284008-vlwdtjbe	147	16	use	use	NN
cord-284008-vlwdtjbe	147	17	of	of	IN
cord-284008-vlwdtjbe	147	18	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	147	19	in	in	IN
cord-284008-vlwdtjbe	147	20	a	a	DT
cord-284008-vlwdtjbe	147	21	flexible	flexible	JJ
cord-284008-vlwdtjbe	147	22	and	and	CC
cord-284008-vlwdtjbe	147	23	timely	timely	JJ
cord-284008-vlwdtjbe	147	24	manner	manner	NN
cord-284008-vlwdtjbe	147	25	when	when	WRB
cord-284008-vlwdtjbe	147	26	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	147	27	are	be	VBP
cord-284008-vlwdtjbe	147	28	used	use	VBN
cord-284008-vlwdtjbe	147	29	in	in	IN
cord-284008-vlwdtjbe	147	30	the	the	DT
cord-284008-vlwdtjbe	147	31	lack	lack	NN
cord-284008-vlwdtjbe	147	32	of	of	IN
cord-284008-vlwdtjbe	147	33	highquality	highquality	JJ
cord-284008-vlwdtjbe	147	34	clinical	clinical	JJ
cord-284008-vlwdtjbe	147	35	trials	trial	NNS
cord-284008-vlwdtjbe	147	36	that	that	WDT
cord-284008-vlwdtjbe	147	37	can	can	MD
cord-284008-vlwdtjbe	147	38	provide	provide	VB
cord-284008-vlwdtjbe	147	39	more	more	RBR
cord-284008-vlwdtjbe	147	40	precise	precise	JJ
cord-284008-vlwdtjbe	147	41	guidance	guidance	NN
cord-284008-vlwdtjbe	147	42	for	for	IN
cord-284008-vlwdtjbe	147	43	clinicians	clinician	NNS
cord-284008-vlwdtjbe	147	44	'	'	POS
cord-284008-vlwdtjbe	147	45	work	work	NN
cord-284008-vlwdtjbe	147	46	.	.	.
cord-284008-vlwdtjbe	148	1	This	this	DT
cord-284008-vlwdtjbe	148	2	study	study	NN
cord-284008-vlwdtjbe	148	3	was	be	VBD
cord-284008-vlwdtjbe	148	4	supported	support	VBN
cord-284008-vlwdtjbe	148	5	by	by	IN
cord-284008-vlwdtjbe	148	6	Key	Key	NNP
cord-284008-vlwdtjbe	148	7	Research	Research	NNP
cord-284008-vlwdtjbe	148	8	of	of	IN
cord-284008-vlwdtjbe	148	9	Shanghai	Shanghai	NNP
cord-284008-vlwdtjbe	148	10	Fifth	Fifth	NNP
cord-284008-vlwdtjbe	148	11	People	People	NNPS
cord-284008-vlwdtjbe	148	12	's	's	POS
cord-284008-vlwdtjbe	148	13	Hospital	Hospital	NNP
cord-284008-vlwdtjbe	148	14	(	(	-LRB-
cord-284008-vlwdtjbe	148	15	2019WYZD03	2019wyzd03	CD
cord-284008-vlwdtjbe	148	16	)	)	-RRB-
cord-284008-vlwdtjbe	148	17	.	.	.
cord-284008-vlwdtjbe	149	1	WHO	who	WP
cord-284008-vlwdtjbe	149	2	.	.	.
cord-284008-vlwdtjbe	150	1	Coronavirus	Coronavirus	NNP
cord-284008-vlwdtjbe	150	2	disease	disease	NN
cord-284008-vlwdtjbe	150	3	2019	2019	CD
cord-284008-vlwdtjbe	150	4	(	(	-LRB-
cord-284008-vlwdtjbe	150	5	COVID-19	covid-19	NN
cord-284008-vlwdtjbe	150	6	)	)	-RRB-
cord-284008-vlwdtjbe	151	1	Situation	situation	NN
cord-284008-vlwdtjbe	151	2	Report-86	report-86	XX
cord-284008-vlwdtjbe	151	3	.	.	.
cord-284008-vlwdtjbe	152	1	Available	available	JJ
cord-284008-vlwdtjbe	152	2	at	at	IN
cord-284008-vlwdtjbe	152	3	Emerging	emerge	VBG
cord-284008-vlwdtjbe	152	4	coronaviruses	coronaviruse	NNS
cord-284008-vlwdtjbe	152	5	:	:	:
cord-284008-vlwdtjbe	153	1	Genome	genome	NN
cord-284008-vlwdtjbe	153	2	structure	structure	NN
cord-284008-vlwdtjbe	153	3	,	,	,
cord-284008-vlwdtjbe	153	4	replication	replication	NN
cord-284008-vlwdtjbe	153	5	,	,	,
cord-284008-vlwdtjbe	153	6	and	and	CC
cord-284008-vlwdtjbe	153	7	pathogenesis	pathogenesis	NN
cord-284008-vlwdtjbe	154	1	The	the	DT
cord-284008-vlwdtjbe	154	2	continuing	continue	VBG
cord-284008-vlwdtjbe	154	3	2019-nCoV	2019-ncov	CD
cord-284008-vlwdtjbe	154	4	epidemic	epidemic	NN
cord-284008-vlwdtjbe	154	5	threat	threat	NN
cord-284008-vlwdtjbe	154	6	of	of	IN
cord-284008-vlwdtjbe	154	7	novel	novel	JJ
cord-284008-vlwdtjbe	154	8	coronaviruses	coronaviruse	NNS
cord-284008-vlwdtjbe	154	9	to	to	IN
cord-284008-vlwdtjbe	154	10	global	global	JJ
cord-284008-vlwdtjbe	154	11	health	health	NN
cord-284008-vlwdtjbe	154	12	-	-	,
cord-284008-vlwdtjbe	154	13	The	the	DT
cord-284008-vlwdtjbe	154	14	latest	late	JJS
cord-284008-vlwdtjbe	154	15	2019	2019	CD
cord-284008-vlwdtjbe	154	16	novel	novel	JJ
cord-284008-vlwdtjbe	154	17	coronavirus	coronavirus	NN
cord-284008-vlwdtjbe	154	18	outbreak	outbreak	NN
cord-284008-vlwdtjbe	154	19	in	in	IN
cord-284008-vlwdtjbe	154	20	Wuhan	Wuhan	NNP
cord-284008-vlwdtjbe	154	21	,	,	,
cord-284008-vlwdtjbe	155	1	China	China	NNP
cord-284008-vlwdtjbe	155	2	Updated	update	VBN
cord-284008-vlwdtjbe	155	3	understanding	understanding	NN
cord-284008-vlwdtjbe	155	4	of	of	IN
cord-284008-vlwdtjbe	155	5	the	the	DT
cord-284008-vlwdtjbe	155	6	outbreak	outbreak	NN
cord-284008-vlwdtjbe	155	7	of	of	IN
cord-284008-vlwdtjbe	155	8	2019	2019	CD
cord-284008-vlwdtjbe	155	9	novel	novel	JJ
cord-284008-vlwdtjbe	155	10	coronavirus	coronavirus	NN
cord-284008-vlwdtjbe	155	11	(	(	-LRB-
cord-284008-vlwdtjbe	155	12	2019-nCoV	2019-ncov	CD
cord-284008-vlwdtjbe	155	13	)	)	-RRB-
cord-284008-vlwdtjbe	155	14	in	in	IN
cord-284008-vlwdtjbe	155	15	Wuhan	Wuhan	NNP
cord-284008-vlwdtjbe	155	16	WHO	WHO	NNP
cord-284008-vlwdtjbe	155	17	.	.	.
cord-284008-vlwdtjbe	156	1	Summary	summary	NN
cord-284008-vlwdtjbe	156	2	of	of	IN
cord-284008-vlwdtjbe	156	3	probable	probable	JJ
cord-284008-vlwdtjbe	156	4	SARS	SARS	NNP
cord-284008-vlwdtjbe	156	5	cases	case	NNS
cord-284008-vlwdtjbe	156	6	with	with	IN
cord-284008-vlwdtjbe	156	7	onset	onset	NN
cord-284008-vlwdtjbe	156	8	of	of	IN
cord-284008-vlwdtjbe	156	9	illness	illness	NN
cord-284008-vlwdtjbe	156	10	from	from	IN
cord-284008-vlwdtjbe	156	11	1	1	CD
cord-284008-vlwdtjbe	156	12	Available	available	JJ
cord-284008-vlwdtjbe	156	13	at	at	IN
cord-284008-vlwdtjbe	156	14	:	:	:
cord-284008-vlwdtjbe	156	15	Accessed	access	VBN
cord-284008-vlwdtjbe	156	16	25	25	CD
cord-284008-vlwdtjbe	156	17	Clinical	clinical	JJ
cord-284008-vlwdtjbe	156	18	course	course	NN
cord-284008-vlwdtjbe	156	19	and	and	CC
cord-284008-vlwdtjbe	156	20	risk	risk	NN
cord-284008-vlwdtjbe	156	21	factors	factor	NNS
cord-284008-vlwdtjbe	156	22	for	for	IN
cord-284008-vlwdtjbe	156	23	mortality	mortality	NN
cord-284008-vlwdtjbe	156	24	of	of	IN
cord-284008-vlwdtjbe	156	25	adult	adult	NN
cord-284008-vlwdtjbe	156	26	inpatients	inpatient	NNS
cord-284008-vlwdtjbe	156	27	with	with	IN
cord-284008-vlwdtjbe	156	28	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	156	29	in	in	IN
cord-284008-vlwdtjbe	156	30	Wuhan	Wuhan	NNP
cord-284008-vlwdtjbe	156	31	,	,	,
cord-284008-vlwdtjbe	156	32	China	China	NNP
cord-284008-vlwdtjbe	156	33	:	:	:
cord-284008-vlwdtjbe	157	1	a	a	DT
cord-284008-vlwdtjbe	157	2	retrospective	retrospective	JJ
cord-284008-vlwdtjbe	157	3	cohort	cohort	NN
cord-284008-vlwdtjbe	157	4	study	study	NN
cord-284008-vlwdtjbe	157	5	Dysregulation	Dysregulation	NNP
cord-284008-vlwdtjbe	157	6	of	of	IN
cord-284008-vlwdtjbe	157	7	immune	immune	JJ
cord-284008-vlwdtjbe	157	8	response	response	NN
cord-284008-vlwdtjbe	157	9	in	in	IN
cord-284008-vlwdtjbe	157	10	patients	patient	NNS
cord-284008-vlwdtjbe	157	11	with	with	IN
cord-284008-vlwdtjbe	157	12	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	157	13	in	in	IN
cord-284008-vlwdtjbe	157	14	Wuhan	Wuhan	NNP
cord-284008-vlwdtjbe	157	15	,	,	,
cord-284008-vlwdtjbe	157	16	China	China	NNP
cord-284008-vlwdtjbe	157	17	Plasma	Plasma	NNP
cord-284008-vlwdtjbe	157	18	inflammatory	inflammatory	JJ
cord-284008-vlwdtjbe	157	19	cytokines	cytokine	NNS
cord-284008-vlwdtjbe	157	20	and	and	CC
cord-284008-vlwdtjbe	157	21	chemokines	chemokine	NNS
cord-284008-vlwdtjbe	157	22	in	in	IN
cord-284008-vlwdtjbe	157	23	severe	severe	JJ
cord-284008-vlwdtjbe	157	24	acute	acute	JJ
cord-284008-vlwdtjbe	157	25	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	157	26	syndrome	syndrome	NN
cord-284008-vlwdtjbe	157	27	Comparative	Comparative	NNP
cord-284008-vlwdtjbe	157	28	and	and	CC
cord-284008-vlwdtjbe	157	29	kinetic	kinetic	JJ
cord-284008-vlwdtjbe	157	30	analysis	analysis	NN
cord-284008-vlwdtjbe	157	31	of	of	IN
cord-284008-vlwdtjbe	157	32	viral	viral	JJ
cord-284008-vlwdtjbe	157	33	shedding	shedding	NN
cord-284008-vlwdtjbe	157	34	and	and	CC
cord-284008-vlwdtjbe	157	35	immunological	immunological	JJ
cord-284008-vlwdtjbe	157	36	responses	response	NNS
cord-284008-vlwdtjbe	157	37	in	in	IN
cord-284008-vlwdtjbe	157	38	MERS	MERS	NNP
cord-284008-vlwdtjbe	157	39	patients	patient	NNS
cord-284008-vlwdtjbe	157	40	representing	represent	VBG
cord-284008-vlwdtjbe	157	41	a	a	DT
cord-284008-vlwdtjbe	157	42	broad	broad	JJ
cord-284008-vlwdtjbe	157	43	spectrum	spectrum	NN
cord-284008-vlwdtjbe	157	44	of	of	IN
cord-284008-vlwdtjbe	157	45	disease	disease	NN
cord-284008-vlwdtjbe	157	46	severity	severity	NN
cord-284008-vlwdtjbe	157	47	Epidemiological	epidemiological	JJ
cord-284008-vlwdtjbe	157	48	and	and	CC
cord-284008-vlwdtjbe	157	49	clinical	clinical	JJ
cord-284008-vlwdtjbe	157	50	characteristics	characteristic	NNS
cord-284008-vlwdtjbe	157	51	of	of	IN
cord-284008-vlwdtjbe	157	52	99	99	CD
cord-284008-vlwdtjbe	157	53	cases	case	NNS
cord-284008-vlwdtjbe	157	54	of	of	IN
cord-284008-vlwdtjbe	157	55	2019	2019	CD
cord-284008-vlwdtjbe	157	56	novel	novel	JJ
cord-284008-vlwdtjbe	157	57	coronavirus	coronavirus	NN
cord-284008-vlwdtjbe	157	58	pneumonia	pneumonia	NN
cord-284008-vlwdtjbe	157	59	in	in	IN
cord-284008-vlwdtjbe	157	60	Wuhan	Wuhan	NNP
cord-284008-vlwdtjbe	157	61	,	,	,
cord-284008-vlwdtjbe	157	62	China	China	NNP
cord-284008-vlwdtjbe	157	63	:	:	:
cord-284008-vlwdtjbe	157	64	a	a	DT
cord-284008-vlwdtjbe	157	65	descriptive	descriptive	JJ
cord-284008-vlwdtjbe	157	66	study	study	NN
cord-284008-vlwdtjbe	157	67	Longitudinal	longitudinal	JJ
cord-284008-vlwdtjbe	157	68	characteristics	characteristic	NNS
cord-284008-vlwdtjbe	157	69	of	of	IN
cord-284008-vlwdtjbe	157	70	lymphocyte	lymphocyte	NN
cord-284008-vlwdtjbe	157	71	responses	response	NNS
cord-284008-vlwdtjbe	157	72	and	and	CC
cord-284008-vlwdtjbe	157	73	cytokine	cytokine	NN
cord-284008-vlwdtjbe	157	74	profiles	profile	NNS
cord-284008-vlwdtjbe	157	75	in	in	IN
cord-284008-vlwdtjbe	157	76	the	the	DT
cord-284008-vlwdtjbe	157	77	peripheral	peripheral	JJ
cord-284008-vlwdtjbe	157	78	blood	blood	NN
cord-284008-vlwdtjbe	157	79	of	of	IN
cord-284008-vlwdtjbe	157	80	SARS	SARS	NNP
cord-284008-vlwdtjbe	157	81	-	-	HYPH
cord-284008-vlwdtjbe	157	82	CoV-2	CoV-2	NNP
cord-284008-vlwdtjbe	157	83	infected	infect	VBN
cord-284008-vlwdtjbe	157	84	patients	patient	NNS
cord-284008-vlwdtjbe	157	85	Characteristics	characteristic	NNS
cord-284008-vlwdtjbe	157	86	of	of	IN
cord-284008-vlwdtjbe	157	87	lymphocyte	lymphocyte	NN
cord-284008-vlwdtjbe	157	88	subsets	subset	NNS
cord-284008-vlwdtjbe	157	89	and	and	CC
cord-284008-vlwdtjbe	157	90	cytokines	cytokine	NNS
cord-284008-vlwdtjbe	157	91	in	in	IN
cord-284008-vlwdtjbe	157	92	peripheral	peripheral	JJ
cord-284008-vlwdtjbe	157	93	blood	blood	NN
cord-284008-vlwdtjbe	157	94	of	of	IN
cord-284008-vlwdtjbe	157	95	123	123	CD
cord-284008-vlwdtjbe	157	96	hospitalized	hospitalize	VBN
cord-284008-vlwdtjbe	157	97	patients	patient	NNS
cord-284008-vlwdtjbe	157	98	with	with	IN
cord-284008-vlwdtjbe	157	99	2019	2019	CD
cord-284008-vlwdtjbe	157	100	novel	novel	JJ
cord-284008-vlwdtjbe	157	101	coronavirus	coronavirus	NN
cord-284008-vlwdtjbe	157	102	pneumonia	pneumonia	NN
cord-284008-vlwdtjbe	157	103	(	(	-LRB-
cord-284008-vlwdtjbe	157	104	NCP	NCP	NNP
cord-284008-vlwdtjbe	157	105	)	)	-RRB-
cord-284008-vlwdtjbe	158	1	The	the	DT
cord-284008-vlwdtjbe	158	2	use	use	NN
cord-284008-vlwdtjbe	158	3	of	of	IN
cord-284008-vlwdtjbe	158	4	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	158	5	as	as	IN
cord-284008-vlwdtjbe	158	6	treatment	treatment	NN
cord-284008-vlwdtjbe	158	7	in	in	IN
cord-284008-vlwdtjbe	158	8	SARS	SARS	NNP
cord-284008-vlwdtjbe	158	9	was	be	VBD
cord-284008-vlwdtjbe	158	10	associated	associate	VBN
cord-284008-vlwdtjbe	158	11	with	with	IN
cord-284008-vlwdtjbe	158	12	adverse	adverse	JJ
cord-284008-vlwdtjbe	158	13	outcomes	outcome	NNS
cord-284008-vlwdtjbe	158	14	:	:	:
cord-284008-vlwdtjbe	158	15	a	a	DT
cord-284008-vlwdtjbe	158	16	retrospective	retrospective	JJ
cord-284008-vlwdtjbe	158	17	cohort	cohort	NN
cord-284008-vlwdtjbe	158	18	study	study	NN
cord-284008-vlwdtjbe	158	19	SARS	SARS	NNP
cord-284008-vlwdtjbe	158	20	:	:	:
cord-284008-vlwdtjbe	158	21	systematic	systematic	JJ
cord-284008-vlwdtjbe	158	22	review	review	NN
cord-284008-vlwdtjbe	158	23	of	of	IN
cord-284008-vlwdtjbe	158	24	treatment	treatment	NN
cord-284008-vlwdtjbe	158	25	effects	effect	NNS
cord-284008-vlwdtjbe	158	26	Steroid	Steroid	NNP
cord-284008-vlwdtjbe	158	27	therapy	therapy	NN
cord-284008-vlwdtjbe	158	28	and	and	CC
cord-284008-vlwdtjbe	158	29	the	the	DT
cord-284008-vlwdtjbe	158	30	risk	risk	NN
cord-284008-vlwdtjbe	158	31	of	of	IN
cord-284008-vlwdtjbe	158	32	osteonecrosis	osteonecrosis	NN
cord-284008-vlwdtjbe	158	33	in	in	IN
cord-284008-vlwdtjbe	158	34	SARS	SARS	NNP
cord-284008-vlwdtjbe	158	35	patients	patient	NNS
cord-284008-vlwdtjbe	158	36	:	:	:
cord-284008-vlwdtjbe	158	37	a	a	DT
cord-284008-vlwdtjbe	158	38	dose	dose	JJ
cord-284008-vlwdtjbe	158	39	-	-	HYPH
cord-284008-vlwdtjbe	158	40	response	response	NN
cord-284008-vlwdtjbe	158	41	meta	meta	NN
cord-284008-vlwdtjbe	158	42	-	-	HYPH
cord-284008-vlwdtjbe	158	43	analysis	analysis	NN
cord-284008-vlwdtjbe	158	44	Treatment	treatment	NN
cord-284008-vlwdtjbe	158	45	of	of	IN
cord-284008-vlwdtjbe	158	46	severe	severe	JJ
cord-284008-vlwdtjbe	158	47	acute	acute	JJ
cord-284008-vlwdtjbe	158	48	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	158	49	syndrome	syndrome	NN
cord-284008-vlwdtjbe	158	50	with	with	IN
cord-284008-vlwdtjbe	158	51	glucosteroids	glucosteroid	NNS
cord-284008-vlwdtjbe	158	52	:	:	:
cord-284008-vlwdtjbe	159	1	the	the	DT
cord-284008-vlwdtjbe	159	2	Guangzhou	Guangzhou	NNP
cord-284008-vlwdtjbe	159	3	experience	experience	NN
cord-284008-vlwdtjbe	159	4	Corticosteroid	Corticosteroid	NNP
cord-284008-vlwdtjbe	159	5	Therapy	Therapy	NNP
cord-284008-vlwdtjbe	159	6	for	for	IN
cord-284008-vlwdtjbe	159	7	Critically	Critically	NNP
cord-284008-vlwdtjbe	159	8	Ill	Ill	NNP
cord-284008-vlwdtjbe	159	9	Patients	patient	NNS
cord-284008-vlwdtjbe	159	10	with	with	IN
cord-284008-vlwdtjbe	159	11	Middle	Middle	NNP
cord-284008-vlwdtjbe	159	12	East	East	NNP
cord-284008-vlwdtjbe	159	13	Respiratory	Respiratory	NNP
cord-284008-vlwdtjbe	159	14	Syndrome	Syndrome	NNP
cord-284008-vlwdtjbe	159	15	Clinical	clinical	JJ
cord-284008-vlwdtjbe	159	16	predictors	predictor	NNS
cord-284008-vlwdtjbe	159	17	of	of	IN
cord-284008-vlwdtjbe	159	18	mortality	mortality	NN
cord-284008-vlwdtjbe	159	19	of	of	IN
cord-284008-vlwdtjbe	159	20	Middle	Middle	NNP
cord-284008-vlwdtjbe	159	21	East	East	NNP
cord-284008-vlwdtjbe	159	22	Respiratory	Respiratory	NNP
cord-284008-vlwdtjbe	159	23	Syndrome	Syndrome	NNP
cord-284008-vlwdtjbe	159	24	Coronavirus	Coronavirus	NNP
cord-284008-vlwdtjbe	159	25	(	(	-LRB-
cord-284008-vlwdtjbe	159	26	MERS	MERS	NNP
cord-284008-vlwdtjbe	159	27	-	-	HYPH
cord-284008-vlwdtjbe	159	28	CoV	CoV	NNP
cord-284008-vlwdtjbe	159	29	)	)	-RRB-
cord-284008-vlwdtjbe	159	30	infection	infection	NN
cord-284008-vlwdtjbe	159	31	:	:	:
cord-284008-vlwdtjbe	160	1	A	a	DT
cord-284008-vlwdtjbe	160	2	cohort	cohort	NN
cord-284008-vlwdtjbe	160	3	study	study	NN
cord-284008-vlwdtjbe	160	4	Corticosteroids	Corticosteroids	NNPS
cord-284008-vlwdtjbe	160	5	as	as	IN
cord-284008-vlwdtjbe	160	6	Adjunctive	Adjunctive	NNP
cord-284008-vlwdtjbe	160	7	Therapy	Therapy	NNP
cord-284008-vlwdtjbe	160	8	in	in	IN
cord-284008-vlwdtjbe	160	9	the	the	DT
cord-284008-vlwdtjbe	160	10	Treatment	Treatment	NNP
cord-284008-vlwdtjbe	160	11	of	of	IN
cord-284008-vlwdtjbe	160	12	Influenza	Influenza	NNP
cord-284008-vlwdtjbe	160	13	:	:	:
cord-284008-vlwdtjbe	161	1	An	an	DT
cord-284008-vlwdtjbe	161	2	Updated	update	VBN
cord-284008-vlwdtjbe	161	3	Cochrane	Cochrane	NNP
cord-284008-vlwdtjbe	161	4	Systematic	Systematic	NNP
cord-284008-vlwdtjbe	161	5	Review	Review	NNP
cord-284008-vlwdtjbe	161	6	and	and	CC
cord-284008-vlwdtjbe	161	7	Meta	Meta	NNP
cord-284008-vlwdtjbe	161	8	-	-	HYPH
cord-284008-vlwdtjbe	161	9	analysis	analysis	NN
cord-284008-vlwdtjbe	161	10	Effect	effect	NN
cord-284008-vlwdtjbe	161	11	of	of	IN
cord-284008-vlwdtjbe	161	12	low	low	JJ
cord-284008-vlwdtjbe	161	13	-	-	HYPH
cord-284008-vlwdtjbe	161	14	tomoderate	tomoderate	NN
cord-284008-vlwdtjbe	161	15	-	-	HYPH
cord-284008-vlwdtjbe	161	16	dose	dose	NN
cord-284008-vlwdtjbe	161	17	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	161	18	on	on	IN
cord-284008-vlwdtjbe	161	19	mortality	mortality	NN
cord-284008-vlwdtjbe	161	20	of	of	IN
cord-284008-vlwdtjbe	161	21	hospitalized	hospitalize	VBN
cord-284008-vlwdtjbe	161	22	adolescents	adolescent	NNS
cord-284008-vlwdtjbe	161	23	and	and	CC
cord-284008-vlwdtjbe	161	24	adults	adult	NNS
cord-284008-vlwdtjbe	161	25	with	with	IN
cord-284008-vlwdtjbe	161	26	influenza	influenza	NN
cord-284008-vlwdtjbe	161	27	A(H1N1)pdm09	a(h1n1)pdm09	IN
cord-284008-vlwdtjbe	161	28	viral	viral	JJ
cord-284008-vlwdtjbe	161	29	pneumonia	pneumonia	NN
cord-284008-vlwdtjbe	161	30	Adjuvant	Adjuvant	NNP
cord-284008-vlwdtjbe	161	31	Corticosteroid	Corticosteroid	NNP
cord-284008-vlwdtjbe	161	32	Treatment	Treatment	NNP
cord-284008-vlwdtjbe	161	33	in	in	IN
cord-284008-vlwdtjbe	161	34	Adults	Adults	NNPS
cord-284008-vlwdtjbe	162	1	With	with	IN
cord-284008-vlwdtjbe	162	2	Influenza	Influenza	NNP
cord-284008-vlwdtjbe	162	3	A	A	NNP
cord-284008-vlwdtjbe	162	4	(	(	-LRB-
cord-284008-vlwdtjbe	162	5	H7N9	H7N9	NNP
cord-284008-vlwdtjbe	162	6	)	)	-RRB-
cord-284008-vlwdtjbe	163	1	Viral	Viral	NNP
cord-284008-vlwdtjbe	163	2	Pneumonia	Pneumonia	NNP
cord-284008-vlwdtjbe	163	3	Clinical	clinical	JJ
cord-284008-vlwdtjbe	163	4	evidence	evidence	NN
cord-284008-vlwdtjbe	163	5	does	do	VBZ
cord-284008-vlwdtjbe	163	6	not	not	RB
cord-284008-vlwdtjbe	163	7	support	support	VB
cord-284008-vlwdtjbe	163	8	corticosteroid	corticosteroid	NN
cord-284008-vlwdtjbe	163	9	treatment	treatment	NN
cord-284008-vlwdtjbe	163	10	for	for	IN
cord-284008-vlwdtjbe	163	11	2019-nCoV	2019-ncov	CD
cord-284008-vlwdtjbe	163	12	lung	lung	NN
cord-284008-vlwdtjbe	163	13	injury	injury	NN
cord-284008-vlwdtjbe	164	1	Pathological	pathological	JJ
cord-284008-vlwdtjbe	164	2	findings	finding	NNS
cord-284008-vlwdtjbe	164	3	of	of	IN
cord-284008-vlwdtjbe	164	4	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	164	5	associated	associate	VBN
cord-284008-vlwdtjbe	164	6	with	with	IN
cord-284008-vlwdtjbe	164	7	acute	acute	JJ
cord-284008-vlwdtjbe	164	8	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	164	9	distress	distress	NN
cord-284008-vlwdtjbe	164	10	syndrome	syndrome	NN
cord-284008-vlwdtjbe	164	11	Clinical	clinical	JJ
cord-284008-vlwdtjbe	164	12	features	feature	NNS
cord-284008-vlwdtjbe	164	13	and	and	CC
cord-284008-vlwdtjbe	164	14	progression	progression	NN
cord-284008-vlwdtjbe	164	15	of	of	IN
cord-284008-vlwdtjbe	164	16	acute	acute	JJ
cord-284008-vlwdtjbe	164	17	respiratory	respiratory	JJ
cord-284008-vlwdtjbe	164	18	distress	distress	NN
cord-284008-vlwdtjbe	164	19	syndrome	syndrome	NN
cord-284008-vlwdtjbe	164	20	in	in	IN
cord-284008-vlwdtjbe	164	21	coronavirus	coronavirus	NN
cord-284008-vlwdtjbe	164	22	disease	disease	NN
cord-284008-vlwdtjbe	164	23	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	164	24	with	with	IN
cord-284008-vlwdtjbe	164	25	Different	different	JJ
cord-284008-vlwdtjbe	164	26	Severity	severity	NN
cord-284008-vlwdtjbe	164	27	:	:	:
cord-284008-vlwdtjbe	164	28	A	a	DT
cord-284008-vlwdtjbe	164	29	Multi	multi	JJ
cord-284008-vlwdtjbe	164	30	-	-	JJ
cord-284008-vlwdtjbe	164	31	center	center	JJ
cord-284008-vlwdtjbe	164	32	Study	Study	NNP
cord-284008-vlwdtjbe	164	33	of	of	IN
cord-284008-vlwdtjbe	164	34	Clinical	Clinical	NNP
cord-284008-vlwdtjbe	164	35	Features	feature	NNS
cord-284008-vlwdtjbe	165	1	The	the	DT
cord-284008-vlwdtjbe	165	2	Treatment	Treatment	NNP
cord-284008-vlwdtjbe	165	3	and	and	CC
cord-284008-vlwdtjbe	165	4	Outcomes	Outcomes	NNPS
cord-284008-vlwdtjbe	165	5	of	of	IN
cord-284008-vlwdtjbe	165	6	Patients	Patients	NNPS
cord-284008-vlwdtjbe	165	7	with	with	IN
cord-284008-vlwdtjbe	165	8	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	165	9	in	in	IN
cord-284008-vlwdtjbe	165	10	Hubei	Hubei	NNP
cord-284008-vlwdtjbe	165	11	,	,	,
cord-284008-vlwdtjbe	165	12	China	China	NNP
cord-284008-vlwdtjbe	165	13	:	:	:
cord-284008-vlwdtjbe	165	14	A	a	DT
cord-284008-vlwdtjbe	165	15	Multi	Multi	NNP
cord-284008-vlwdtjbe	165	16	-	-	HYPH
cord-284008-vlwdtjbe	165	17	Centered	centered	JJ
cord-284008-vlwdtjbe	165	18	,	,	,
cord-284008-vlwdtjbe	165	19	Retrospective	Retrospective	NNP
cord-284008-vlwdtjbe	165	20	,	,	,
cord-284008-vlwdtjbe	165	21	Observational	Observational	NNP
cord-284008-vlwdtjbe	165	22	Study	Study	NNP
cord-284008-vlwdtjbe	165	23	(	(	-LRB-
cord-284008-vlwdtjbe	165	24	2/26/2020	2/26/2020	CD
cord-284008-vlwdtjbe	165	25	)	)	-RRB-
cord-284008-vlwdtjbe	166	1	Potential	potential	JJ
cord-284008-vlwdtjbe	166	2	benefits	benefit	NNS
cord-284008-vlwdtjbe	166	3	of	of	IN
cord-284008-vlwdtjbe	166	4	precise	precise	JJ
cord-284008-vlwdtjbe	166	5	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	166	6	therapy	therapy	NN
cord-284008-vlwdtjbe	166	7	for	for	IN
cord-284008-vlwdtjbe	166	8	severe	severe	JJ
cord-284008-vlwdtjbe	166	9	2019-nCoV	2019-ncov	CD
cord-284008-vlwdtjbe	166	10	pneumonia	pneumonia	NN
cord-284008-vlwdtjbe	166	11	Risk	risk	NN
cord-284008-vlwdtjbe	166	12	Factors	factor	NNS
cord-284008-vlwdtjbe	166	13	Associated	associate	VBN
cord-284008-vlwdtjbe	166	14	With	with	IN
cord-284008-vlwdtjbe	166	15	Acute	acute	JJ
cord-284008-vlwdtjbe	166	16	Respiratory	respiratory	JJ
cord-284008-vlwdtjbe	166	17	Distress	Distress	NNP
cord-284008-vlwdtjbe	166	18	Syndrome	Syndrome	NNP
cord-284008-vlwdtjbe	166	19	and	and	CC
cord-284008-vlwdtjbe	166	20	Death	death	NN
cord-284008-vlwdtjbe	166	21	in	in	IN
cord-284008-vlwdtjbe	166	22	Patients	Patients	NNP
cord-284008-vlwdtjbe	166	23	With	with	IN
cord-284008-vlwdtjbe	166	24	Coronavirus	Coronavirus	NNP
cord-284008-vlwdtjbe	166	25	Disease	Disease	NNP
cord-284008-vlwdtjbe	167	1	Short	short	JJ
cord-284008-vlwdtjbe	167	2	-	-	HYPH
cord-284008-vlwdtjbe	167	3	Term	Term	NNP
cord-284008-vlwdtjbe	167	4	Moderate	moderate	JJ
cord-284008-vlwdtjbe	167	5	-	-	HYPH
cord-284008-vlwdtjbe	167	6	Dose	dose	NN
cord-284008-vlwdtjbe	167	7	Corticosteroid	Corticosteroid	NNP
cord-284008-vlwdtjbe	168	1	Plus	plus	CC
cord-284008-vlwdtjbe	168	2	Immunoglobulin	Immunoglobulin	NNP
cord-284008-vlwdtjbe	168	3	Effectively	effectively	RB
cord-284008-vlwdtjbe	168	4	Reverses	reverse	VBZ
cord-284008-vlwdtjbe	168	5	COVID-19	covid-19	CD
cord-284008-vlwdtjbe	168	6	Patients	patient	NNS
cord-284008-vlwdtjbe	168	7	Who	who	WP
cord-284008-vlwdtjbe	168	8	Have	have	VBP
cord-284008-vlwdtjbe	168	9	Failed	fail	VBN
cord-284008-vlwdtjbe	168	10	Low	Low	NNP
cord-284008-vlwdtjbe	168	11	-	-	HYPH
cord-284008-vlwdtjbe	168	12	Dose	dose	NN
cord-284008-vlwdtjbe	168	13	Therapy	therapy	NN
cord-284008-vlwdtjbe	168	14	On	on	IN
cord-284008-vlwdtjbe	168	15	the	the	DT
cord-284008-vlwdtjbe	168	16	use	use	NN
cord-284008-vlwdtjbe	168	17	of	of	IN
cord-284008-vlwdtjbe	168	18	corticosteroids	corticosteroid	NNS
cord-284008-vlwdtjbe	168	19	for	for	IN
cord-284008-vlwdtjbe	168	20	2019-nCoV	2019-ncov	CD
cord-284008-vlwdtjbe	168	21	pneumonia	pneumonia	NN
cord-284008-vlwdtjbe	168	22	Clinical	Clinical	NNP
cord-284008-vlwdtjbe	168	23	Characteristics	Characteristics	NNPS
cord-284008-vlwdtjbe	168	24	of	of	IN
cord-284008-vlwdtjbe	168	25	Coronavirus	Coronavirus	NNP
cord-284008-vlwdtjbe	168	26	Disease	Disease	NNP
cord-284008-vlwdtjbe	168	27	2019	2019	CD
cord-284008-vlwdtjbe	168	28	in	in	IN
cord-284008-vlwdtjbe	168	29	China	China	NNP
cord-284008-vlwdtjbe	168	30	Shanghai	Shanghai	NNP
cord-284008-vlwdtjbe	168	31	Clinical	Clinical	NNP
cord-284008-vlwdtjbe	168	32	Treatment	Treatment	NNP
cord-284008-vlwdtjbe	168	33	Expert	Expert	NNP
cord-284008-vlwdtjbe	168	34	Group	Group	NNP
cord-284008-vlwdtjbe	168	35	for	for	IN
cord-284008-vlwdtjbe	168	36	corona	corona	NNP
cord-284008-vlwdtjbe	168	37	virus	virus	NN
cord-284008-vlwdtjbe	168	38	disease	disease	NNP
cord-284008-vlwdtjbe	168	39	2019	2019	CD
cord-284008-vlwdtjbe	168	40	.	.	.
cord-284008-vlwdtjbe	169	1	[	[	-LRB-
cord-284008-vlwdtjbe	169	2	Comprehensive	comprehensive	JJ
cord-284008-vlwdtjbe	169	3	treatment	treatment	NN
cord-284008-vlwdtjbe	169	4	and	and	CC
cord-284008-vlwdtjbe	169	5	management	management	NN
cord-284008-vlwdtjbe	169	6	of	of	IN
cord-284008-vlwdtjbe	169	7	corona	corona	NNP
cord-284008-vlwdtjbe	169	8	virus	virus	NN
cord-284008-vlwdtjbe	169	9	disease	disease	NNP
cord-284008-vlwdtjbe	169	10	2019	2019	CD
cord-284008-vlwdtjbe	169	11	:	:	:
cord-284008-vlwdtjbe	169	12	expert	expert	JJ
cord-284008-vlwdtjbe	169	13	consensus	consensus	NN
cord-284008-vlwdtjbe	169	14	statement	statement	NN
cord-284008-vlwdtjbe	169	15	from	from	IN
cord-284008-vlwdtjbe	169	16	Shanghai	Shanghai	NNP
cord-284008-vlwdtjbe	169	17	National	National	NNP
cord-284008-vlwdtjbe	169	18	Health	Health	NNP
cord-284008-vlwdtjbe	169	19	Commission	Commission	NNP
cord-284008-vlwdtjbe	169	20	of	of	IN
cord-284008-vlwdtjbe	169	21	the	the	DT
cord-284008-vlwdtjbe	169	22	People	People	NNPS
cord-284008-vlwdtjbe	169	23	's	's	POS
cord-284008-vlwdtjbe	169	24	Republic	Republic	NNP
cord-284008-vlwdtjbe	169	25	of	of	IN
cord-284008-vlwdtjbe	169	26	China	China	NNP
cord-284008-vlwdtjbe	169	27	.	.	.
cord-284008-vlwdtjbe	170	1	Guideline	guideline	NN
cord-284008-vlwdtjbe	170	2	for	for	IN
cord-284008-vlwdtjbe	170	3	the	the	DT
cord-284008-vlwdtjbe	170	4	diagnosis	diagnosis	NN
cord-284008-vlwdtjbe	170	5	and	and	CC
cord-284008-vlwdtjbe	170	6	treatment	treatment	NN
cord-284008-vlwdtjbe	170	7	of	of	IN
cord-284008-vlwdtjbe	170	8	COVID-19	COVID-19	NNP
cord-284008-vlwdtjbe	170	9	infections	infection	NNS
cord-284008-vlwdtjbe	170	10	None	None	NNP
cord-284008-vlwdtjbe	170	11	declared	declare	VBD
cord-284008-vlwdtjbe	170	12	.	.	.